<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang xml:lang>
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <meta name="author" content="Dr. Siddalingaiah H S, Professor, Community Medicine, SIMSRH, Tumkur" />
  <meta name="dcterms.date" content="2025-01-01" />
  <title>Comprehensive Study Design and Methods Guide: Epidemiology and Statistics</title>
  <style>

html {
font-size: 11pt;
color: #1a1a1a;
background-color: #fdfdfd;
}
body {
margin: 0 auto;
max-width: 36em;
padding-left: 50px;
padding-right: 50px;
padding-top: 50px;
padding-bottom: 50px;
hyphens: auto;
overflow-wrap: break-word;
text-rendering: optimizeLegibility;
font-kerning: normal;
}
@media (max-width: 600px) {
body {
font-size: 0.9em;
padding: 12px;
}
h1 {
font-size: 1.8em;
}
}
@media print {
html {
background-color: white;
}
body {
background-color: transparent;
color: black;
font-size: 12pt;
}
p, h2, h3 {
orphans: 3;
widows: 3;
}
h2, h3, h4 {
page-break-after: avoid;
}
}
p {
margin: 1em 0;
}
a {
color: blue;
}
a:visited {
color: blue;
}
img {
max-width: 100%;
}
svg {
height: auto;
max-width: 100%;
}
h1, h2, h3, h4, h5, h6 {
margin-top: 1.4em;
}
h5, h6 {
font-size: 1em;
font-style: italic;
}
h6 {
font-weight: normal;
}
ol, ul {
padding-left: 1.7em;
margin-top: 1em;
}
li > ol, li > ul {
margin-top: 0;
}
blockquote {
margin: 1em 0 1em 1.7em;
padding-left: 1em;
border-left: 2px solid #e6e6e6;
color: #606060;
}
code {
font-family: Menlo, Monaco, Consolas, 'Lucida Console', monospace;
font-size: 85%;
margin: 0;
hyphens: manual;
}
pre {
margin: 1em 0;
overflow: auto;
}
pre code {
padding: 0;
overflow: visible;
overflow-wrap: normal;
}
.sourceCode {
background-color: transparent;
overflow: visible;
}
hr {
border: none;
border-top: 1px solid #1a1a1a;
height: 1px;
margin: 1em 0;
}
table {
margin: 1em 0;
border-collapse: collapse;
width: 100%;
overflow-x: auto;
display: block;
font-variant-numeric: lining-nums tabular-nums;
}
table caption {
margin-bottom: 0.75em;
}
tbody {
margin-top: 0.5em;
border-top: 1px solid #1a1a1a;
border-bottom: 1px solid #1a1a1a;
}
th {
border-top: 1px solid #1a1a1a;
padding: 0.25em 0.5em 0.25em 0.5em;
}
td {
padding: 0.125em 0.5em 0.25em 0.5em;
}
header {
margin-bottom: 4em;
text-align: center;
}
#TOC li {
list-style: none;
}
#TOC ul {
padding-left: 1.3em;
}
#TOC > ul {
padding-left: 0;
}
#TOC a:not(:hover) {
text-decoration: none;
}
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}

ul.task-list[class]{list-style: none;}
ul.task-list li input[type="checkbox"] {
font-size: inherit;
width: 0.8em;
margin: 0 0.8em 0.2em -1.6em;
vertical-align: middle;
}
.display.math{display: block; text-align: center; margin: 0.5rem auto;}
</style>
</head>
<body>
<div class="title-page" style="text-align: center; margin: 150px 0; page-break-after: always; background-color: #ffffff; padding: 80px; border: 3px solid #2c3e50; box-shadow: 0 0 20px rgba(0,0,0,0.1);">
  <h1 style="font-size: 3.5em; margin-bottom: 30px; color: #2c3e50; font-weight: bold; text-shadow: 2px 2px 4px rgba(0,0,0,0.1);">Comprehensive Study Design and Methods Guide</h1>
  <h2 style="font-size: 2.2em; margin-bottom: 50px; color: #666; font-style: italic;">Epidemiology and Statistics</h2>

  <div style="margin: 60px 0; font-size: 1.4em;">
    <p style="margin-bottom: 20px; font-size: 1.1em; color: #666;"><strong>Author:</strong></p>
    <p style="font-size: 1.8em; margin-bottom: 30px; font-weight: bold; color: #2c3e50;">Dr. Siddalingaiah H S</p>
    <p style="font-size: 1.3em; margin-bottom: 20px; color: #555;">Professor, Community Medicine</p>
    <p style="font-size: 1.3em; margin-bottom: 50px; color: #555;">SIMSRH, Tumkur</p>
  </div>

  <div style="margin: 60px 0;">
    <p style="font-size: 1.4em; color: #666;"><strong>Publication Date:</strong> <span style="color: #2c3e50; font-weight: bold;">2025</span></p>
  </div>

  <div style="margin: 100px 0 60px 0; border-top: 4px solid #2c3e50; padding-top: 40px;">
    <p style="font-size: 1.3em; font-style: italic; line-height: 1.7; color: #444; max-width: 800px; margin: 0 auto;">A comprehensive guide for understanding epidemiological study designs and statistical methods in health research.</p>
  </div>
</div>

<div style="page-break-before: always;"></div>

<header id="title-block-header" style="display: none;">
<h1 class="title">Comprehensive Study Design and Methods Guide: Epidemiology and Statistics</h1>
<p class="author">Dr. Siddalingaiah H S, Professor, Community Medicine, SIMSRH, Tumkur</p>
<p class="date">2025</p>
</header>

<nav id="TOC" role="doc-toc">
<ul>
<li><a href="#comprehensive-study-design-and-methods-guide-epidemiology-and-statistics" id="toc-comprehensive-study-design-and-methods-guide-epidemiology-and-statistics"><span class="toc-section-number">1</span> Comprehensive Study Design and
Methods Guide: Epidemiology and Statistics</a>
<ul>
<li><a href="#part-i-epidemiology-study-designs" id="toc-part-i-epidemiology-study-designs"><span class="toc-section-number">1.1</span> Part I: Epidemiology Study
Designs</a></li>
</ul></li>
<li><a href="#module-1-introduction-to-epidemiological-study-designs" id="toc-module-1-introduction-to-epidemiological-study-designs"><span class="toc-section-number">2</span> Module 1: Introduction to
Epidemiological Study Designs</a>
<ul>
<li><a href="#learning-objectives" id="toc-learning-objectives"><span class="toc-section-number">2.1</span> Learning Objectives</a></li>
<li><a href="#what-is-epidemiology" id="toc-what-is-epidemiology"><span class="toc-section-number">2.2</span> What is Epidemiology?</a></li>
<li><a href="#levels-of-epidemiological-study" id="toc-levels-of-epidemiological-study"><span class="toc-section-number">2.3</span> Levels of Epidemiological
Study</a>
<ul>
<li><a href="#descriptive-epidemiology" id="toc-descriptive-epidemiology"><span class="toc-section-number">2.3.1</span> 1. Descriptive
Epidemiology</a></li>
<li><a href="#analytical-epidemiology" id="toc-analytical-epidemiology"><span class="toc-section-number">2.3.2</span> 2. Analytical
Epidemiology</a></li>
</ul></li>
<li><a href="#epidemiological-study-designs" id="toc-epidemiological-study-designs"><span class="toc-section-number">2.4</span> Epidemiological Study Designs</a>
<ul>
<li><a href="#major-categories" id="toc-major-categories"><span class="toc-section-number">2.4.1</span> Major Categories:</a></li>
</ul></li>
<li><a href="#key-principles-in-epidemiological-research" id="toc-key-principles-in-epidemiological-research"><span class="toc-section-number">2.5</span> Key Principles in Epidemiological
Research</a>
<ul>
<li><a href="#study-population" id="toc-study-population"><span class="toc-section-number">2.5.1</span> 1. Study Population</a></li>
<li><a href="#exposure-and-outcome" id="toc-exposure-and-outcome"><span class="toc-section-number">2.5.2</span> 2. Exposure and Outcome</a></li>
<li><a href="#comparison-groups" id="toc-comparison-groups"><span class="toc-section-number">2.5.3</span> 3. Comparison Groups</a></li>
<li><a href="#bias-and-confounding" id="toc-bias-and-confounding"><span class="toc-section-number">2.5.4</span> 4. Bias and Confounding</a></li>
</ul></li>
<li><a href="#establishing-causality" id="toc-establishing-causality"><span class="toc-section-number">2.6</span> Establishing Causality</a>
<ul>
<li><a href="#bradford-hill-criteria-1965" id="toc-bradford-hill-criteria-1965"><span class="toc-section-number">2.6.1</span> Bradford Hill Criteria
(1965)</a></li>
</ul></li>
<li><a href="#importance-of-study-design-selection" id="toc-importance-of-study-design-selection"><span class="toc-section-number">2.7</span> Importance of Study Design
Selection</a></li>
<li><a href="#summary" id="toc-summary"><span class="toc-section-number">2.8</span> Summary</a></li>
<li><a href="#learning-objectives-1" id="toc-learning-objectives-1"><span class="toc-section-number">2.9</span> Learning Objectives</a></li>
<li><a href="#overview-of-observational-studies" id="toc-overview-of-observational-studies"><span class="toc-section-number">2.10</span> Overview of Observational
Studies</a></li>
<li><a href="#descriptive-studies" id="toc-descriptive-studies"><span class="toc-section-number">2.11</span> 1. Descriptive Studies</a>
<ul>
<li><a href="#ecological-studies" id="toc-ecological-studies"><span class="toc-section-number">2.11.1</span> Ecological Studies</a></li>
<li><a href="#case-reports-and-case-series" id="toc-case-reports-and-case-series"><span class="toc-section-number">2.11.2</span> Case Reports and Case
Series</a></li>
</ul></li>
<li><a href="#analytical-observational-studies" id="toc-analytical-observational-studies"><span class="toc-section-number">2.12</span> 2. Analytical Observational
Studies</a>
<ul>
<li><a href="#cohort-studies" id="toc-cohort-studies"><span class="toc-section-number">2.12.1</span> Cohort Studies</a></li>
<li><a href="#case-control-studies" id="toc-case-control-studies"><span class="toc-section-number">2.12.2</span> Case-Control Studies</a></li>
<li><a href="#cross-sectional-studies" id="toc-cross-sectional-studies"><span class="toc-section-number">2.12.3</span> Cross-Sectional
Studies</a></li>
</ul></li>
<li><a href="#choosing-an-observational-study-design" id="toc-choosing-an-observational-study-design"><span class="toc-section-number">2.13</span> Choosing an Observational Study
Design</a>
<ul>
<li><a href="#factors-to-consider" id="toc-factors-to-consider"><span class="toc-section-number">2.13.1</span> Factors to Consider:</a></li>
<li><a href="#decision-framework" id="toc-decision-framework"><span class="toc-section-number">2.13.2</span> Decision Framework:</a></li>
</ul></li>
<li><a href="#summary-1" id="toc-summary-1"><span class="toc-section-number">2.14</span> Summary</a></li>
<li><a href="#learning-objectives-2" id="toc-learning-objectives-2"><span class="toc-section-number">2.15</span> Learning Objectives</a></li>
<li><a href="#overview-of-experimental-studies" id="toc-overview-of-experimental-studies"><span class="toc-section-number">2.16</span> Overview of Experimental
Studies</a></li>
<li><a href="#clinical-trials" id="toc-clinical-trials"><span class="toc-section-number">2.17</span> Clinical Trials</a>
<ul>
<li><a href="#definition-2" id="toc-definition-2"><span class="toc-section-number">2.17.1</span> Definition</a></li>
<li><a href="#phases-of-clinical-trials" id="toc-phases-of-clinical-trials"><span class="toc-section-number">2.17.2</span> Phases of Clinical
Trials</a></li>
<li><a href="#types-of-clinical-trials" id="toc-types-of-clinical-trials"><span class="toc-section-number">2.17.3</span> Types of Clinical
Trials</a></li>
<li><a href="#field-trials-and-community-trials" id="toc-field-trials-and-community-trials"><span class="toc-section-number">2.17.4</span> Field Trials and Community
Trials</a></li>
</ul></li>
<li><a href="#key-principles-of-experimental-design" id="toc-key-principles-of-experimental-design"><span class="toc-section-number">2.18</span> Key Principles of Experimental
Design</a>
<ul>
<li><a href="#randomization" id="toc-randomization"><span class="toc-section-number">2.18.1</span> 1. Randomization</a></li>
<li><a href="#blindingmasking" id="toc-blindingmasking"><span class="toc-section-number">2.18.2</span> 2. Blinding/Masking</a></li>
<li><a href="#control-groups" id="toc-control-groups"><span class="toc-section-number">2.18.3</span> 3. Control Groups</a></li>
<li><a href="#sample-size-and-power" id="toc-sample-size-and-power"><span class="toc-section-number">2.18.4</span> 4. Sample Size and
Power</a></li>
</ul></li>
<li><a href="#ethical-considerations" id="toc-ethical-considerations"><span class="toc-section-number">2.19</span> Ethical Considerations</a>
<ul>
<li><a href="#key-principles-declaration-of-helsinki" id="toc-key-principles-declaration-of-helsinki"><span class="toc-section-number">2.19.1</span> Key Principles (Declaration of
Helsinki)</a></li>
<li><a href="#informed-consent" id="toc-informed-consent"><span class="toc-section-number">2.19.2</span> Informed Consent</a></li>
<li><a href="#equipoise" id="toc-equipoise"><span class="toc-section-number">2.19.3</span> Equipoise</a></li>
<li><a href="#special-considerations" id="toc-special-considerations"><span class="toc-section-number">2.19.4</span> Special Considerations</a></li>
</ul></li>
<li><a href="#analysis-of-experimental-studies" id="toc-analysis-of-experimental-studies"><span class="toc-section-number">2.20</span> Analysis of Experimental
Studies</a>
<ul>
<li><a href="#intention-to-treat-itt-analysis" id="toc-intention-to-treat-itt-analysis"><span class="toc-section-number">2.20.1</span> Intention-to-Treat (ITT)
Analysis</a></li>
<li><a href="#per-protocol-analysis" id="toc-per-protocol-analysis"><span class="toc-section-number">2.20.2</span> Per-Protocol Analysis</a></li>
<li><a href="#measures-of-effect" id="toc-measures-of-effect"><span class="toc-section-number">2.20.3</span> Measures of Effect</a></li>
</ul></li>
<li><a href="#limitations-and-challenges" id="toc-limitations-and-challenges"><span class="toc-section-number">2.21</span> Limitations and Challenges</a>
<ul>
<li><a href="#internal-validity-threats" id="toc-internal-validity-threats"><span class="toc-section-number">2.21.1</span> Internal Validity
Threats</a></li>
<li><a href="#external-validity" id="toc-external-validity"><span class="toc-section-number">2.21.2</span> External Validity</a></li>
<li><a href="#practical-challenges" id="toc-practical-challenges"><span class="toc-section-number">2.21.3</span> Practical Challenges</a></li>
</ul></li>
<li><a href="#summary-2" id="toc-summary-2"><span class="toc-section-number">2.22</span> Summary</a></li>
<li><a href="#learning-objectives-3" id="toc-learning-objectives-3"><span class="toc-section-number">2.23</span> Learning Objectives</a></li>
<li><a href="#what-is-bias" id="toc-what-is-bias"><span class="toc-section-number">2.24</span> What is Bias?</a></li>
<li><a href="#classification-of-bias" id="toc-classification-of-bias"><span class="toc-section-number">2.25</span> Classification of Bias</a>
<ul>
<li><a href="#selection-bias" id="toc-selection-bias"><span class="toc-section-number">2.25.1</span> 1. Selection Bias</a></li>
<li><a href="#information-bias-measurement-bias" id="toc-information-bias-measurement-bias"><span class="toc-section-number">2.25.2</span> 2. Information Bias
(Measurement Bias)</a></li>
<li><a href="#confounding-bias" id="toc-confounding-bias"><span class="toc-section-number">2.25.3</span> 3. Confounding Bias</a></li>
</ul></li>
<li><a href="#bias-in-different-study-designs" id="toc-bias-in-different-study-designs"><span class="toc-section-number">2.26</span> Bias in Different Study
Designs</a>
<ul>
<li><a href="#cohort-studies-1" id="toc-cohort-studies-1"><span class="toc-section-number">2.26.1</span> Cohort Studies</a></li>
<li><a href="#case-control-studies-1" id="toc-case-control-studies-1"><span class="toc-section-number">2.26.2</span> Case-Control Studies</a></li>
<li><a href="#cross-sectional-studies-1" id="toc-cross-sectional-studies-1"><span class="toc-section-number">2.26.3</span> Cross-Sectional
Studies</a></li>
<li><a href="#experimental-studies" id="toc-experimental-studies"><span class="toc-section-number">2.26.4</span> Experimental Studies</a></li>
</ul></li>
<li><a href="#quantifying-the-impact-of-bias" id="toc-quantifying-the-impact-of-bias"><span class="toc-section-number">2.27</span> Quantifying the Impact of
Bias</a>
<ul>
<li><a href="#direction-of-bias" id="toc-direction-of-bias"><span class="toc-section-number">2.27.1</span> Direction of Bias</a></li>
<li><a href="#magnitude-of-bias" id="toc-magnitude-of-bias"><span class="toc-section-number">2.27.2</span> Magnitude of Bias</a></li>
</ul></li>
<li><a href="#methods-to-minimize-bias" id="toc-methods-to-minimize-bias"><span class="toc-section-number">2.28</span> Methods to Minimize Bias</a>
<ul>
<li><a href="#study-design-level" id="toc-study-design-level"><span class="toc-section-number">2.28.1</span> Study Design Level</a></li>
<li><a href="#data-collection-level" id="toc-data-collection-level"><span class="toc-section-number">2.28.2</span> Data Collection Level</a></li>
<li><a href="#analysis-level" id="toc-analysis-level"><span class="toc-section-number">2.28.3</span> Analysis Level</a></li>
</ul></li>
<li><a href="#assessing-bias-in-published-studies" id="toc-assessing-bias-in-published-studies"><span class="toc-section-number">2.29</span> Assessing Bias in Published
Studies</a>
<ul>
<li><a href="#critical-appraisal-questions" id="toc-critical-appraisal-questions"><span class="toc-section-number">2.29.1</span> Critical Appraisal
Questions</a></li>
<li><a href="#sensitivity-analysis" id="toc-sensitivity-analysis"><span class="toc-section-number">2.29.2</span> Sensitivity Analysis</a></li>
</ul></li>
<li><a href="#common-sources-of-bias-in-epidemiological-research" id="toc-common-sources-of-bias-in-epidemiological-research"><span class="toc-section-number">2.30</span> Common Sources of Bias in
Epidemiological Research</a>
<ul>
<li><a href="#publication-bias" id="toc-publication-bias"><span class="toc-section-number">2.30.1</span> Publication Bias</a></li>
<li><a href="#reporting-bias" id="toc-reporting-bias"><span class="toc-section-number">2.30.2</span> Reporting Bias</a></li>
<li><a href="#time-related-biases" id="toc-time-related-biases"><span class="toc-section-number">2.30.3</span> Time-Related Biases</a></li>
</ul></li>
<li><a href="#summary-3" id="toc-summary-3"><span class="toc-section-number">2.31</span> Summary</a></li>
<li><a href="#learning-objectives-4" id="toc-learning-objectives-4"><span class="toc-section-number">2.32</span> Learning Objectives</a></li>
<li><a href="#confounding" id="toc-confounding"><span class="toc-section-number">2.33</span> Confounding</a>
<ul>
<li><a href="#definition-3" id="toc-definition-3"><span class="toc-section-number">2.33.1</span> Definition</a></li>
<li><a href="#characteristics-of-a-confounder" id="toc-characteristics-of-a-confounder"><span class="toc-section-number">2.33.2</span> Characteristics of a
Confounder</a></li>
<li><a href="#example-smoking-and-lung-cancer" id="toc-example-smoking-and-lung-cancer"><span class="toc-section-number">2.33.3</span> Example: Smoking and Lung
Cancer</a></li>
</ul></li>
<li><a href="#types-of-confounding" id="toc-types-of-confounding"><span class="toc-section-number">2.34</span> Types of Confounding</a>
<ul>
<li><a href="#positive-confounding" id="toc-positive-confounding"><span class="toc-section-number">2.34.1</span> 1. Positive
Confounding</a></li>
<li><a href="#negative-confounding" id="toc-negative-confounding"><span class="toc-section-number">2.34.2</span> 2. Negative
Confounding</a></li>
<li><a href="#quantifying-confounding" id="toc-quantifying-confounding"><span class="toc-section-number">2.34.3</span> 3. Quantifying
Confounding</a></li>
</ul></li>
<li><a href="#methods-to-control-confounding" id="toc-methods-to-control-confounding"><span class="toc-section-number">2.35</span> Methods to Control
Confounding</a>
<ul>
<li><a href="#study-design-level-1" id="toc-study-design-level-1"><span class="toc-section-number">2.35.1</span> 1. Study Design Level</a></li>
<li><a href="#analysis-level-1" id="toc-analysis-level-1"><span class="toc-section-number">2.35.2</span> 2. Analysis Level</a></li>
</ul></li>
<li><a href="#effect-modification-interaction" id="toc-effect-modification-interaction"><span class="toc-section-number">2.36</span> Effect Modification
(Interaction)</a>
<ul>
<li><a href="#definition-4" id="toc-definition-4"><span class="toc-section-number">2.36.1</span> Definition</a></li>
<li><a href="#key-differences-from-confounding" id="toc-key-differences-from-confounding"><span class="toc-section-number">2.36.2</span> Key Differences from
Confounding</a></li>
<li><a href="#example-exercise-and-heart-disease" id="toc-example-exercise-and-heart-disease"><span class="toc-section-number">2.36.3</span> Example: Exercise and Heart
Disease</a></li>
<li><a href="#types-of-interaction" id="toc-types-of-interaction"><span class="toc-section-number">2.36.4</span> Types of Interaction</a></li>
<li><a href="#testing-for-interaction" id="toc-testing-for-interaction"><span class="toc-section-number">2.36.5</span> Testing for
Interaction</a></li>
</ul></li>
<li><a href="#confounding-vs.-interaction-decision-framework" id="toc-confounding-vs.-interaction-decision-framework"><span class="toc-section-number">2.37</span> Confounding vs. Interaction:
Decision Framework</a>
<ul>
<li><a href="#is-the-third-variable-a-confounder-or-effect-modifier" id="toc-is-the-third-variable-a-confounder-or-effect-modifier"><span class="toc-section-number">2.37.1</span> Is the third variable a
confounder or effect modifier?</a></li>
<li><a href="#example-age-in-a-drug-study" id="toc-example-age-in-a-drug-study"><span class="toc-section-number">2.37.2</span> Example: Age in a Drug
Study</a></li>
</ul></li>
<li><a href="#advanced-topics" id="toc-advanced-topics"><span class="toc-section-number">2.38</span> Advanced Topics</a>
<ul>
<li><a href="#confounding-by-indication" id="toc-confounding-by-indication"><span class="toc-section-number">2.38.1</span> 1. Confounding by
Indication</a></li>
<li><a href="#residual-confounding" id="toc-residual-confounding"><span class="toc-section-number">2.38.2</span> 2. Residual
Confounding</a></li>
<li><a href="#over-adjustment" id="toc-over-adjustment"><span class="toc-section-number">2.38.3</span> 3. Over-adjustment</a></li>
<li><a href="#collider-bias" id="toc-collider-bias"><span class="toc-section-number">2.38.4</span> 4. Collider Bias</a></li>
</ul></li>
<li><a href="#practical-applications" id="toc-practical-applications"><span class="toc-section-number">2.39</span> Practical Applications</a>
<ul>
<li><a href="#causal-diagrams-dags" id="toc-causal-diagrams-dags"><span class="toc-section-number">2.39.1</span> 1. Causal Diagrams
(DAGs)</a></li>
<li><a href="#propensity-scores" id="toc-propensity-scores"><span class="toc-section-number">2.39.2</span> 2. Propensity Scores</a></li>
<li><a href="#instrumental-variable-analysis" id="toc-instrumental-variable-analysis"><span class="toc-section-number">2.39.3</span> 3. Instrumental Variable
Analysis</a></li>
</ul></li>
<li><a href="#summary-4" id="toc-summary-4"><span class="toc-section-number">2.40</span> Summary</a></li>
<li><a href="#learning-objectives-5" id="toc-learning-objectives-5"><span class="toc-section-number">2.41</span> Learning Objectives</a></li>
<li><a href="#comprehensive-framework-for-controlling-threats-to-validity" id="toc-comprehensive-framework-for-controlling-threats-to-validity"><span class="toc-section-number">2.42</span> Comprehensive Framework for
Controlling Threats to Validity</a>
<ul>
<li><a href="#hierarchy-of-control-strategies" id="toc-hierarchy-of-control-strategies"><span class="toc-section-number">2.42.1</span> Hierarchy of Control
Strategies</a></li>
</ul></li>
<li><a href="#prevention-strategies-study-design" id="toc-prevention-strategies-study-design"><span class="toc-section-number">2.43</span> 1. Prevention Strategies (Study
Design)</a>
<ul>
<li><a href="#a.-randomization-1" id="toc-a.-randomization-1"><span class="toc-section-number">2.43.1</span> A. Randomization</a></li>
<li><a href="#b.-matching" id="toc-b.-matching"><span class="toc-section-number">2.43.2</span> B. Matching</a></li>
<li><a href="#c.-restriction" id="toc-c.-restriction"><span class="toc-section-number">2.43.3</span> C. Restriction</a></li>
</ul></li>
<li><a href="#measurement-strategies-data-collection" id="toc-measurement-strategies-data-collection"><span class="toc-section-number">2.44</span> 2. Measurement Strategies (Data
Collection)</a>
<ul>
<li><a href="#a.-blindingmasking" id="toc-a.-blindingmasking"><span class="toc-section-number">2.44.1</span> A. Blinding/Masking</a></li>
<li><a href="#b.-standardization" id="toc-b.-standardization"><span class="toc-section-number">2.44.2</span> B. Standardization</a></li>
<li><a href="#c.-objective-measurements" id="toc-c.-objective-measurements"><span class="toc-section-number">2.44.3</span> C. Objective
Measurements</a></li>
<li><a href="#d.-multiple-measures" id="toc-d.-multiple-measures"><span class="toc-section-number">2.44.4</span> D. Multiple Measures</a></li>
</ul></li>
<li><a href="#analysis-strategies-statistical-control" id="toc-analysis-strategies-statistical-control"><span class="toc-section-number">2.45</span> 3. Analysis Strategies
(Statistical Control)</a>
<ul>
<li><a href="#a.-stratification-1" id="toc-a.-stratification-1"><span class="toc-section-number">2.45.1</span> A. Stratification</a></li>
<li><a href="#b.-regression-models" id="toc-b.-regression-models"><span class="toc-section-number">2.45.2</span> B. Regression Models</a></li>
<li><a href="#c.-propensity-score-methods" id="toc-c.-propensity-score-methods"><span class="toc-section-number">2.45.3</span> C. Propensity Score
Methods</a></li>
<li><a href="#d.-instrumental-variable-analysis" id="toc-d.-instrumental-variable-analysis"><span class="toc-section-number">2.45.4</span> D. Instrumental Variable
Analysis</a></li>
</ul></li>
<li><a href="#assessment-strategies-sensitivity-analysis" id="toc-assessment-strategies-sensitivity-analysis"><span class="toc-section-number">2.46</span> 4. Assessment Strategies
(Sensitivity Analysis)</a>
<ul>
<li><a href="#a.-sensitivity-analysis" id="toc-a.-sensitivity-analysis"><span class="toc-section-number">2.46.1</span> A. Sensitivity
Analysis</a></li>
<li><a href="#b.-subgroup-analysis" id="toc-b.-subgroup-analysis"><span class="toc-section-number">2.46.2</span> B. Subgroup Analysis</a></li>
<li><a href="#c.-meta-analysis" id="toc-c.-meta-analysis"><span class="toc-section-number">2.46.3</span> C. Meta-analysis</a></li>
</ul></li>
<li><a href="#improving-precision" id="toc-improving-precision"><span class="toc-section-number">2.47</span> Improving Precision</a>
<ul>
<li><a href="#sample-size-considerations" id="toc-sample-size-considerations"><span class="toc-section-number">2.47.1</span> 1. Sample Size
Considerations</a></li>
<li><a href="#study-design-efficiency" id="toc-study-design-efficiency"><span class="toc-section-number">2.47.2</span> 2. Study Design
Efficiency</a></li>
<li><a href="#measurement-precision" id="toc-measurement-precision"><span class="toc-section-number">2.47.3</span> 3. Measurement
Precision</a></li>
<li><a href="#analytical-precision" id="toc-analytical-precision"><span class="toc-section-number">2.47.4</span> 4. Analytical
Precision</a></li>
</ul></li>
<li><a href="#improving-validity" id="toc-improving-validity"><span class="toc-section-number">2.48</span> Improving Validity</a>
<ul>
<li><a href="#internal-validity" id="toc-internal-validity"><span class="toc-section-number">2.48.1</span> Internal Validity</a></li>
<li><a href="#external-validity-generalizability" id="toc-external-validity-generalizability"><span class="toc-section-number">2.48.2</span> External Validity
(Generalizability)</a></li>
<li><a href="#construct-validity" id="toc-construct-validity"><span class="toc-section-number">2.48.3</span> Construct Validity</a></li>
</ul></li>
<li><a href="#advanced-control-methods" id="toc-advanced-control-methods"><span class="toc-section-number">2.49</span> Advanced Control Methods</a>
<ul>
<li><a href="#causal-inference-methods" id="toc-causal-inference-methods"><span class="toc-section-number">2.49.1</span> 1. Causal Inference
Methods</a></li>
<li><a href="#machine-learning-approaches" id="toc-machine-learning-approaches"><span class="toc-section-number">2.49.2</span> 2. Machine Learning
Approaches</a></li>
<li><a href="#bayesian-methods" id="toc-bayesian-methods"><span class="toc-section-number">2.49.3</span> 3. Bayesian Methods</a></li>
</ul></li>
<li><a href="#practical-applications-1" id="toc-practical-applications-1"><span class="toc-section-number">2.50</span> Practical Applications</a>
<ul>
<li><a href="#case-study-controlling-confounding-in-observational-studies" id="toc-case-study-controlling-confounding-in-observational-studies"><span class="toc-section-number">2.50.1</span> Case Study: Controlling
Confounding in Observational Studies</a></li>
<li><a href="#case-study-minimizing-bias-in-case-control-studies" id="toc-case-study-minimizing-bias-in-case-control-studies"><span class="toc-section-number">2.50.2</span> Case Study: Minimizing Bias in
Case-Control Studies</a></li>
</ul></li>
<li><a href="#evaluation-framework" id="toc-evaluation-framework"><span class="toc-section-number">2.51</span> Evaluation Framework</a>
<ul>
<li><a href="#assessing-control-effectiveness" id="toc-assessing-control-effectiveness"><span class="toc-section-number">2.51.1</span> Assessing Control
Effectiveness</a></li>
<li><a href="#reporting-standards" id="toc-reporting-standards"><span class="toc-section-number">2.51.2</span> Reporting Standards</a></li>
</ul></li>
<li><a href="#summary-5" id="toc-summary-5"><span class="toc-section-number">2.52</span> Summary</a></li>
<li><a href="#learning-objectives-6" id="toc-learning-objectives-6"><span class="toc-section-number">2.53</span> Learning Objectives</a></li>
<li><a href="#introduction-to-critical-appraisal" id="toc-introduction-to-critical-appraisal"><span class="toc-section-number">2.54</span> Introduction to Critical
Appraisal</a>
<ul>
<li><a href="#why-critical-appraisal-matters" id="toc-why-critical-appraisal-matters"><span class="toc-section-number">2.54.1</span> Why Critical Appraisal
Matters</a></li>
</ul></li>
<li><a href="#frameworks-for-critical-appraisal" id="toc-frameworks-for-critical-appraisal"><span class="toc-section-number">2.55</span> Frameworks for Critical
Appraisal</a>
<ul>
<li><a href="#casp-critical-appraisal-skills-programme" id="toc-casp-critical-appraisal-skills-programme"><span class="toc-section-number">2.55.1</span> 1. CASP (Critical Appraisal
Skills Programme)</a></li>
<li><a href="#grade-grading-of-recommendations-assessment-development-and-evaluation" id="toc-grade-grading-of-recommendations-assessment-development-and-evaluation"><span class="toc-section-number">2.55.2</span> 2. GRADE (Grading of
Recommendations Assessment, Development and Evaluation)</a></li>
<li><a href="#strobe-strengthening-the-reporting-of-observational-studies-in-epidemiology" id="toc-strobe-strengthening-the-reporting-of-observational-studies-in-epidemiology"><span class="toc-section-number">2.55.3</span> 3. STROBE (Strengthening the
Reporting of Observational Studies in Epidemiology)</a></li>
</ul></li>
<li><a href="#critical-appraisal-of-observational-studies" id="toc-critical-appraisal-of-observational-studies"><span class="toc-section-number">2.56</span> Critical Appraisal of
Observational Studies</a>
<ul>
<li><a href="#cohort-studies-2" id="toc-cohort-studies-2"><span class="toc-section-number">2.56.1</span> Cohort Studies</a></li>
<li><a href="#case-control-studies-2" id="toc-case-control-studies-2"><span class="toc-section-number">2.56.2</span> Case-Control Studies</a></li>
<li><a href="#cross-sectional-studies-2" id="toc-cross-sectional-studies-2"><span class="toc-section-number">2.56.3</span> Cross-Sectional
Studies</a></li>
</ul></li>
<li><a href="#critical-appraisal-of-experimental-studies" id="toc-critical-appraisal-of-experimental-studies"><span class="toc-section-number">2.57</span> Critical Appraisal of
Experimental Studies</a>
<ul>
<li><a href="#randomized-controlled-trials-rcts-1" id="toc-randomized-controlled-trials-rcts-1"><span class="toc-section-number">2.57.1</span> Randomized Controlled Trials
(RCTs)</a></li>
<li><a href="#non-randomized-trials" id="toc-non-randomized-trials"><span class="toc-section-number">2.57.2</span> Non-Randomized Trials</a></li>
</ul></li>
<li><a href="#assessing-risk-of-bias" id="toc-assessing-risk-of-bias"><span class="toc-section-number">2.58</span> Assessing Risk of Bias</a>
<ul>
<li><a href="#cochrane-risk-of-bias-tool-for-rcts" id="toc-cochrane-risk-of-bias-tool-for-rcts"><span class="toc-section-number">2.58.1</span> Cochrane Risk of Bias Tool (for
RCTs)</a></li>
<li><a href="#robins-i-tool-for-non-randomized-studies" id="toc-robins-i-tool-for-non-randomized-studies"><span class="toc-section-number">2.58.2</span> ROBINS-I Tool (for
Non-Randomized Studies)</a></li>
</ul></li>
<li><a href="#evaluating-precision-and-validity" id="toc-evaluating-precision-and-validity"><span class="toc-section-number">2.59</span> Evaluating Precision and
Validity</a>
<ul>
<li><a href="#precision" id="toc-precision"><span class="toc-section-number">2.59.1</span> Precision</a></li>
<li><a href="#internal-validity-1" id="toc-internal-validity-1"><span class="toc-section-number">2.59.2</span> Internal Validity</a></li>
<li><a href="#external-validity-generalizability-1" id="toc-external-validity-generalizability-1"><span class="toc-section-number">2.59.3</span> External Validity
(Generalizability)</a></li>
</ul></li>
<li><a href="#quantitative-synthesis" id="toc-quantitative-synthesis"><span class="toc-section-number">2.60</span> Quantitative Synthesis</a>
<ul>
<li><a href="#meta-analysis" id="toc-meta-analysis"><span class="toc-section-number">2.60.1</span> Meta-Analysis</a></li>
<li><a href="#grade-approach" id="toc-grade-approach"><span class="toc-section-number">2.60.2</span> GRADE Approach</a></li>
</ul></li>
<li><a href="#practical-application-critical-appraisal-worksheet" id="toc-practical-application-critical-appraisal-worksheet"><span class="toc-section-number">2.61</span> Practical Application: Critical
Appraisal Worksheet</a>
<ul>
<li><a href="#study-identification" id="toc-study-identification"><span class="toc-section-number">2.61.1</span> Study Identification</a></li>
<li><a href="#methodology-assessment" id="toc-methodology-assessment"><span class="toc-section-number">2.61.2</span> Methodology Assessment</a></li>
<li><a href="#results-evaluation" id="toc-results-evaluation"><span class="toc-section-number">2.61.3</span> Results Evaluation</a></li>
<li><a href="#applicability" id="toc-applicability"><span class="toc-section-number">2.61.4</span> Applicability</a></li>
<li><a href="#overall-assessment" id="toc-overall-assessment"><span class="toc-section-number">2.61.5</span> Overall Assessment</a></li>
</ul></li>
<li><a href="#case-studies-in-critical-appraisal" id="toc-case-studies-in-critical-appraisal"><span class="toc-section-number">2.62</span> Case Studies in Critical
Appraisal</a>
<ul>
<li><a href="#case-study-1-vitamin-d-and-cancer-prevention" id="toc-case-study-1-vitamin-d-and-cancer-prevention"><span class="toc-section-number">2.62.1</span> Case Study 1: Vitamin D and
Cancer Prevention</a></li>
<li><a href="#case-study-2-mobile-phones-and-brain-cancer" id="toc-case-study-2-mobile-phones-and-brain-cancer"><span class="toc-section-number">2.62.2</span> Case Study 2: Mobile Phones and
Brain Cancer</a></li>
<li><a href="#case-study-3-mediterranean-diet-and-cardiovascular-disease" id="toc-case-study-3-mediterranean-diet-and-cardiovascular-disease"><span class="toc-section-number">2.62.3</span> Case Study 3: Mediterranean
Diet and Cardiovascular Disease</a></li>
</ul></li>
<li><a href="#common-mistakes-in-critical-appraisal" id="toc-common-mistakes-in-critical-appraisal"><span class="toc-section-number">2.63</span> Common Mistakes in Critical
Appraisal</a></li>
<li><a href="#resources-for-critical-appraisal" id="toc-resources-for-critical-appraisal"><span class="toc-section-number">2.64</span> Resources for Critical
Appraisal</a>
<ul>
<li><a href="#online-tools" id="toc-online-tools"><span class="toc-section-number">2.64.1</span> Online Tools</a></li>
<li><a href="#training-programs" id="toc-training-programs"><span class="toc-section-number">2.64.2</span> Training Programs</a></li>
<li><a href="#software-tools" id="toc-software-tools"><span class="toc-section-number">2.64.3</span> Software Tools</a></li>
</ul></li>
<li><a href="#summary-6" id="toc-summary-6"><span class="toc-section-number">2.65</span> Summary</a></li>
<li><a href="#part-ii-statistical-methods" id="toc-part-ii-statistical-methods"><span class="toc-section-number">2.66</span> Part II: Statistical
Methods</a></li>
</ul></li>
<li><a href="#module-1-introduction-to-statistical-methods" id="toc-module-1-introduction-to-statistical-methods"><span class="toc-section-number">3</span> Module 1: Introduction to
Statistical Methods</a>
<ul>
<li><a href="#learning-objectives-7" id="toc-learning-objectives-7"><span class="toc-section-number">3.1</span> Learning Objectives</a></li>
<li><a href="#what-is-statistics" id="toc-what-is-statistics"><span class="toc-section-number">3.2</span> What is Statistics?</a></li>
<li><a href="#branches-of-statistics" id="toc-branches-of-statistics"><span class="toc-section-number">3.3</span> Branches of Statistics</a>
<ul>
<li><a href="#descriptive-statistics" id="toc-descriptive-statistics"><span class="toc-section-number">3.3.1</span> 1. Descriptive
Statistics</a></li>
<li><a href="#inferential-statistics" id="toc-inferential-statistics"><span class="toc-section-number">3.3.2</span> 2. Inferential
Statistics</a></li>
</ul></li>
<li><a href="#types-of-data" id="toc-types-of-data"><span class="toc-section-number">3.4</span> Types of Data</a>
<ul>
<li><a href="#by-nature" id="toc-by-nature"><span class="toc-section-number">3.4.1</span> By Nature</a></li>
<li><a href="#by-measurement-scale" id="toc-by-measurement-scale"><span class="toc-section-number">3.4.2</span> By Measurement Scale</a></li>
</ul></li>
<li><a href="#the-research-process" id="toc-the-research-process"><span class="toc-section-number">3.5</span> The Research Process</a>
<ul>
<li><a href="#problem-identification" id="toc-problem-identification"><span class="toc-section-number">3.5.1</span> 1. Problem
Identification</a></li>
<li><a href="#study-design" id="toc-study-design"><span class="toc-section-number">3.5.2</span> 2. Study Design</a></li>
<li><a href="#data-collection" id="toc-data-collection"><span class="toc-section-number">3.5.3</span> 3. Data Collection</a></li>
<li><a href="#data-analysis" id="toc-data-analysis"><span class="toc-section-number">3.5.4</span> 4. Data Analysis</a></li>
<li><a href="#reporting-results" id="toc-reporting-results"><span class="toc-section-number">3.5.5</span> 5. Reporting Results</a></li>
</ul></li>
<li><a href="#study-designs-in-research" id="toc-study-designs-in-research"><span class="toc-section-number">3.6</span> Study Designs in Research</a>
<ul>
<li><a href="#experimental-designs" id="toc-experimental-designs"><span class="toc-section-number">3.6.1</span> Experimental Designs</a></li>
<li><a href="#observational-designs" id="toc-observational-designs"><span class="toc-section-number">3.6.2</span> Observational Designs</a></li>
</ul></li>
<li><a href="#ethical-considerations-1" id="toc-ethical-considerations-1"><span class="toc-section-number">3.7</span> Ethical Considerations</a>
<ul>
<li><a href="#key-principles" id="toc-key-principles"><span class="toc-section-number">3.7.1</span> Key Principles</a></li>
<li><a href="#statistical-ethics" id="toc-statistical-ethics"><span class="toc-section-number">3.7.2</span> Statistical Ethics</a></li>
</ul></li>
<li><a href="#software-tools-for-statistics" id="toc-software-tools-for-statistics"><span class="toc-section-number">3.8</span> Software Tools for Statistics</a>
<ul>
<li><a href="#statistical-software" id="toc-statistical-software"><span class="toc-section-number">3.8.1</span> Statistical Software</a></li>
<li><a href="#data-visualization" id="toc-data-visualization"><span class="toc-section-number">3.8.2</span> Data Visualization</a></li>
</ul></li>
<li><a href="#summary-7" id="toc-summary-7"><span class="toc-section-number">3.9</span> Summary</a></li>
<li><a href="#key-takeaways" id="toc-key-takeaways"><span class="toc-section-number">3.10</span> Key Takeaways</a></li>
<li><a href="#practice-questions" id="toc-practice-questions"><span class="toc-section-number">3.11</span> Practice Questions</a></li>
<li><a href="#further-reading" id="toc-further-reading"><span class="toc-section-number">3.12</span> Further Reading</a></li>
<li><a href="#learning-objectives-8" id="toc-learning-objectives-8"><span class="toc-section-number">3.13</span> Learning Objectives</a></li>
<li><a href="#measures-of-central-tendency" id="toc-measures-of-central-tendency"><span class="toc-section-number">3.14</span> Measures of Central Tendency</a>
<ul>
<li><a href="#mean-arithmetic-average" id="toc-mean-arithmetic-average"><span class="toc-section-number">3.14.1</span> Mean (Arithmetic
Average)</a></li>
<li><a href="#median-middle-value" id="toc-median-middle-value"><span class="toc-section-number">3.14.2</span> Median (Middle Value)</a></li>
<li><a href="#mode-most-frequent-value" id="toc-mode-most-frequent-value"><span class="toc-section-number">3.14.3</span> Mode (Most Frequent
Value)</a></li>
</ul></li>
<li><a href="#measures-of-dispersion" id="toc-measures-of-dispersion"><span class="toc-section-number">3.15</span> Measures of Dispersion</a>
<ul>
<li><a href="#range" id="toc-range"><span class="toc-section-number">3.15.1</span> Range</a></li>
<li><a href="#variance" id="toc-variance"><span class="toc-section-number">3.15.2</span> Variance</a></li>
<li><a href="#standard-deviation" id="toc-standard-deviation"><span class="toc-section-number">3.15.3</span> Standard Deviation</a></li>
</ul></li>
<li><a href="#data-distributions" id="toc-data-distributions"><span class="toc-section-number">3.16</span> Data Distributions</a>
<ul>
<li><a href="#normal-distribution" id="toc-normal-distribution"><span class="toc-section-number">3.16.1</span> Normal Distribution</a></li>
<li><a href="#skewness" id="toc-skewness"><span class="toc-section-number">3.16.2</span> Skewness</a></li>
<li><a href="#kurtosis" id="toc-kurtosis"><span class="toc-section-number">3.16.3</span> Kurtosis</a></li>
</ul></li>
<li><a href="#data-visualization-1" id="toc-data-visualization-1"><span class="toc-section-number">3.17</span> Data Visualization</a>
<ul>
<li><a href="#histograms" id="toc-histograms"><span class="toc-section-number">3.17.1</span> Histograms</a></li>
<li><a href="#box-plots-box-and-whisker-plots" id="toc-box-plots-box-and-whisker-plots"><span class="toc-section-number">3.17.2</span> Box Plots (Box-and-Whisker
Plots)</a></li>
<li><a href="#scatter-plots" id="toc-scatter-plots"><span class="toc-section-number">3.17.3</span> Scatter Plots</a></li>
<li><a href="#bar-charts-and-pie-charts" id="toc-bar-charts-and-pie-charts"><span class="toc-section-number">3.17.4</span> Bar Charts and Pie
Charts</a></li>
</ul></li>
<li><a href="#sampling-distributions" id="toc-sampling-distributions"><span class="toc-section-number">3.18</span> Sampling Distributions</a>
<ul>
<li><a href="#central-limit-theorem" id="toc-central-limit-theorem"><span class="toc-section-number">3.18.1</span> Central Limit Theorem</a></li>
<li><a href="#standard-error" id="toc-standard-error"><span class="toc-section-number">3.18.2</span> Standard Error</a></li>
</ul></li>
<li><a href="#summary-8" id="toc-summary-8"><span class="toc-section-number">3.19</span> Summary</a></li>
<li><a href="#key-takeaways-1" id="toc-key-takeaways-1"><span class="toc-section-number">3.20</span> Key Takeaways</a></li>
<li><a href="#practice-questions-1" id="toc-practice-questions-1"><span class="toc-section-number">3.21</span> Practice Questions</a></li>
<li><a href="#further-reading-1" id="toc-further-reading-1"><span class="toc-section-number">3.22</span> Further Reading</a></li>
<li><a href="#learning-objectives-9" id="toc-learning-objectives-9"><span class="toc-section-number">3.23</span> Learning Objectives</a></li>
<li><a href="#basic-probability-concepts" id="toc-basic-probability-concepts"><span class="toc-section-number">3.24</span> Basic Probability Concepts</a>
<ul>
<li><a href="#probability" id="toc-probability"><span class="toc-section-number">3.24.1</span> Probability</a></li>
<li><a href="#sample-space" id="toc-sample-space"><span class="toc-section-number">3.24.2</span> Sample Space</a></li>
<li><a href="#events" id="toc-events"><span class="toc-section-number">3.24.3</span> Events</a></li>
</ul></li>
<li><a href="#probability-rules" id="toc-probability-rules"><span class="toc-section-number">3.25</span> Probability Rules</a>
<ul>
<li><a href="#addition-rule" id="toc-addition-rule"><span class="toc-section-number">3.25.1</span> Addition Rule</a></li>
<li><a href="#multiplication-rule" id="toc-multiplication-rule"><span class="toc-section-number">3.25.2</span> Multiplication Rule</a></li>
<li><a href="#complement-rule" id="toc-complement-rule"><span class="toc-section-number">3.25.3</span> Complement Rule</a></li>
<li><a href="#conditional-probability" id="toc-conditional-probability"><span class="toc-section-number">3.25.4</span> Conditional
Probability</a></li>
</ul></li>
<li><a href="#bayes-theorem" id="toc-bayes-theorem"><span class="toc-section-number">3.26</span> Bayes’ Theorem</a>
<ul>
<li><a href="#formula" id="toc-formula"><span class="toc-section-number">3.26.1</span> Formula</a></li>
<li><a href="#extended-form" id="toc-extended-form"><span class="toc-section-number">3.26.2</span> Extended Form</a></li>
<li><a href="#applications" id="toc-applications"><span class="toc-section-number">3.26.3</span> Applications</a></li>
</ul></li>
<li><a href="#common-probability-distributions" id="toc-common-probability-distributions"><span class="toc-section-number">3.27</span> Common Probability
Distributions</a>
<ul>
<li><a href="#discrete-distributions" id="toc-discrete-distributions"><span class="toc-section-number">3.27.1</span> Discrete Distributions</a></li>
<li><a href="#continuous-distributions" id="toc-continuous-distributions"><span class="toc-section-number">3.27.2</span> Continuous
Distributions</a></li>
</ul></li>
<li><a href="#expected-value-and-variance" id="toc-expected-value-and-variance"><span class="toc-section-number">3.28</span> Expected Value and Variance</a>
<ul>
<li><a href="#expected-value-mean" id="toc-expected-value-mean"><span class="toc-section-number">3.28.1</span> Expected Value (Mean)</a></li>
<li><a href="#variance-1" id="toc-variance-1"><span class="toc-section-number">3.28.2</span> Variance</a></li>
<li><a href="#properties" id="toc-properties"><span class="toc-section-number">3.28.3</span> Properties</a></li>
</ul></li>
<li><a href="#summary-9" id="toc-summary-9"><span class="toc-section-number">3.29</span> Summary</a></li>
<li><a href="#key-takeaways-2" id="toc-key-takeaways-2"><span class="toc-section-number">3.30</span> Key Takeaways</a></li>
<li><a href="#practice-questions-2" id="toc-practice-questions-2"><span class="toc-section-number">3.31</span> Practice Questions</a></li>
<li><a href="#further-reading-2" id="toc-further-reading-2"><span class="toc-section-number">3.32</span> Further Reading</a></li>
<li><a href="#learning-objectives-10" id="toc-learning-objectives-10"><span class="toc-section-number">3.33</span> Learning Objectives</a></li>
<li><a href="#sampling-theory" id="toc-sampling-theory"><span class="toc-section-number">3.34</span> Sampling Theory</a>
<ul>
<li><a href="#populations-and-samples" id="toc-populations-and-samples"><span class="toc-section-number">3.34.1</span> Populations and
Samples</a></li>
<li><a href="#sampling-distributions-1" id="toc-sampling-distributions-1"><span class="toc-section-number">3.34.2</span> Sampling Distributions</a></li>
</ul></li>
<li><a href="#confidence-intervals" id="toc-confidence-intervals"><span class="toc-section-number">3.35</span> Confidence Intervals</a>
<ul>
<li><a href="#concept" id="toc-concept"><span class="toc-section-number">3.35.1</span> Concept</a></li>
<li><a href="#formula-for-mean-σ-known" id="toc-formula-for-mean-σ-known"><span class="toc-section-number">3.35.2</span> Formula for Mean (σ
known)</a></li>
<li><a href="#formula-for-mean-σ-unknown" id="toc-formula-for-mean-σ-unknown"><span class="toc-section-number">3.35.3</span> Formula for Mean (σ
unknown)</a></li>
<li><a href="#formula-for-proportion" id="toc-formula-for-proportion"><span class="toc-section-number">3.35.4</span> Formula for Proportion</a></li>
<li><a href="#interpretation" id="toc-interpretation"><span class="toc-section-number">3.35.5</span> Interpretation</a></li>
</ul></li>
<li><a href="#hypothesis-testing" id="toc-hypothesis-testing"><span class="toc-section-number">3.36</span> Hypothesis Testing</a>
<ul>
<li><a href="#steps-in-hypothesis-testing" id="toc-steps-in-hypothesis-testing"><span class="toc-section-number">3.36.1</span> Steps in Hypothesis
Testing</a></li>
<li><a href="#types-of-errors" id="toc-types-of-errors"><span class="toc-section-number">3.36.2</span> Types of Errors</a></li>
<li><a href="#power-analysis" id="toc-power-analysis"><span class="toc-section-number">3.36.3</span> Power Analysis</a></li>
</ul></li>
<li><a href="#common-statistical-tests" id="toc-common-statistical-tests"><span class="toc-section-number">3.37</span> Common Statistical Tests</a>
<ul>
<li><a href="#parametric-tests-normal-data-equal-variances" id="toc-parametric-tests-normal-data-equal-variances"><span class="toc-section-number">3.37.1</span> Parametric Tests (Normal data,
equal variances)</a></li>
<li><a href="#non-parametric-tests-no-normality-assumption" id="toc-non-parametric-tests-no-normality-assumption"><span class="toc-section-number">3.37.2</span> Non-parametric Tests (No
normality assumption)</a></li>
</ul></li>
<li><a href="#p-values-and-significance" id="toc-p-values-and-significance"><span class="toc-section-number">3.38</span> p-Values and Significance</a>
<ul>
<li><a href="#p-value-definition" id="toc-p-value-definition"><span class="toc-section-number">3.38.1</span> p-Value Definition</a></li>
<li><a href="#significance-levels" id="toc-significance-levels"><span class="toc-section-number">3.38.2</span> Significance Levels</a></li>
<li><a href="#misconceptions" id="toc-misconceptions"><span class="toc-section-number">3.38.3</span> Misconceptions</a></li>
</ul></li>
<li><a href="#effect-size" id="toc-effect-size"><span class="toc-section-number">3.39</span> Effect Size</a>
<ul>
<li><a href="#importance" id="toc-importance"><span class="toc-section-number">3.39.1</span> Importance</a></li>
<li><a href="#common-measures" id="toc-common-measures"><span class="toc-section-number">3.39.2</span> Common Measures</a></li>
</ul></li>
<li><a href="#summary-10" id="toc-summary-10"><span class="toc-section-number">3.40</span> Summary</a></li>
<li><a href="#key-takeaways-3" id="toc-key-takeaways-3"><span class="toc-section-number">3.41</span> Key Takeaways</a></li>
<li><a href="#practice-questions-3" id="toc-practice-questions-3"><span class="toc-section-number">3.42</span> Practice Questions</a></li>
<li><a href="#further-reading-3" id="toc-further-reading-3"><span class="toc-section-number">3.43</span> Further Reading</a></li>
<li><a href="#learning-objectives-11" id="toc-learning-objectives-11"><span class="toc-section-number">3.44</span> Learning Objectives</a></li>
<li><a href="#assumptions-of-parametric-tests" id="toc-assumptions-of-parametric-tests"><span class="toc-section-number">3.45</span> Assumptions of Parametric
Tests</a>
<ul>
<li><a href="#normality" id="toc-normality"><span class="toc-section-number">3.45.1</span> Normality</a></li>
<li><a href="#homoscedasticity-equal-variances" id="toc-homoscedasticity-equal-variances"><span class="toc-section-number">3.45.2</span> Homoscedasticity (Equal
Variances)</a></li>
<li><a href="#independence" id="toc-independence"><span class="toc-section-number">3.45.3</span> Independence</a></li>
<li><a href="#linearity" id="toc-linearity"><span class="toc-section-number">3.45.4</span> Linearity</a></li>
</ul></li>
<li><a href="#t-tests" id="toc-t-tests"><span class="toc-section-number">3.46</span> t-Tests</a>
<ul>
<li><a href="#one-sample-t-test-1" id="toc-one-sample-t-test-1"><span class="toc-section-number">3.46.1</span> One-Sample t-Test</a></li>
<li><a href="#independent-samples-t-test" id="toc-independent-samples-t-test"><span class="toc-section-number">3.46.2</span> Independent Samples
t-Test</a></li>
<li><a href="#paired-t-test" id="toc-paired-t-test"><span class="toc-section-number">3.46.3</span> Paired t-Test</a></li>
</ul></li>
<li><a href="#analysis-of-variance-anova" id="toc-analysis-of-variance-anova"><span class="toc-section-number">3.47</span> Analysis of Variance (ANOVA)</a>
<ul>
<li><a href="#one-way-anova-1" id="toc-one-way-anova-1"><span class="toc-section-number">3.47.1</span> One-Way ANOVA</a></li>
<li><a href="#two-way-anova" id="toc-two-way-anova"><span class="toc-section-number">3.47.2</span> Two-Way ANOVA</a></li>
<li><a href="#repeated-measures-anova" id="toc-repeated-measures-anova"><span class="toc-section-number">3.47.3</span> Repeated Measures
ANOVA</a></li>
</ul></li>
<li><a href="#correlation-analysis" id="toc-correlation-analysis"><span class="toc-section-number">3.48</span> Correlation Analysis</a>
<ul>
<li><a href="#pearson-correlation-1" id="toc-pearson-correlation-1"><span class="toc-section-number">3.48.1</span> Pearson Correlation</a></li>
<li><a href="#correlation-vs.-causation" id="toc-correlation-vs.-causation"><span class="toc-section-number">3.48.2</span> Correlation
vs. Causation</a></li>
</ul></li>
<li><a href="#linear-regression" id="toc-linear-regression"><span class="toc-section-number">3.49</span> Linear Regression</a>
<ul>
<li><a href="#simple-linear-regression" id="toc-simple-linear-regression"><span class="toc-section-number">3.49.1</span> Simple Linear
Regression</a></li>
<li><a href="#multiple-linear-regression" id="toc-multiple-linear-regression"><span class="toc-section-number">3.49.2</span> Multiple Linear
Regression</a></li>
<li><a href="#model-evaluation" id="toc-model-evaluation"><span class="toc-section-number">3.49.3</span> Model Evaluation</a></li>
<li><a href="#regression-diagnostics" id="toc-regression-diagnostics"><span class="toc-section-number">3.49.4</span> Regression Diagnostics</a></li>
</ul></li>
<li><a href="#summary-11" id="toc-summary-11"><span class="toc-section-number">3.50</span> Summary</a></li>
<li><a href="#key-takeaways-4" id="toc-key-takeaways-4"><span class="toc-section-number">3.51</span> Key Takeaways</a></li>
<li><a href="#practice-questions-4" id="toc-practice-questions-4"><span class="toc-section-number">3.52</span> Practice Questions</a></li>
<li><a href="#further-reading-4" id="toc-further-reading-4"><span class="toc-section-number">3.53</span> Further Reading</a></li>
<li><a href="#learning-objectives-12" id="toc-learning-objectives-12"><span class="toc-section-number">3.54</span> Learning Objectives</a></li>
<li><a href="#when-to-use-non-parametric-tests" id="toc-when-to-use-non-parametric-tests"><span class="toc-section-number">3.55</span> When to Use Non-Parametric
Tests</a>
<ul>
<li><a href="#advantages" id="toc-advantages"><span class="toc-section-number">3.55.1</span> Advantages</a></li>
<li><a href="#disadvantages" id="toc-disadvantages"><span class="toc-section-number">3.55.2</span> Disadvantages</a></li>
<li><a href="#decision-criteria" id="toc-decision-criteria"><span class="toc-section-number">3.55.3</span> Decision Criteria</a></li>
</ul></li>
<li><a href="#chi-square-tests" id="toc-chi-square-tests"><span class="toc-section-number">3.56</span> Chi-Square Tests</a>
<ul>
<li><a href="#chi-square-goodness-of-fit" id="toc-chi-square-goodness-of-fit"><span class="toc-section-number">3.56.1</span> Chi-Square Goodness of
Fit</a></li>
<li><a href="#chi-square-test-of-independence" id="toc-chi-square-test-of-independence"><span class="toc-section-number">3.56.2</span> Chi-Square Test of
Independence</a></li>
<li><a href="#fishers-exact-test" id="toc-fishers-exact-test"><span class="toc-section-number">3.56.3</span> Fisher’s Exact Test</a></li>
</ul></li>
<li><a href="#mann-whitney-u-test-1" id="toc-mann-whitney-u-test-1"><span class="toc-section-number">3.57</span> Mann-Whitney U Test</a>
<ul>
<li><a href="#purpose" id="toc-purpose"><span class="toc-section-number">3.57.1</span> Purpose</a></li>
<li><a href="#logic" id="toc-logic"><span class="toc-section-number">3.57.2</span> Logic</a></li>
<li><a href="#formula-1" id="toc-formula-1"><span class="toc-section-number">3.57.3</span> Formula</a></li>
<li><a href="#effect-size-1" id="toc-effect-size-1"><span class="toc-section-number">3.57.4</span> Effect Size</a></li>
</ul></li>
<li><a href="#kruskal-wallis-test-1" id="toc-kruskal-wallis-test-1"><span class="toc-section-number">3.58</span> Kruskal-Wallis Test</a>
<ul>
<li><a href="#purpose-1" id="toc-purpose-1"><span class="toc-section-number">3.58.1</span> Purpose</a></li>
<li><a href="#logic-1" id="toc-logic-1"><span class="toc-section-number">3.58.2</span> Logic</a></li>
<li><a href="#post-hoc-tests" id="toc-post-hoc-tests"><span class="toc-section-number">3.58.3</span> Post-hoc Tests</a></li>
</ul></li>
<li><a href="#wilcoxon-signed-rank-test" id="toc-wilcoxon-signed-rank-test"><span class="toc-section-number">3.59</span> Wilcoxon Signed-Rank Test</a>
<ul>
<li><a href="#purpose-2" id="toc-purpose-2"><span class="toc-section-number">3.59.1</span> Purpose</a></li>
<li><a href="#procedure" id="toc-procedure"><span class="toc-section-number">3.59.2</span> Procedure</a></li>
</ul></li>
<li><a href="#spearmans-rank-correlation" id="toc-spearmans-rank-correlation"><span class="toc-section-number">3.60</span> Spearman’s Rank Correlation</a>
<ul>
<li><a href="#purpose-3" id="toc-purpose-3"><span class="toc-section-number">3.60.1</span> Purpose</a></li>
<li><a href="#calculation" id="toc-calculation"><span class="toc-section-number">3.60.2</span> Calculation</a></li>
</ul></li>
<li><a href="#summary-12" id="toc-summary-12"><span class="toc-section-number">3.61</span> Summary</a></li>
<li><a href="#key-takeaways-5" id="toc-key-takeaways-5"><span class="toc-section-number">3.62</span> Key Takeaways</a></li>
<li><a href="#practice-questions-5" id="toc-practice-questions-5"><span class="toc-section-number">3.63</span> Practice Questions</a></li>
<li><a href="#further-reading-5" id="toc-further-reading-5"><span class="toc-section-number">3.64</span> Further Reading</a></li>
</ul></li>
</ul>
</nav>
<h1 data-number="1" id="comprehensive-study-design-and-methods-guide-epidemiology-and-statistics"><span class="header-section-number">1</span> Comprehensive Study Design and
Methods Guide: Epidemiology and Statistics</h1>
<p><strong>Created by: Dr. Siddalingaiah H S, Professor, Community
Medicine, SIMSRH, Tumkur</strong></p>
<p>This comprehensive guide combines epidemiology study designs and
statistical methods for research in public health and medicine.</p>
<h2 data-number="1.1" id="part-i-epidemiology-study-designs"><span class="header-section-number">1.1</span> Part I: Epidemiology Study
Designs</h2>
<h1 data-number="2" id="module-1-introduction-to-epidemiological-study-designs"><span class="header-section-number">2</span> Module 1: Introduction to
Epidemiological Study Designs</h1>
<h2 data-number="2.1" id="learning-objectives"><span class="header-section-number">2.1</span> Learning Objectives</h2>
<ul>
<li>Define epidemiology and its role in public health</li>
<li>Understand the basic principles of epidemiological research</li>
<li>Differentiate between descriptive and analytical epidemiology</li>
<li>Identify the key components of epidemiological study designs</li>
<li>Understand the importance of study design in establishing
causality</li>
</ul>
<h2 data-number="2.2" id="what-is-epidemiology"><span class="header-section-number">2.2</span> What is Epidemiology?</h2>
<p>Epidemiology is the study of the distribution and determinants of
health-related states or events in specified populations, and the
application of this study to control health problems.</p>
<p><strong>Key terms:</strong> - <strong>Distribution</strong>: Who,
when, where of health events - <strong>Determinants</strong>: Causes and
risk factors - <strong>Health-related states</strong>: Diseases,
injuries, disabilities, deaths - <strong>Specified populations</strong>:
Defined groups of people - <strong>Control</strong>: Prevention and
intervention</p>
<h2 data-number="2.3" id="levels-of-epidemiological-study"><span class="header-section-number">2.3</span> Levels of Epidemiological
Study</h2>
<h3 data-number="2.3.1" id="descriptive-epidemiology"><span class="header-section-number">2.3.1</span> 1. Descriptive
Epidemiology</h3>
<ul>
<li>Describes the distribution of disease in terms of person, place, and
time</li>
<li>Answers: Who gets the disease? Where? When?</li>
<li>Does not test hypotheses about causes</li>
<li>Useful for generating hypotheses and planning interventions</li>
</ul>
<h3 data-number="2.3.2" id="analytical-epidemiology"><span class="header-section-number">2.3.2</span> 2. Analytical
Epidemiology</h3>
<ul>
<li>Examines associations between exposures and outcomes</li>
<li>Tests hypotheses about causal relationships</li>
<li>Determines whether associations are causal</li>
</ul>
<h2 data-number="2.4" id="epidemiological-study-designs"><span class="header-section-number">2.4</span> Epidemiological Study
Designs</h2>
<p>Study designs are classified based on: - <strong>Timing</strong>:
Prospective vs. Retrospective - <strong>Direction of inquiry</strong>:
Forward vs. Backward - <strong>Manipulation of exposure</strong>:
Observational vs. Experimental</p>
<h3 data-number="2.4.1" id="major-categories"><span class="header-section-number">2.4.1</span> Major Categories:</h3>
<ol type="1">
<li><strong>Observational Studies</strong>: Researcher observes without
intervention
<ul>
<li>Descriptive studies</li>
<li>Analytical observational studies (cohort, case-control,
cross-sectional)</li>
</ul></li>
<li><strong>Experimental Studies</strong>: Researcher intervenes or
manipulates exposure
<ul>
<li>Clinical trials</li>
<li>Field trials</li>
<li>Community trials</li>
</ul></li>
</ol>
<h2 data-number="2.5" id="key-principles-in-epidemiological-research"><span class="header-section-number">2.5</span> Key Principles in
Epidemiological Research</h2>
<h3 data-number="2.5.1" id="study-population"><span class="header-section-number">2.5.1</span> 1. Study Population</h3>
<ul>
<li>Clearly defined population from which subjects are drawn</li>
<li>Target population vs. study population vs. source population</li>
</ul>
<h3 data-number="2.5.2" id="exposure-and-outcome"><span class="header-section-number">2.5.2</span> 2. Exposure and Outcome</h3>
<ul>
<li><strong>Exposure</strong>: Factor of interest (risk factor,
intervention)</li>
<li><strong>Outcome</strong>: Health event or condition being
studied</li>
<li>Clear definitions essential for validity</li>
</ul>
<h3 data-number="2.5.3" id="comparison-groups"><span class="header-section-number">2.5.3</span> 3. Comparison Groups</h3>
<ul>
<li>Essential for analytical studies</li>
<li>Exposed vs. unexposed groups</li>
<li>Cases vs. controls</li>
</ul>
<h3 data-number="2.5.4" id="bias-and-confounding"><span class="header-section-number">2.5.4</span> 4. Bias and Confounding</h3>
<ul>
<li>Threats to validity that must be controlled</li>
<li>Bias: Systematic error in design, conduct, or analysis</li>
<li>Confounding: Mixing of effects of exposure with other factors</li>
</ul>
<h2 data-number="2.6" id="establishing-causality"><span class="header-section-number">2.6</span> Establishing Causality</h2>
<h3 data-number="2.6.1" id="bradford-hill-criteria-1965"><span class="header-section-number">2.6.1</span> Bradford Hill Criteria
(1965)</h3>
<ol type="1">
<li><strong>Strength of association</strong>: Strong associations more
likely causal</li>
<li><strong>Consistency</strong>: Findings replicated in different
studies/settings</li>
<li><strong>Specificity</strong>: Exposure leads to specific
outcome</li>
<li><strong>Temporality</strong>: Exposure precedes outcome</li>
<li><strong>Biological gradient</strong>: Dose-response
relationship</li>
<li><strong>Plausibility</strong>: Biologically credible</li>
<li><strong>Coherence</strong>: Fits with existing knowledge</li>
<li><strong>Experiment</strong>: Experimental evidence supports</li>
<li><strong>Analogy</strong>: Similar to known causal relationships</li>
</ol>
<h2 data-number="2.7" id="importance-of-study-design-selection"><span class="header-section-number">2.7</span> Importance of Study Design
Selection</h2>
<ul>
<li>Different research questions require different designs</li>
<li>Each design has strengths and limitations</li>
<li>Choice affects validity, precision, and generalizability</li>
<li>Ethical considerations influence design selection</li>
</ul>
<h2 data-number="2.8" id="summary"><span class="header-section-number">2.8</span> Summary</h2>
<p>Epidemiological study designs provide the framework for investigating
health-related questions. Understanding the principles of epidemiology
and the characteristics of different study designs is essential for
conducting valid research and critically appraising published studies. #
Module 2: Observational Study Designs</p>
<h2 data-number="2.9" id="learning-objectives-1"><span class="header-section-number">2.9</span> Learning Objectives</h2>
<ul>
<li>Describe the characteristics of different observational study
designs</li>
<li>Understand the strengths and limitations of each design</li>
<li>Identify appropriate situations for using each design</li>
<li>Calculate and interpret measures of association</li>
</ul>
<h2 data-number="2.10" id="overview-of-observational-studies"><span class="header-section-number">2.10</span> Overview of Observational
Studies</h2>
<p>Observational studies involve observation of subjects without
manipulation of exposure by the researcher. They are essential when
experimental designs are unethical, impractical, or impossible.</p>
<h2 data-number="2.11" id="descriptive-studies"><span class="header-section-number">2.11</span> 1. Descriptive Studies</h2>
<h3 data-number="2.11.1" id="ecological-studies"><span class="header-section-number">2.11.1</span> Ecological Studies</h3>
<ul>
<li><strong>Definition</strong>: Study of groups or populations rather
than individuals</li>
<li><strong>Unit of analysis</strong>: Groups (countries, regions,
communities)</li>
<li><strong>Data sources</strong>: Routinely collected data (mortality
rates, disease registries)</li>
</ul>
<p><strong>Example</strong>: Correlation between per capita fat
consumption and breast cancer rates across countries</p>
<p><strong>Advantages:</strong> - Inexpensive and quick - Use existing
data - Good for hypothesis generation</p>
<p><strong>Limitations:</strong> - <strong>Ecological fallacy</strong>:
Associations at group level may not reflect individual level - Cannot
establish causality - Confounding at individual level</p>
<p><strong>Measures:</strong> - Correlation coefficients - Rates and
proportions</p>
<h3 data-number="2.11.2" id="case-reports-and-case-series"><span class="header-section-number">2.11.2</span> Case Reports and Case
Series</h3>
<ul>
<li><strong>Case Report</strong>: Detailed description of single
case</li>
<li><strong>Case Series</strong>: Description of multiple similar
cases</li>
<li><strong>Purpose</strong>: Describe unusual presentations, generate
hypotheses</li>
<li><strong>Limitations</strong>: No comparison group, cannot establish
causality</li>
</ul>
<h2 data-number="2.12" id="analytical-observational-studies"><span class="header-section-number">2.12</span> 2. Analytical Observational
Studies</h2>
<h3 data-number="2.12.1" id="cohort-studies"><span class="header-section-number">2.12.1</span> Cohort Studies</h3>
<h4 data-number="2.12.1.1" id="prospective-cohort-studies"><span class="header-section-number">2.12.1.1</span> Prospective Cohort
Studies</h4>
<ul>
<li><strong>Definition</strong>: Follow groups of people who are free of
disease forward in time</li>
<li><strong>Exposure assessment</strong>: Before outcome occurs</li>
<li><strong>Direction</strong>: Forward in time</li>
</ul>
<p><strong>Example</strong>: Framingham Heart Study - followed healthy
individuals to study cardiovascular risk factors</p>
<p><strong>Advantages:</strong> - Can study multiple outcomes - Exposure
precedes outcome (temporality) - Can calculate incidence rates - Good
for rare exposures</p>
<p><strong>Limitations:</strong> - Expensive and time-consuming - Loss
to follow-up - Changes in exposure classification over time - Not
suitable for rare outcomes</p>
<p><strong>Measures of Association:</strong> - <strong>Relative Risk
(RR)</strong>: Incidence in exposed / Incidence in unexposed -
<strong>Attributable Risk</strong>: Excess risk due to exposure -
<strong>Attributable Fraction</strong>: Proportion of disease due to
exposure</p>
<h4 data-number="2.12.1.2" id="retrospective-historical-cohort-studies"><span class="header-section-number">2.12.1.2</span> Retrospective (Historical)
Cohort Studies</h4>
<ul>
<li><strong>Definition</strong>: Use existing records to reconstruct
cohorts</li>
<li><strong>Exposure assessment</strong>: From historical records</li>
<li><strong>Direction</strong>: Backward in time from outcome</li>
</ul>
<p><strong>Example</strong>: Occupational studies using employment
records</p>
<p><strong>Advantages:</strong> - Quicker and cheaper than prospective
studies - Can study past exposures - Good for rare exposures</p>
<p><strong>Limitations:</strong> - Dependent on quality of historical
records - Exposure misclassification possible - Cannot study new
exposures</p>
<h3 data-number="2.12.2" id="case-control-studies"><span class="header-section-number">2.12.2</span> Case-Control Studies</h3>
<h4 data-number="2.12.2.1" id="definition"><span class="header-section-number">2.12.2.1</span> Definition</h4>
<ul>
<li><strong>Study base</strong>: Population that gives rise to
cases</li>
<li><strong>Cases</strong>: Individuals with the outcome of
interest</li>
<li><strong>Controls</strong>: Individuals without the outcome, from
same study base</li>
</ul>
<p><strong>Example</strong>: Study of lung cancer cases and controls to
examine smoking history</p>
<p><strong>Advantages:</strong> - Efficient for rare outcomes - Can
study multiple exposures - Relatively quick and inexpensive - Good for
studying diseases with long latency</p>
<p><strong>Limitations:</strong> - Cannot calculate incidence rates -
Prone to recall bias - Selection bias possible - Not suitable for rare
exposures</p>
<p><strong>Measures of Association:</strong> - <strong>Odds Ratio
(OR)</strong>: (Cases exposed/Cases unexposed) / (Controls
exposed/Controls unexposed) - When disease is rare, OR ≈ RR</p>
<h4 data-number="2.12.2.2" id="types-of-case-control-studies"><span class="header-section-number">2.12.2.2</span> Types of Case-Control
Studies</h4>
<ol type="1">
<li><strong>Population-based</strong>: Cases and controls from defined
population</li>
<li><strong>Hospital-based</strong>: Cases from hospitals, controls from
same hospitals</li>
<li><strong>Nested case-control</strong>: Within a cohort study</li>
</ol>
<h3 data-number="2.12.3" id="cross-sectional-studies"><span class="header-section-number">2.12.3</span> Cross-Sectional Studies</h3>
<h4 data-number="2.12.3.1" id="definition-1"><span class="header-section-number">2.12.3.1</span> Definition</h4>
<ul>
<li><strong>Prevalence study</strong>: Measures prevalence of exposure
and outcome at single point in time</li>
<li><strong>Direction</strong>: Neither forward nor backward - both
exposure and outcome measured simultaneously</li>
</ul>
<p><strong>Example</strong>: National Health Survey measuring current
smoking and current health status</p>
<p><strong>Advantages:</strong> - Quick and inexpensive - Can study
multiple outcomes and exposures - Good for hypothesis generation - Can
determine prevalence</p>
<p><strong>Limitations:</strong> - Cannot establish temporality -
Prevalence-incidence bias (Neyman bias) - Cannot distinguish between
cause and effect - Cross-sectional fallacy</p>
<p><strong>Measures of Association:</strong> - <strong>Prevalence Ratio
(PR)</strong>: Prevalence in exposed / Prevalence in unexposed -
<strong>Prevalence Odds Ratio (POR)</strong></p>
<h2 data-number="2.13" id="choosing-an-observational-study-design"><span class="header-section-number">2.13</span> Choosing an Observational
Study Design</h2>
<h3 data-number="2.13.1" id="factors-to-consider"><span class="header-section-number">2.13.1</span> Factors to Consider:</h3>
<ol type="1">
<li><strong>Research question</strong>: What is the exposure? What is
the outcome?</li>
<li><strong>Frequency</strong>: How common are exposure and
outcome?</li>
<li><strong>Time</strong>: When did exposure/outcome occur?</li>
<li><strong>Resources</strong>: Time and budget available</li>
<li><strong>Feasibility</strong>: Can the study be conducted?</li>
</ol>
<h3 data-number="2.13.2" id="decision-framework"><span class="header-section-number">2.13.2</span> Decision Framework:</h3>
<table>
<thead>
<tr>
<th>Scenario</th>
<th>Preferred Design</th>
</tr>
</thead>
<tbody>
<tr>
<td>Rare outcome, common exposure</td>
<td>Cohort study</td>
</tr>
<tr>
<td>Rare outcome, rare exposure</td>
<td>Case-control study</td>
</tr>
<tr>
<td>Common outcome, common exposure</td>
<td>Cross-sectional study</td>
</tr>
<tr>
<td>Multiple outcomes, single exposure</td>
<td>Cohort study</td>
</tr>
<tr>
<td>Multiple exposures, single outcome</td>
<td>Case-control study</td>
</tr>
<tr>
<td>Quick assessment needed</td>
<td>Cross-sectional study</td>
</tr>
</tbody>
</table>
<h2 data-number="2.14" id="summary-1"><span class="header-section-number">2.14</span> Summary</h2>
<p>Each observational study design has unique strengths and limitations.
The choice of design depends on the research question, the frequency of
exposure and outcome, available resources, and feasibility.
Understanding these designs is crucial for both conducting research and
critically appraising published studies. # Module 3: Experimental Study
Designs</p>
<h2 data-number="2.15" id="learning-objectives-2"><span class="header-section-number">2.15</span> Learning Objectives</h2>
<ul>
<li>Describe the characteristics of experimental study designs</li>
<li>Understand randomization and its importance</li>
<li>Identify different types of experimental studies</li>
<li>Recognize ethical considerations in experimental research</li>
<li>Calculate and interpret results from experimental studies</li>
</ul>
<h2 data-number="2.16" id="overview-of-experimental-studies"><span class="header-section-number">2.16</span> Overview of Experimental
Studies</h2>
<p>Experimental studies involve active manipulation of exposure by the
researcher. They are considered the “gold standard” for establishing
causality because they can control for confounding and establish
temporality.</p>
<p><strong>Key features:</strong> - Manipulation of exposure - Random
allocation to groups - Control group for comparison - Prospective
design</p>
<h2 data-number="2.17" id="clinical-trials"><span class="header-section-number">2.17</span> Clinical Trials</h2>
<h3 data-number="2.17.1" id="definition-2"><span class="header-section-number">2.17.1</span> Definition</h3>
<p>Clinical trials are experimental studies conducted in clinical
settings to evaluate the safety and efficacy of interventions in human
subjects.</p>
<h3 data-number="2.17.2" id="phases-of-clinical-trials"><span class="header-section-number">2.17.2</span> Phases of Clinical
Trials</h3>
<ol type="1">
<li><strong>Phase I</strong>: Safety, dosage, pharmacokinetics (small
number of healthy volunteers)</li>
<li><strong>Phase II</strong>: Efficacy and side effects (small number
of patients)</li>
<li><strong>Phase III</strong>: Large-scale evaluation of efficacy and
safety (hundreds to thousands of patients)</li>
<li><strong>Phase IV</strong>: Post-marketing surveillance (ongoing
monitoring after approval)</li>
</ol>
<h3 data-number="2.17.3" id="types-of-clinical-trials"><span class="header-section-number">2.17.3</span> Types of Clinical
Trials</h3>
<h4 data-number="2.17.3.1" id="randomized-controlled-trials-rcts"><span class="header-section-number">2.17.3.1</span> 1. Randomized Controlled
Trials (RCTs)</h4>
<ul>
<li><strong>Definition</strong>: Participants randomly assigned to
intervention or control groups</li>
<li><strong>Gold standard</strong> for clinical research</li>
</ul>
<p><strong>Components:</strong> - <strong>Randomization</strong>:
Ensures groups are comparable - <strong>Control group</strong>: Receives
placebo or standard treatment - <strong>Blinding</strong>: Single-blind,
double-blind, triple-blind - <strong>Intention-to-treat
analysis</strong>: Analyzes participants as originally assigned</p>
<p><strong>Advantages:</strong> - Minimizes confounding - Establishes
temporality - Can measure multiple outcomes - High internal validity</p>
<p><strong>Limitations:</strong> - Expensive and time-consuming -
Ethical constraints - May not be generalizable - Loss to follow-up</p>
<p><strong>Example</strong>: RCT comparing new drug vs. placebo for
hypertension</p>
<h4 data-number="2.17.3.2" id="non-randomized-controlled-trials"><span class="header-section-number">2.17.3.2</span> 2. Non-Randomized
Controlled Trials</h4>
<ul>
<li><strong>Definition</strong>: Participants assigned to groups without
randomization</li>
<li><strong>Methods</strong>: Alternate allocation, physician
preference, etc.</li>
</ul>
<p><strong>Advantages:</strong> - Easier to implement - Less
expensive</p>
<p><strong>Limitations:</strong> - Potential for selection bias - Groups
may not be comparable</p>
<h4 data-number="2.17.3.3" id="crossover-trials"><span class="header-section-number">2.17.3.3</span> 3. Crossover Trials</h4>
<ul>
<li><strong>Definition</strong>: Each participant receives both
intervention and control in sequence</li>
<li><strong>Design</strong>: A-B vs. B-A or A-B vs. A-C</li>
</ul>
<p><strong>Advantages:</strong> - Each participant serves as own control
- Requires fewer participants - Controls for individual differences</p>
<p><strong>Limitations:</strong> - Carryover effects - Not suitable for
irreversible outcomes - Dropout between periods</p>
<p><strong>Example</strong>: Trial comparing two pain medications where
each patient tries both</p>
<h4 data-number="2.17.3.4" id="cluster-randomized-trials"><span class="header-section-number">2.17.3.4</span> 4. Cluster Randomized
Trials</h4>
<ul>
<li><strong>Definition</strong>: Groups (clusters) rather than
individuals are randomized</li>
<li><strong>Examples</strong>: Schools, clinics, communities</li>
</ul>
<p><strong>Advantages:</strong> - Practical for community interventions
- Reduces contamination between groups - Cost-effective</p>
<p><strong>Limitations:</strong> - Requires larger sample size -
Potential for cluster-level confounding</p>
<h3 data-number="2.17.4" id="field-trials-and-community-trials"><span class="header-section-number">2.17.4</span> Field Trials and Community
Trials</h3>
<h4 data-number="2.17.4.1" id="field-trials"><span class="header-section-number">2.17.4.1</span> Field Trials</h4>
<ul>
<li><strong>Definition</strong>: Experimental studies conducted in field
settings</li>
<li><strong>Examples</strong>: Vaccine trials in developing
countries</li>
<li><strong>Similar to RCTs but in natural settings</strong></li>
</ul>
<h4 data-number="2.17.4.2" id="community-trials"><span class="header-section-number">2.17.4.2</span> Community Trials</h4>
<ul>
<li><strong>Definition</strong>: Interventions applied to entire
communities</li>
<li><strong>Examples</strong>: Water fluoridation, community health
programs</li>
<li><strong>Unit of randomization</strong>: Communities or groups</li>
</ul>
<p><strong>Advantages:</strong> - High external validity - Can study
population-level effects - Ethical for public health interventions</p>
<p><strong>Limitations:</strong> - Difficult to control confounding -
Hawthorne effect - Contamination between groups</p>
<h2 data-number="2.18" id="key-principles-of-experimental-design"><span class="header-section-number">2.18</span> Key Principles of Experimental
Design</h2>
<h3 data-number="2.18.1" id="randomization"><span class="header-section-number">2.18.1</span> 1. Randomization</h3>
<ul>
<li><strong>Purpose</strong>: Creates comparable groups</li>
<li><strong>Methods</strong>:
<ul>
<li>Simple randomization</li>
<li>Block randomization (stratified)</li>
<li>Cluster randomization</li>
<li>Minimization</li>
</ul></li>
</ul>
<p><strong>Importance:</strong> - Balances both known and unknown
confounders - Allows for statistical inference - Reduces selection
bias</p>
<h3 data-number="2.18.2" id="blindingmasking"><span class="header-section-number">2.18.2</span> 2. Blinding/Masking</h3>
<ul>
<li><strong>Single-blind</strong>: Participant unaware of
assignment</li>
<li><strong>Double-blind</strong>: Participant and investigator
unaware</li>
<li><strong>Triple-blind</strong>: Participant, investigator, and
analyst unaware</li>
</ul>
<p><strong>Purpose:</strong> - Reduces performance bias - Reduces
detection bias - Improves validity</p>
<h3 data-number="2.18.3" id="control-groups"><span class="header-section-number">2.18.3</span> 3. Control Groups</h3>
<ul>
<li><strong>Placebo control</strong>: Inert substance</li>
<li><strong>Active control</strong>: Standard treatment</li>
<li><strong>No treatment control</strong>: Ethical only when no standard
exists</li>
<li><strong>Historical control</strong>: Uses past data (not
recommended)</li>
</ul>
<h3 data-number="2.18.4" id="sample-size-and-power"><span class="header-section-number">2.18.4</span> 4. Sample Size and
Power</h3>
<ul>
<li><strong>Power</strong>: Probability of detecting true effect</li>
<li><strong>Factors affecting power</strong>: Sample size, effect size,
variability, significance level</li>
<li><strong>Sample size calculation</strong>: Based on expected
difference, variability, power, alpha</li>
</ul>
<h2 data-number="2.19" id="ethical-considerations"><span class="header-section-number">2.19</span> Ethical Considerations</h2>
<h3 data-number="2.19.1" id="key-principles-declaration-of-helsinki"><span class="header-section-number">2.19.1</span> Key Principles (Declaration
of Helsinki)</h3>
<ol type="1">
<li><strong>Respect for persons</strong>: Autonomy and informed
consent</li>
<li><strong>Beneficence</strong>: Maximize benefits, minimize harms</li>
<li><strong>Justice</strong>: Fair distribution of benefits and
burdens</li>
</ol>
<h3 data-number="2.19.2" id="informed-consent"><span class="header-section-number">2.19.2</span> Informed Consent</h3>
<ul>
<li><strong>Elements</strong>:
<ul>
<li>Disclosure of information</li>
<li>Comprehension</li>
<li>Voluntariness</li>
<li>Competence</li>
</ul></li>
</ul>
<h3 data-number="2.19.3" id="equipoise"><span class="header-section-number">2.19.3</span> Equipoise</h3>
<ul>
<li><strong>Clinical equipoise</strong>: Genuine uncertainty about which
intervention is better</li>
<li><strong>Community equipoise</strong>: Uncertainty at community
level</li>
</ul>
<h3 data-number="2.19.4" id="special-considerations"><span class="header-section-number">2.19.4</span> Special Considerations</h3>
<ul>
<li><strong>Vulnerable populations</strong>: Children, prisoners,
mentally ill</li>
<li><strong>Placebo use</strong>: When no proven treatment exists</li>
<li><strong>Emergency research</strong>: Waiver of consent in
emergencies</li>
</ul>
<h2 data-number="2.20" id="analysis-of-experimental-studies"><span class="header-section-number">2.20</span> Analysis of Experimental
Studies</h2>
<h3 data-number="2.20.1" id="intention-to-treat-itt-analysis"><span class="header-section-number">2.20.1</span> Intention-to-Treat (ITT)
Analysis</h3>
<ul>
<li><strong>Definition</strong>: Analyzes participants as originally
randomized</li>
<li><strong>Purpose</strong>: Preserves randomization, reduces bias</li>
<li><strong>Advantages</strong>: More conservative, reflects real-world
effectiveness</li>
</ul>
<h3 data-number="2.20.2" id="per-protocol-analysis"><span class="header-section-number">2.20.2</span> Per-Protocol Analysis</h3>
<ul>
<li><strong>Definition</strong>: Analyzes only participants who
completed treatment as assigned</li>
<li><strong>Purpose</strong>: Estimates efficacy under ideal
conditions</li>
<li><strong>Limitations</strong>: Can introduce bias</li>
</ul>
<h3 data-number="2.20.3" id="measures-of-effect"><span class="header-section-number">2.20.3</span> Measures of Effect</h3>
<ul>
<li><strong>Risk Difference (RD)</strong>: Risk in intervention - Risk
in control</li>
<li><strong>Relative Risk (RR)</strong>: Risk in intervention / Risk in
control</li>
<li><strong>Odds Ratio (OR)</strong>: Odds in intervention / Odds in
control</li>
<li><strong>Number Needed to Treat (NNT)</strong>: 1 / RD</li>
</ul>
<h2 data-number="2.21" id="limitations-and-challenges"><span class="header-section-number">2.21</span> Limitations and
Challenges</h2>
<h3 data-number="2.21.1" id="internal-validity-threats"><span class="header-section-number">2.21.1</span> Internal Validity
Threats</h3>
<ul>
<li><strong>Attrition bias</strong>: Differential loss to follow-up</li>
<li><strong>Non-compliance</strong>: Participants not following
protocol</li>
<li><strong>Contamination</strong>: Control group receives
intervention</li>
<li><strong>Co-intervention</strong>: Additional treatments affect
outcome</li>
</ul>
<h3 data-number="2.21.2" id="external-validity"><span class="header-section-number">2.21.2</span> External Validity</h3>
<ul>
<li><strong>Generalizability</strong>: Can results apply to other
populations?</li>
<li><strong>Factors affecting</strong>: Study population, setting,
intervention delivery</li>
</ul>
<h3 data-number="2.21.3" id="practical-challenges"><span class="header-section-number">2.21.3</span> Practical Challenges</h3>
<ul>
<li><strong>Cost and time</strong>: RCTs are expensive and slow</li>
<li><strong>Feasibility</strong>: Not all questions can be studied
experimentally</li>
<li><strong>Ethical constraints</strong>: Cannot study harmful
exposures</li>
</ul>
<h2 data-number="2.22" id="summary-2"><span class="header-section-number">2.22</span> Summary</h2>
<p>Experimental studies provide the strongest evidence for causality due
to randomization and control. However, they are not always feasible or
ethical. Understanding experimental designs is crucial for both
conducting clinical research and critically appraising the medical
literature. # Module 4: Bias in Epidemiological Research</p>
<h2 data-number="2.23" id="learning-objectives-3"><span class="header-section-number">2.23</span> Learning Objectives</h2>
<ul>
<li>Define different types of bias in epidemiological studies</li>
<li>Understand how bias affects study validity</li>
<li>Identify sources of bias in different study designs</li>
<li>Learn methods to minimize bias in study design and conduct</li>
</ul>
<h2 data-number="2.24" id="what-is-bias"><span class="header-section-number">2.24</span> What is Bias?</h2>
<p><strong>Bias</strong> is systematic error that leads to incorrect
estimates of association between exposure and outcome.</p>
<p><strong>Key characteristics:</strong> - Systematic (not random) -
Leads to incorrect conclusions - Can inflate or deflate associations -
Threatens validity</p>
<p><strong>Types of validity:</strong> - <strong>Internal
validity</strong>: Study measures what it intends to measure -
<strong>External validity</strong>: Results can be generalized to other
populations</p>
<h2 data-number="2.25" id="classification-of-bias"><span class="header-section-number">2.25</span> Classification of Bias</h2>
<h3 data-number="2.25.1" id="selection-bias"><span class="header-section-number">2.25.1</span> 1. Selection Bias</h3>
<p>Selection bias occurs when the relationship between exposure and
outcome differs between selected study participants and the target
population.</p>
<h4 data-number="2.25.1.1" id="types-of-selection-bias"><span class="header-section-number">2.25.1.1</span> Types of Selection
Bias</h4>
<p><strong>A. Sampling Bias</strong> - <strong>Definition</strong>:
Sample not representative of target population -
<strong>Examples</strong>: - Hospital-based controls not representative
of population - Volunteer bias in cohort studies - Non-response bias in
surveys</p>
<p><strong>B. Berkson’s Bias (Admission Rate Bias)</strong> -
<strong>Definition</strong>: Hospital controls may not represent the
general population - <strong>Reason</strong>: Hospitalized people have
higher disease rates - <strong>Example</strong>: Studying risk factors
for disease X using hospitalized controls</p>
<p><strong>C. Healthy Worker Effect</strong> -
<strong>Definition</strong>: Working populations appear healthier than
general population - <strong>Reason</strong>: Unhealthy people less
likely to be employed - <strong>Example</strong>: Occupational studies
showing lower mortality in workers</p>
<p><strong>D. Self-Selection Bias</strong> -
<strong>Definition</strong>: Participants choose their own exposure -
<strong>Example</strong>: Exercise intervention where motivated people
enroll</p>
<p><strong>E. Loss to Follow-up Bias</strong> -
<strong>Definition</strong>: Differential loss to follow-up between
groups - <strong>Example</strong>: In cohort studies, exposed
participants drop out more than unexposed</p>
<h4 data-number="2.25.1.2" id="prevention-of-selection-bias"><span class="header-section-number">2.25.1.2</span> Prevention of Selection
Bias</h4>
<ul>
<li>Random sampling from defined population</li>
<li>Matching cases and controls on important variables</li>
<li>High follow-up rates</li>
<li>Intention-to-treat analysis in RCTs</li>
</ul>
<h3 data-number="2.25.2" id="information-bias-measurement-bias"><span class="header-section-number">2.25.2</span> 2. Information Bias
(Measurement Bias)</h3>
<p>Information bias occurs when information about exposure or outcome is
collected or interpreted differently between comparison groups.</p>
<h4 data-number="2.25.2.1" id="types-of-information-bias"><span class="header-section-number">2.25.2.1</span> Types of Information
Bias</h4>
<p><strong>A. Recall Bias</strong> - <strong>Definition</strong>:
Differential recall of past exposures - <strong>Common in</strong>:
Case-control studies - <strong>Example</strong>: Cancer patients recall
exposures better than controls - <strong>Prevention</strong>: Use
objective measures, blinded interviewers</p>
<p><strong>B. Observer Bias (Detection Bias)</strong> -
<strong>Definition</strong>: Outcome assessment differs between groups -
<strong>Example</strong>: Knowing exposure status affects diagnosis -
<strong>Prevention</strong>: Blinding, standardized criteria</p>
<p><strong>C. Interviewer Bias</strong> - <strong>Definition</strong>:
Interviewer knowledge affects questioning - <strong>Prevention</strong>:
Training, blinding, standardized questionnaires</p>
<p><strong>D. Misclassification Bias</strong> -
<strong>Definition</strong>: Incorrect classification of exposure or
outcome - <strong>Types</strong>: - <strong>Non-differential</strong>:
Equal misclassification in both groups (biases toward null) -
<strong>Differential</strong>: Unequal misclassification between groups
(can bias in either direction)</p>
<p><strong>Examples of Misclassification:</strong> - Exposure
misclassification: Self-reported smoking vs. cotinine levels - Outcome
misclassification: Different diagnostic criteria used</p>
<p><strong>E. Confounding by Indication</strong> -
<strong>Definition</strong>: Treatment indication mistaken for treatment
effect - <strong>Example</strong>: Sicker patients get treatment, appear
to have worse outcomes</p>
<h4 data-number="2.25.2.2" id="prevention-of-information-bias"><span class="header-section-number">2.25.2.2</span> Prevention of Information
Bias</h4>
<ul>
<li>Standardized data collection</li>
<li>Blinding</li>
<li>Objective measurements</li>
<li>Validation studies</li>
<li>Training of observers</li>
</ul>
<h3 data-number="2.25.3" id="confounding-bias"><span class="header-section-number">2.25.3</span> 3. Confounding Bias</h3>
<p><strong>Definition</strong>: Mixing of the effect of exposure with
the effect of another variable (confounder)</p>
<p><strong>Characteristics of a Confounder:</strong> 1. Associated with
exposure 2. Independently associated with outcome 3. Not in causal
pathway between exposure and outcome</p>
<p><strong>Example</strong>: Age as confounder in smoking-lung cancer
association - Older people more likely to smoke (associated with
exposure) - Older people more likely to get lung cancer (associated with
outcome) - Age is not caused by smoking</p>
<p><strong>Note</strong>: Confounding is discussed in detail in Module
5</p>
<h2 data-number="2.26" id="bias-in-different-study-designs"><span class="header-section-number">2.26</span> Bias in Different Study
Designs</h2>
<h3 data-number="2.26.1" id="cohort-studies-1"><span class="header-section-number">2.26.1</span> Cohort Studies</h3>
<p><strong>Common biases:</strong> - Selection bias: Healthy worker
effect, self-selection - Information bias: Differential loss to
follow-up, recall bias (retrospective) - Confounding: Important
issue</p>
<h3 data-number="2.26.2" id="case-control-studies-1"><span class="header-section-number">2.26.2</span> Case-Control Studies</h3>
<p><strong>Common biases:</strong> - Selection bias: Berkson’s bias,
inappropriate controls - Information bias: Recall bias, interviewer bias
- Confounding: Important issue</p>
<h3 data-number="2.26.3" id="cross-sectional-studies-1"><span class="header-section-number">2.26.3</span> Cross-Sectional Studies</h3>
<p><strong>Common biases:</strong> - Selection bias: Non-response -
Information bias: Simultaneous measurement issues - Prevalence-incidence
bias</p>
<h3 data-number="2.26.4" id="experimental-studies"><span class="header-section-number">2.26.4</span> Experimental Studies</h3>
<p><strong>Common biases:</strong> - Selection bias: Non-random
assignment - Information bias: Lack of blinding - Performance bias:
Different care between groups</p>
<h2 data-number="2.27" id="quantifying-the-impact-of-bias"><span class="header-section-number">2.27</span> Quantifying the Impact of
Bias</h2>
<h3 data-number="2.27.1" id="direction-of-bias"><span class="header-section-number">2.27.1</span> Direction of Bias</h3>
<ul>
<li><strong>Bias toward null</strong>: Association underestimated
(non-differential misclassification)</li>
<li><strong>Bias away from null</strong>: Association overestimated</li>
<li><strong>No bias</strong>: Accurate estimate</li>
</ul>
<h3 data-number="2.27.2" id="magnitude-of-bias"><span class="header-section-number">2.27.2</span> Magnitude of Bias</h3>
<p>Depends on: - Prevalence of bias - Strength of association between
bias factor and outcome - Difference in bias between groups</p>
<h2 data-number="2.28" id="methods-to-minimize-bias"><span class="header-section-number">2.28</span> Methods to Minimize Bias</h2>
<h3 data-number="2.28.1" id="study-design-level"><span class="header-section-number">2.28.1</span> Study Design Level</h3>
<ol type="1">
<li><strong>Randomization</strong>: Balances known and unknown
confounders</li>
<li><strong>Matching</strong>: Ensures comparability on key
variables</li>
<li><strong>Blinding</strong>: Prevents observer and performance
bias</li>
<li><strong>Prospective design</strong>: Reduces recall bias</li>
</ol>
<h3 data-number="2.28.2" id="data-collection-level"><span class="header-section-number">2.28.2</span> Data Collection Level</h3>
<ol type="1">
<li><strong>Standardized protocols</strong>: Consistent data
collection</li>
<li><strong>Training</strong>: Ensures quality and consistency</li>
<li><strong>Quality control</strong>: Monitoring and validation</li>
<li><strong>Objective measures</strong>: When possible, use biological
markers</li>
</ol>
<h3 data-number="2.28.3" id="analysis-level"><span class="header-section-number">2.28.3</span> Analysis Level</h3>
<ol type="1">
<li><strong>Restriction</strong>: Limit analysis to homogeneous
subgroups</li>
<li><strong>Matching</strong>: In analysis (frequency matching,
individual matching)</li>
<li><strong>Stratification</strong>: Examine effect in strata of
confounder</li>
<li><strong>Statistical adjustment</strong>: Regression models,
standardization</li>
</ol>
<h2 data-number="2.29" id="assessing-bias-in-published-studies"><span class="header-section-number">2.29</span> Assessing Bias in Published
Studies</h2>
<h3 data-number="2.29.1" id="critical-appraisal-questions"><span class="header-section-number">2.29.1</span> Critical Appraisal
Questions</h3>
<ol type="1">
<li><strong>Selection bias</strong>: Was selection systematic?
Representative sample?</li>
<li><strong>Information bias</strong>: Were measurements objective?
Blinded assessment?</li>
<li><strong>Confounding</strong>: Were important confounders measured
and controlled?</li>
<li><strong>Other biases</strong>: Reporting bias, publication
bias?</li>
</ol>
<h3 data-number="2.29.2" id="sensitivity-analysis"><span class="header-section-number">2.29.2</span> Sensitivity Analysis</h3>
<ul>
<li><strong>Definition</strong>: Test how robust results are to
different assumptions about bias</li>
<li><strong>Methods</strong>: Vary assumptions about misclassification
rates</li>
<li><strong>Purpose</strong>: Assess potential impact of bias on
conclusions</li>
</ul>
<h2 data-number="2.30" id="common-sources-of-bias-in-epidemiological-research"><span class="header-section-number">2.30</span> Common Sources of Bias in
Epidemiological Research</h2>
<h3 data-number="2.30.1" id="publication-bias"><span class="header-section-number">2.30.1</span> Publication Bias</h3>
<ul>
<li><strong>Definition</strong>: Studies with significant results more
likely to be published</li>
<li><strong>Impact</strong>: Overestimation of effects</li>
<li><strong>Prevention</strong>: Register trials, publish protocols,
include all results</li>
</ul>
<h3 data-number="2.30.2" id="reporting-bias"><span class="header-section-number">2.30.2</span> Reporting Bias</h3>
<ul>
<li><strong>Definition</strong>: Selective reporting of outcomes or
analyses</li>
<li><strong>Prevention</strong>: Publish protocols, report all
outcomes</li>
</ul>
<h3 data-number="2.30.3" id="time-related-biases"><span class="header-section-number">2.30.3</span> Time-Related Biases</h3>
<ul>
<li><strong>Immortal time bias</strong>: Follow-up time
misclassified</li>
<li><strong>Lead time bias</strong>: Earlier diagnosis appears to
prolong survival</li>
<li><strong>Length bias</strong>: Slow-growing tumors more likely
detected by screening</li>
</ul>
<h2 data-number="2.31" id="summary-3"><span class="header-section-number">2.31</span> Summary</h2>
<p>Bias is a major threat to the validity of epidemiological studies.
Understanding different types of bias and their sources is essential for
both designing studies and critically appraising research. While some
bias can be prevented through good study design, other biases must be
controlled through analysis or acknowledged as limitations. # Module 5:
Confounding and Interaction</p>
<h2 data-number="2.32" id="learning-objectives-4"><span class="header-section-number">2.32</span> Learning Objectives</h2>
<ul>
<li>Define confounding and understand its impact on study results</li>
<li>Identify confounders in epidemiological studies</li>
<li>Learn methods to control for confounding</li>
<li>Understand effect modification (interaction)</li>
<li>Distinguish between confounding and interaction</li>
</ul>
<h2 data-number="2.33" id="confounding"><span class="header-section-number">2.33</span> Confounding</h2>
<h3 data-number="2.33.1" id="definition-3"><span class="header-section-number">2.33.1</span> Definition</h3>
<p><strong>Confounding</strong> is a mixing of effects where the
apparent association between exposure and outcome is distorted by the
effect of a third variable (confounder).</p>
<h3 data-number="2.33.2" id="characteristics-of-a-confounder"><span class="header-section-number">2.33.2</span> Characteristics of a
Confounder</h3>
<p>A variable is a confounder if it meets ALL THREE criteria:</p>
<ol type="1">
<li><strong>Associated with exposure</strong>: Confounder must be
related to the exposure of interest</li>
<li><strong>Independently associated with outcome</strong>: Confounder
must affect the outcome</li>
<li><strong>Not in the causal pathway</strong>: Confounder should not be
an intermediate variable</li>
</ol>
<h3 data-number="2.33.3" id="example-smoking-and-lung-cancer"><span class="header-section-number">2.33.3</span> Example: Smoking and Lung
Cancer</h3>
<pre><code>Age → Smoking → Lung Cancer
     ↑
     └── Confounder: Age is associated with both smoking and lung cancer</code></pre>
<ul>
<li>Older people are more likely to smoke (age associated with
exposure)</li>
<li>Older people are more likely to develop lung cancer (age associated
with outcome)</li>
<li>Age is not caused by smoking (not in causal pathway)</li>
</ul>
<p><strong>Crude association</strong>: Smoking appears strongly
associated with lung cancer <strong>After controlling for age</strong>:
The association is weaker but still present</p>
<h2 data-number="2.34" id="types-of-confounding"><span class="header-section-number">2.34</span> Types of Confounding</h2>
<h3 data-number="2.34.1" id="positive-confounding"><span class="header-section-number">2.34.1</span> 1. Positive Confounding</h3>
<ul>
<li>Confounder increases the apparent association</li>
<li>Example: Age in smoking-lung cancer association</li>
</ul>
<h3 data-number="2.34.2" id="negative-confounding"><span class="header-section-number">2.34.2</span> 2. Negative Confounding</h3>
<ul>
<li>Confounder decreases the apparent association</li>
<li>Example: Socioeconomic status in some associations</li>
</ul>
<h3 data-number="2.34.3" id="quantifying-confounding"><span class="header-section-number">2.34.3</span> 3. Quantifying
Confounding</h3>
<ul>
<li><strong>Confounding bias</strong>: Difference between crude and
adjusted estimates</li>
<li><strong>Percent change</strong>: [(Crude RR - Adjusted RR) / Crude
RR] × 100</li>
</ul>
<h2 data-number="2.35" id="methods-to-control-confounding"><span class="header-section-number">2.35</span> Methods to Control
Confounding</h2>
<h3 data-number="2.35.1" id="study-design-level-1"><span class="header-section-number">2.35.1</span> 1. Study Design Level</h3>
<h4 data-number="2.35.1.1" id="a.-randomization"><span class="header-section-number">2.35.1.1</span> A. Randomization</h4>
<ul>
<li><strong>How it works</strong>: Balances confounders across
groups</li>
<li><strong>Best method</strong>: In experimental studies</li>
<li><strong>Limitations</strong>: Not always possible (observational
studies)</li>
</ul>
<h4 data-number="2.35.1.2" id="b.-restriction"><span class="header-section-number">2.35.1.2</span> B. Restriction</h4>
<ul>
<li><strong>Definition</strong>: Limit study to participants with
similar levels of confounder</li>
<li><strong>Example</strong>: Study only adults aged 40-60 to control
for age</li>
<li><strong>Advantages</strong>: Simple, effective</li>
<li><strong>Limitations</strong>: Reduces generalizability, may not
control multiple confounders</li>
</ul>
<h4 data-number="2.35.1.3" id="c.-matching"><span class="header-section-number">2.35.1.3</span> C. Matching</h4>
<ul>
<li><strong>Definition</strong>: Select controls similar to cases on
confounding variables</li>
<li><strong>Types</strong>:
<ul>
<li><strong>Individual matching</strong>: Each case matched to specific
control(s)</li>
<li><strong>Frequency matching</strong>: Controls selected to match case
distribution</li>
</ul></li>
<li><strong>Example</strong>: Match cases and controls by age and
sex</li>
<li><strong>Advantages</strong>: Ensures balance on matched
variables</li>
<li><strong>Limitations</strong>: Can only match on known confounders,
matching on too many variables difficult</li>
</ul>
<h3 data-number="2.35.2" id="analysis-level-1"><span class="header-section-number">2.35.2</span> 2. Analysis Level</h3>
<h4 data-number="2.35.2.1" id="a.-stratification"><span class="header-section-number">2.35.2.1</span> A. Stratification</h4>
<ul>
<li><strong>Definition</strong>: Analyze data separately within strata
of the confounder</li>
<li><strong>Example</strong>: Calculate association separately for
different age groups</li>
<li><strong>Mantel-Haenszel method</strong>: Combines stratum-specific
estimates</li>
<li><strong>Advantages</strong>: Simple, shows effect modification</li>
<li><strong>Limitations</strong>: Limited to few confounders</li>
</ul>
<h4 data-number="2.35.2.2" id="b.-statistical-adjustment"><span class="header-section-number">2.35.2.2</span> B. Statistical
Adjustment</h4>
<ul>
<li><strong>Multivariable regression</strong>: Controls for multiple
confounders simultaneously</li>
<li><strong>Types</strong>:
<ul>
<li>Linear regression (continuous outcomes)</li>
<li>Logistic regression (binary outcomes)</li>
<li>Cox regression (time-to-event outcomes)</li>
</ul></li>
<li><strong>Advantages</strong>: Can control many confounders, handles
continuous variables</li>
<li><strong>Limitations</strong>: Requires assumptions, can
over-adjust</li>
</ul>
<h4 data-number="2.35.2.3" id="c.-standardization"><span class="header-section-number">2.35.2.3</span> C. Standardization</h4>
<ul>
<li><strong>Direct standardization</strong>: Apply study rates to
standard population</li>
<li><strong>Indirect standardization</strong>: Compare observed
vs. expected rates</li>
<li><strong>Purpose</strong>: Compare rates across populations with
different age structures</li>
</ul>
<h2 data-number="2.36" id="effect-modification-interaction"><span class="header-section-number">2.36</span> Effect Modification
(Interaction)</h2>
<h3 data-number="2.36.1" id="definition-4"><span class="header-section-number">2.36.1</span> Definition</h3>
<p><strong>Effect modification</strong> occurs when the association
between exposure and outcome differs across levels of a third
variable.</p>
<h3 data-number="2.36.2" id="key-differences-from-confounding"><span class="header-section-number">2.36.2</span> Key Differences from
Confounding</h3>
<table>
<colgroup>
<col style="width: 20%" />
<col style="width: 32%" />
<col style="width: 47%" />
</colgroup>
<thead>
<tr>
<th>Aspect</th>
<th>Confounding</th>
<th>Effect Modification</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Effect on association</strong></td>
<td>Distorts the association</td>
<td>Changes the association</td>
</tr>
<tr>
<td><strong>Control method</strong></td>
<td>Should be controlled</td>
<td>Should NOT be controlled</td>
</tr>
<tr>
<td><strong>Interpretation</strong></td>
<td>Single effect estimate</td>
<td>Separate estimates for subgroups</td>
</tr>
<tr>
<td><strong>Terminology</strong></td>
<td>Confounder</td>
<td>Effect modifier</td>
</tr>
</tbody>
</table>
<h3 data-number="2.36.3" id="example-exercise-and-heart-disease"><span class="header-section-number">2.36.3</span> Example: Exercise and Heart
Disease</h3>
<pre><code>Exercise → Heart Disease
↑
Sex (Effect Modifier)</code></pre>
<ul>
<li>In men: Exercise reduces heart disease risk by 30%</li>
<li>In women: Exercise reduces heart disease risk by 50%</li>
<li>Overall: Exercise reduces heart disease risk by 40%</li>
</ul>
<h3 data-number="2.36.4" id="types-of-interaction"><span class="header-section-number">2.36.4</span> Types of Interaction</h3>
<h4 data-number="2.36.4.1" id="quantitative-interaction"><span class="header-section-number">2.36.4.1</span> 1. Quantitative
Interaction</h4>
<ul>
<li><strong>Definition</strong>: Direction of association same, but
magnitude differs</li>
<li><strong>Example</strong>: Drug effect stronger in younger
patients</li>
</ul>
<h4 data-number="2.36.4.2" id="qualitative-interaction"><span class="header-section-number">2.36.4.2</span> 2. Qualitative
Interaction</h4>
<ul>
<li><strong>Definition</strong>: Direction of association differs
between subgroups</li>
<li><strong>Example</strong>: Treatment beneficial in men but harmful in
women</li>
</ul>
<h3 data-number="2.36.5" id="testing-for-interaction"><span class="header-section-number">2.36.5</span> Testing for Interaction</h3>
<h4 data-number="2.36.5.1" id="stratified-analysis"><span class="header-section-number">2.36.5.1</span> 1. Stratified
Analysis</h4>
<ul>
<li>Calculate effect estimates in each stratum</li>
<li>Compare estimates across strata</li>
<li>Look for statistical significance of interaction term</li>
</ul>
<h4 data-number="2.36.5.2" id="statistical-tests"><span class="header-section-number">2.36.5.2</span> 2. Statistical Tests</h4>
<ul>
<li><strong>Interaction term</strong> in regression models</li>
<li><strong>Likelihood ratio test</strong>: Compare models with/without
interaction</li>
<li><strong>Wald test</strong>: Test significance of interaction
coefficient</li>
</ul>
<h4 data-number="2.36.5.3" id="graphical-methods"><span class="header-section-number">2.36.5.3</span> 3. Graphical Methods</h4>
<ul>
<li><strong>Effect plots</strong>: Show how association changes across
levels of modifier</li>
<li><strong>Interaction plots</strong>: Lines that cross or diverge
indicate interaction</li>
</ul>
<h2 data-number="2.37" id="confounding-vs.-interaction-decision-framework"><span class="header-section-number">2.37</span> Confounding vs. Interaction:
Decision Framework</h2>
<h3 data-number="2.37.1" id="is-the-third-variable-a-confounder-or-effect-modifier"><span class="header-section-number">2.37.1</span> Is the third variable a
confounder or effect modifier?</h3>
<ol type="1">
<li><strong>Biological plausibility</strong>: Does it make sense that
the variable modifies the effect?</li>
<li><strong>Consistency</strong>: Is the pattern seen in other
studies?</li>
<li><strong>Statistical evidence</strong>: Is there significant
interaction?</li>
<li><strong>Clinical importance</strong>: Does it change clinical
decisions?</li>
</ol>
<h3 data-number="2.37.2" id="example-age-in-a-drug-study"><span class="header-section-number">2.37.2</span> Example: Age in a Drug
Study</h3>
<ul>
<li><strong>Confounding</strong>: Age associated with both drug use and
outcome</li>
<li><strong>Effect modification</strong>: Drug works differently in
young vs. old patients</li>
</ul>
<h2 data-number="2.38" id="advanced-topics"><span class="header-section-number">2.38</span> Advanced Topics</h2>
<h3 data-number="2.38.1" id="confounding-by-indication"><span class="header-section-number">2.38.1</span> 1. Confounding by
Indication</h3>
<ul>
<li><strong>Definition</strong>: Treatment appears harmful because
sicker patients receive it</li>
<li><strong>Example</strong>: Drug appears to cause worse outcomes
because given to severe cases</li>
<li><strong>Control</strong>: Instrumental variable analysis, propensity
scores</li>
</ul>
<h3 data-number="2.38.2" id="residual-confounding"><span class="header-section-number">2.38.2</span> 2. Residual Confounding</h3>
<ul>
<li><strong>Definition</strong>: Confounding not fully controlled due to
measurement error</li>
<li><strong>Example</strong>: Age categorized as 20-40, 41-60, but true
effect varies within categories</li>
<li><strong>Prevention</strong>: Better measurement, more
categories</li>
</ul>
<h3 data-number="2.38.3" id="over-adjustment"><span class="header-section-number">2.38.3</span> 3. Over-adjustment</h3>
<ul>
<li><strong>Definition</strong>: Controlling for variables in the causal
pathway</li>
<li><strong>Example</strong>: Controlling for intermediate variables
weakens true associations</li>
<li><strong>Prevention</strong>: Careful consideration of causal
diagrams</li>
</ul>
<h3 data-number="2.38.4" id="collider-bias"><span class="header-section-number">2.38.4</span> 4. Collider Bias</h3>
<ul>
<li><strong>Definition</strong>: Conditioning on a collider creates
spurious associations</li>
<li><strong>Example</strong>: Studying factors associated with hospital
admission creates associations between unrelated conditions</li>
</ul>
<h2 data-number="2.39" id="practical-applications"><span class="header-section-number">2.39</span> Practical Applications</h2>
<h3 data-number="2.39.1" id="causal-diagrams-dags"><span class="header-section-number">2.39.1</span> 1. Causal Diagrams
(DAGs)</h3>
<ul>
<li><strong>Directed Acyclic Graphs</strong>: Visual representation of
causal relationships</li>
<li><strong>Purpose</strong>: Identify confounders, mediators,
colliders</li>
<li><strong>Use</strong>: Guide analysis and control strategies</li>
</ul>
<h3 data-number="2.39.2" id="propensity-scores"><span class="header-section-number">2.39.2</span> 2. Propensity Scores</h3>
<ul>
<li><strong>Definition</strong>: Probability of exposure given
covariates</li>
<li><strong>Methods</strong>: Logistic regression to estimate
propensity</li>
<li><strong>Uses</strong>: Matching, stratification, weighting</li>
<li><strong>Advantages</strong>: Control many confounders
simultaneously</li>
</ul>
<h3 data-number="2.39.3" id="instrumental-variable-analysis"><span class="header-section-number">2.39.3</span> 3. Instrumental Variable
Analysis</h3>
<ul>
<li><strong>Definition</strong>: Use instrumental variables to estimate
causal effects</li>
<li><strong>Requirements</strong>: Instrument associated with exposure,
affects outcome only through exposure</li>
<li><strong>Example</strong>: Physician preference as instrument for
treatment choice</li>
</ul>
<h2 data-number="2.40" id="summary-4"><span class="header-section-number">2.40</span> Summary</h2>
<p>Confounding and interaction are critical concepts in epidemiology.
Confounding distorts associations and must be controlled, while effect
modification reveals important heterogeneity in effects that should be
explored. Understanding these concepts is essential for valid
epidemiological research and appropriate interpretation of study
results. # Module 6: Methods to Control Bias, Confounding, and Improve
Precision/Validity</p>
<h2 data-number="2.41" id="learning-objectives-5"><span class="header-section-number">2.41</span> Learning Objectives</h2>
<ul>
<li>Understand comprehensive strategies to control bias and
confounding</li>
<li>Learn methods to improve precision and validity</li>
<li>Apply appropriate control methods for different study designs</li>
<li>Evaluate the effectiveness of control strategies</li>
</ul>
<h2 data-number="2.42" id="comprehensive-framework-for-controlling-threats-to-validity"><span class="header-section-number">2.42</span> Comprehensive Framework for
Controlling Threats to Validity</h2>
<h3 data-number="2.42.1" id="hierarchy-of-control-strategies"><span class="header-section-number">2.42.1</span> Hierarchy of Control
Strategies</h3>
<ol type="1">
<li><strong>Prevention</strong> (Study Design Level)</li>
<li><strong>Measurement</strong> (Data Collection Level)</li>
<li><strong>Analysis</strong> (Statistical Control Level)</li>
<li><strong>Assessment</strong> (Sensitivity Analysis Level)</li>
</ol>
<h2 data-number="2.43" id="prevention-strategies-study-design"><span class="header-section-number">2.43</span> 1. Prevention Strategies
(Study Design)</h2>
<h3 data-number="2.43.1" id="a.-randomization-1"><span class="header-section-number">2.43.1</span> A. Randomization</h3>
<ul>
<li><strong>Purpose</strong>: Balance both known and unknown
confounders</li>
<li><strong>Types</strong>:
<ul>
<li><strong>Simple randomization</strong>: Equal probability
assignment</li>
<li><strong>Stratified randomization</strong>: Balance on key
variables</li>
<li><strong>Block randomization</strong>: Ensure balance within
blocks</li>
<li><strong>Cluster randomization</strong>: Randomize groups</li>
</ul></li>
<li><strong>Advantages</strong>: Controls all confounders, allows
statistical inference</li>
<li><strong>Limitations</strong>: Not always feasible, ethical
constraints</li>
</ul>
<h3 data-number="2.43.2" id="b.-matching"><span class="header-section-number">2.43.2</span> B. Matching</h3>
<ul>
<li><strong>Purpose</strong>: Ensure comparability on key variables</li>
<li><strong>Types</strong>:
<ul>
<li><strong>Individual matching</strong>: Pair cases with similar
controls</li>
<li><strong>Frequency matching</strong>: Match distribution of
variables</li>
<li><strong>Caliper matching</strong>: Allow small differences</li>
</ul></li>
<li><strong>Variables to match</strong>: Age, sex, socioeconomic
status</li>
<li><strong>Advantages</strong>: Ensures balance, increases
efficiency</li>
<li><strong>Limitations</strong>: Can only match on measured variables,
reduces sample size</li>
</ul>
<h3 data-number="2.43.3" id="c.-restriction"><span class="header-section-number">2.43.3</span> C. Restriction</h3>
<ul>
<li><strong>Purpose</strong>: Limit study to homogeneous population</li>
<li><strong>Examples</strong>:
<ul>
<li>Age-restricted studies</li>
<li>Single-sex studies</li>
<li>Geographic restriction</li>
</ul></li>
<li><strong>Advantages</strong>: Simple, effective for known
confounders</li>
<li><strong>Limitations</strong>: Reduces generalizability, cannot
control multiple factors</li>
</ul>
<h2 data-number="2.44" id="measurement-strategies-data-collection"><span class="header-section-number">2.44</span> 2. Measurement Strategies
(Data Collection)</h2>
<h3 data-number="2.44.1" id="a.-blindingmasking"><span class="header-section-number">2.44.1</span> A. Blinding/Masking</h3>
<ul>
<li><strong>Types</strong>:
<ul>
<li><strong>Single-blind</strong>: Participant unaware</li>
<li><strong>Double-blind</strong>: Participant and investigator
unaware</li>
<li><strong>Triple-blind</strong>: Participant, investigator, and
analyst unaware</li>
</ul></li>
<li><strong>Purpose</strong>: Prevent performance and detection
bias</li>
<li><strong>Implementation</strong>: Placebo controls, identical
packaging</li>
</ul>
<h3 data-number="2.44.2" id="b.-standardization"><span class="header-section-number">2.44.2</span> B. Standardization</h3>
<ul>
<li><strong>Protocols</strong>: Standardized data collection
procedures</li>
<li><strong>Training</strong>: Ensure consistency across observers</li>
<li><strong>Quality control</strong>: Regular monitoring and
retraining</li>
<li><strong>Validation</strong>: Compare against gold standards</li>
</ul>
<h3 data-number="2.44.3" id="c.-objective-measurements"><span class="header-section-number">2.44.3</span> C. Objective
Measurements</h3>
<ul>
<li><strong>Biological markers</strong>: Cotinine for smoking, HbA1c for
diabetes</li>
<li><strong>Medical records</strong>: Independent of self-report</li>
<li><strong>Administrative data</strong>: Less prone to recall bias</li>
<li><strong>Device calibration</strong>: Regular maintenance and
validation</li>
</ul>
<h3 data-number="2.44.4" id="d.-multiple-measures"><span class="header-section-number">2.44.4</span> D. Multiple Measures</h3>
<ul>
<li><strong>Triangulation</strong>: Use multiple methods to measure same
construct</li>
<li><strong>Reliability testing</strong>: Test-retest, inter-observer
agreement</li>
<li><strong>Validity assessment</strong>: Compare against established
standards</li>
</ul>
<h2 data-number="2.45" id="analysis-strategies-statistical-control"><span class="header-section-number">2.45</span> 3. Analysis Strategies
(Statistical Control)</h2>
<h3 data-number="2.45.1" id="a.-stratification-1"><span class="header-section-number">2.45.1</span> A. Stratification</h3>
<ul>
<li><strong>Purpose</strong>: Examine association within subgroups</li>
<li><strong>Methods</strong>:
<ul>
<li><strong>Crude analysis</strong>: Unadjusted association</li>
<li><strong>Stratified analysis</strong>: Association within strata</li>
<li><strong>Mantel-Haenszel</strong>: Summary estimate across
strata</li>
</ul></li>
<li><strong>Advantages</strong>: Simple, reveals effect
modification</li>
<li><strong>Limitations</strong>: Limited to categorical variables, few
confounders</li>
</ul>
<h3 data-number="2.45.2" id="b.-regression-models"><span class="header-section-number">2.45.2</span> B. Regression Models</h3>
<ul>
<li><strong>Types</strong>:
<ul>
<li><strong>Linear regression</strong>: Continuous outcomes</li>
<li><strong>Logistic regression</strong>: Binary outcomes</li>
<li><strong>Poisson regression</strong>: Count outcomes</li>
<li><strong>Cox regression</strong>: Time-to-event outcomes</li>
</ul></li>
<li><strong>Advantages</strong>: Control multiple confounders
simultaneously</li>
<li><strong>Considerations</strong>: Include confounders, avoid
over-adjustment</li>
</ul>
<h3 data-number="2.45.3" id="c.-propensity-score-methods"><span class="header-section-number">2.45.3</span> C. Propensity Score
Methods</h3>
<ul>
<li><strong>Definition</strong>: Probability of exposure given
covariates</li>
<li><strong>Methods</strong>:
<ul>
<li><strong>Matching</strong>: Match on propensity score</li>
<li><strong>Stratification</strong>: Stratify by propensity score</li>
<li><strong>Weighting</strong>: Inverse probability weighting</li>
<li><strong>Covariate adjustment</strong>: Include propensity score in
model</li>
</ul></li>
<li><strong>Advantages</strong>: Control many confounders, reduce
dimensionality</li>
</ul>
<h3 data-number="2.45.4" id="d.-instrumental-variable-analysis"><span class="header-section-number">2.45.4</span> D. Instrumental Variable
Analysis</h3>
<ul>
<li><strong>Requirements</strong>:
<ul>
<li>Instrument associated with exposure</li>
<li>Instrument affects outcome only through exposure</li>
<li>Instrument independent of confounders</li>
</ul></li>
<li><strong>Examples</strong>: Physician preference, lottery for
treatment</li>
<li><strong>Advantages</strong>: Controls unmeasured confounding</li>
<li><strong>Limitations</strong>: Hard to find valid instruments</li>
</ul>
<h2 data-number="2.46" id="assessment-strategies-sensitivity-analysis"><span class="header-section-number">2.46</span> 4. Assessment Strategies
(Sensitivity Analysis)</h2>
<h3 data-number="2.46.1" id="a.-sensitivity-analysis"><span class="header-section-number">2.46.1</span> A. Sensitivity Analysis</h3>
<ul>
<li><strong>Purpose</strong>: Test robustness of conclusions to
different assumptions</li>
<li><strong>Types</strong>:
<ul>
<li><strong>Bias analysis</strong>: Vary assumptions about bias
magnitude</li>
<li><strong>Missing data</strong>: Different imputation methods</li>
<li><strong>Unmeasured confounding</strong>: Assume strength of
unmeasured confounder</li>
</ul></li>
</ul>
<h3 data-number="2.46.2" id="b.-subgroup-analysis"><span class="header-section-number">2.46.2</span> B. Subgroup Analysis</h3>
<ul>
<li><strong>Purpose</strong>: Examine consistency across subgroups</li>
<li><strong>Methods</strong>: Test for interaction, stratified
estimates</li>
<li><strong>Caution</strong>: Multiple testing, power issues</li>
</ul>
<h3 data-number="2.46.3" id="c.-meta-analysis"><span class="header-section-number">2.46.3</span> C. Meta-analysis</h3>
<ul>
<li><strong>Purpose</strong>: Combine results across studies</li>
<li><strong>Methods</strong>: Fixed vs. random effects models</li>
<li><strong>Assessment</strong>: Heterogeneity, publication bias</li>
</ul>
<h2 data-number="2.47" id="improving-precision"><span class="header-section-number">2.47</span> Improving Precision</h2>
<h3 data-number="2.47.1" id="sample-size-considerations"><span class="header-section-number">2.47.1</span> 1. Sample Size
Considerations</h3>
<ul>
<li><strong>Power calculation</strong>: Probability of detecting true
effect</li>
<li><strong>Factors affecting power</strong>:
<ul>
<li>Sample size (primary factor)</li>
<li>Effect size</li>
<li>Variability</li>
<li>Significance level</li>
</ul></li>
<li><strong>Sample size formulas</strong>: Based on desired power and
effect size</li>
</ul>
<h3 data-number="2.47.2" id="study-design-efficiency"><span class="header-section-number">2.47.2</span> 2. Study Design
Efficiency</h3>
<ul>
<li><strong>Matching</strong>: Increases precision for matched
variables</li>
<li><strong>Stratification</strong>: More efficient than regression for
few variables</li>
<li><strong>Cluster design</strong>: May reduce precision due to
intra-cluster correlation</li>
</ul>
<h3 data-number="2.47.3" id="measurement-precision"><span class="header-section-number">2.47.3</span> 3. Measurement
Precision</h3>
<ul>
<li><strong>Reliable instruments</strong>: High test-retest
reliability</li>
<li><strong>Calibration</strong>: Regular instrument calibration</li>
<li><strong>Quality assurance</strong>: Ongoing monitoring</li>
</ul>
<h3 data-number="2.47.4" id="analytical-precision"><span class="header-section-number">2.47.4</span> 4. Analytical Precision</h3>
<ul>
<li><strong>Appropriate models</strong>: Correct model
specification</li>
<li><strong>Variance estimation</strong>: Proper standard error
calculation</li>
<li><strong>Confidence intervals</strong>: Report precision
measures</li>
</ul>
<h2 data-number="2.48" id="improving-validity"><span class="header-section-number">2.48</span> Improving Validity</h2>
<h3 data-number="2.48.1" id="internal-validity"><span class="header-section-number">2.48.1</span> Internal Validity</h3>
<ul>
<li><strong>Control confounding</strong>: Use appropriate methods
above</li>
<li><strong>Minimize bias</strong>: Design and measurement
strategies</li>
<li><strong>Account for interaction</strong>: Test and report effect
modification</li>
</ul>
<h3 data-number="2.48.2" id="external-validity-generalizability"><span class="header-section-number">2.48.2</span> External Validity
(Generalizability)</h3>
<ul>
<li><strong>Target population</strong>: Clearly define and describe</li>
<li><strong>Study population</strong>: How representative?</li>
<li><strong>Setting</strong>: Clinic vs. community vs. hospital</li>
<li><strong>Time period</strong>: Current vs. historical</li>
</ul>
<h3 data-number="2.48.3" id="construct-validity"><span class="header-section-number">2.48.3</span> Construct Validity</h3>
<ul>
<li><strong>Operational definitions</strong>: Clear measurement of
concepts</li>
<li><strong>Face validity</strong>: Measures appear to assess intended
construct</li>
<li><strong>Content validity</strong>: Measures cover all aspects of
construct</li>
<li><strong>Criterion validity</strong>: Correlates with gold
standard</li>
</ul>
<h2 data-number="2.49" id="advanced-control-methods"><span class="header-section-number">2.49</span> Advanced Control Methods</h2>
<h3 data-number="2.49.1" id="causal-inference-methods"><span class="header-section-number">2.49.1</span> 1. Causal Inference
Methods</h3>
<ul>
<li><strong>Directed Acyclic Graphs (DAGs)</strong>: Visual causal
models</li>
<li><strong>Front-door criterion</strong>: Identify causal effects with
unmeasured confounding</li>
<li><strong>G-methods</strong>: Control time-varying confounding</li>
</ul>
<h3 data-number="2.49.2" id="machine-learning-approaches"><span class="header-section-number">2.49.2</span> 2. Machine Learning
Approaches</h3>
<ul>
<li><strong>Regularization</strong>: LASSO for variable selection</li>
<li><strong>Ensemble methods</strong>: Random forests for
prediction</li>
<li><strong>Dimensionality reduction</strong>: Principal components</li>
</ul>
<h3 data-number="2.49.3" id="bayesian-methods"><span class="header-section-number">2.49.3</span> 3. Bayesian Methods</h3>
<ul>
<li><strong>Prior knowledge</strong>: Incorporate existing evidence</li>
<li><strong>Posterior distributions</strong>: Uncertainty
quantification</li>
<li><strong>Sensitivity analysis</strong>: Robust to assumptions</li>
</ul>
<h2 data-number="2.50" id="practical-applications-1"><span class="header-section-number">2.50</span> Practical Applications</h2>
<h3 data-number="2.50.1" id="case-study-controlling-confounding-in-observational-studies"><span class="header-section-number">2.50.1</span> Case Study: Controlling
Confounding in Observational Studies</h3>
<p><strong>Scenario</strong>: Studying effect of statin use on
cardiovascular outcomes</p>
<p><strong>Potential confounders</strong>: Age, sex, smoking, diabetes,
hypertension</p>
<p><strong>Control strategies</strong>: 1. <strong>Design</strong>:
Match on age and sex 2. <strong>Measurement</strong>: Use pharmacy
records for exposure, medical records for outcomes 3.
<strong>Analysis</strong>: Propensity score adjustment for multiple
confounders 4. <strong>Assessment</strong>: Sensitivity analysis for
unmeasured confounding</p>
<h3 data-number="2.50.2" id="case-study-minimizing-bias-in-case-control-studies"><span class="header-section-number">2.50.2</span> Case Study: Minimizing Bias
in Case-Control Studies</h3>
<p><strong>Scenario</strong>: Studying risk factors for breast
cancer</p>
<p><strong>Bias concerns</strong>: Recall bias, selection bias</p>
<p><strong>Control strategies</strong>: 1. <strong>Design</strong>:
Population-based controls, incident cases 2.
<strong>Measurement</strong>: Use medical records, blinded interviewers
3. <strong>Analysis</strong>: Conditional logistic regression 4.
<strong>Assessment</strong>: Validation substudy for exposure
measurement</p>
<h2 data-number="2.51" id="evaluation-framework"><span class="header-section-number">2.51</span> Evaluation Framework</h2>
<h3 data-number="2.51.1" id="assessing-control-effectiveness"><span class="header-section-number">2.51.1</span> Assessing Control
Effectiveness</h3>
<ol type="1">
<li><strong>Balance assessment</strong>: Compare groups on
confounders</li>
<li><strong>Residual confounding</strong>: Test for remaining
association</li>
<li><strong>Sensitivity analysis</strong>: How much bias would change
conclusions?</li>
<li><strong>Consistency</strong>: Results consistent across
methods?</li>
</ol>
<h3 data-number="2.51.2" id="reporting-standards"><span class="header-section-number">2.51.2</span> Reporting Standards</h3>
<ul>
<li><strong>STROBE guidelines</strong>: For observational studies</li>
<li><strong>CONSORT guidelines</strong>: For randomized trials</li>
<li><strong>PRISMA guidelines</strong>: For systematic reviews</li>
<li><strong>Complete reporting</strong>: Methods, results,
limitations</li>
</ul>
<h2 data-number="2.52" id="summary-5"><span class="header-section-number">2.52</span> Summary</h2>
<p>Controlling bias and confounding requires a multi-level approach
combining prevention, measurement, analysis, and assessment strategies.
The choice of methods depends on study design, resources, and research
question. Effective control improves both precision and validity,
leading to more reliable epidemiological evidence. # Module 7: Critical
Appraisal of Study Designs</p>
<h2 data-number="2.53" id="learning-objectives-6"><span class="header-section-number">2.53</span> Learning Objectives</h2>
<ul>
<li>Apply critical appraisal frameworks to epidemiological studies</li>
<li>Evaluate the validity and reliability of study findings</li>
<li>Identify strengths and limitations of different study designs</li>
<li>Make informed decisions about study quality and applicability</li>
</ul>
<h2 data-number="2.54" id="introduction-to-critical-appraisal"><span class="header-section-number">2.54</span> Introduction to Critical
Appraisal</h2>
<p><strong>Critical appraisal</strong> is the systematic evaluation of
research evidence to assess its validity, reliability, and applicability
to clinical practice or policy.</p>
<h3 data-number="2.54.1" id="why-critical-appraisal-matters"><span class="header-section-number">2.54.1</span> Why Critical Appraisal
Matters</h3>
<ul>
<li><strong>Evidence-based practice</strong>: Base decisions on best
available evidence</li>
<li><strong>Research quality</strong>: Identify high-quality
vs. low-quality studies</li>
<li><strong>Bias identification</strong>: Recognize potential threats to
validity</li>
<li><strong>Clinical relevance</strong>: Determine applicability to
specific contexts</li>
</ul>
<h2 data-number="2.55" id="frameworks-for-critical-appraisal"><span class="header-section-number">2.55</span> Frameworks for Critical
Appraisal</h2>
<h3 data-number="2.55.1" id="casp-critical-appraisal-skills-programme"><span class="header-section-number">2.55.1</span> 1. CASP (Critical Appraisal
Skills Programme)</h3>
<ul>
<li><strong>CASP checklists</strong>: Structured questions for different
study types</li>
<li><strong>Domains</strong>: Validity, reliability, applicability</li>
<li><strong>Scoring</strong>: Clear criteria for evaluation</li>
</ul>
<h3 data-number="2.55.2" id="grade-grading-of-recommendations-assessment-development-and-evaluation"><span class="header-section-number">2.55.2</span> 2. GRADE (Grading of
Recommendations Assessment, Development and Evaluation)</h3>
<ul>
<li><strong>Quality assessment</strong>: High, moderate, low, very low
quality</li>
<li><strong>Factors considered</strong>: Study design, risk of bias,
inconsistency, indirectness, imprecision, publication bias</li>
<li><strong>Strength of recommendations</strong>: Strong vs. weak
recommendations</li>
</ul>
<h3 data-number="2.55.3" id="strobe-strengthening-the-reporting-of-observational-studies-in-epidemiology"><span class="header-section-number">2.55.3</span> 3. STROBE (Strengthening the
Reporting of Observational Studies in Epidemiology)</h3>
<ul>
<li><strong>Checklist</strong>: 22 items for reporting observational
studies</li>
<li><strong>Domains</strong>: Title, abstract, introduction, methods,
results, discussion</li>
<li><strong>Purpose</strong>: Improve transparency and completeness of
reporting</li>
</ul>
<h2 data-number="2.56" id="critical-appraisal-of-observational-studies"><span class="header-section-number">2.56</span> Critical Appraisal of
Observational Studies</h2>
<h3 data-number="2.56.1" id="cohort-studies-2"><span class="header-section-number">2.56.1</span> Cohort Studies</h3>
<h4 data-number="2.56.1.1" id="key-questions-to-ask"><span class="header-section-number">2.56.1.1</span> Key Questions to Ask:</h4>
<ol type="1">
<li><strong>Study population</strong>: Clearly defined?
Representative?</li>
<li><strong>Exposure assessment</strong>: Valid and reliable
measurement?</li>
<li><strong>Outcome assessment</strong>: Objective criteria? Blinded
assessment?</li>
<li><strong>Follow-up</strong>: Complete? Differential loss to
follow-up?</li>
<li><strong>Confounding</strong>: Important confounders measured and
controlled?</li>
<li><strong>Analysis</strong>: Appropriate statistical methods?</li>
</ol>
<h4 data-number="2.56.1.2" id="common-pitfalls"><span class="header-section-number">2.56.1.2</span> Common Pitfalls:</h4>
<ul>
<li><strong>Immortal time bias</strong>: Misclassification of follow-up
time</li>
<li><strong>Time-varying confounding</strong>: Confounders change over
time</li>
<li><strong>Competing risks</strong>: Other outcomes affect results</li>
</ul>
<h4 data-number="2.56.1.3" id="example-appraisal"><span class="header-section-number">2.56.1.3</span> Example Appraisal:</h4>
<p><strong>Study</strong>: Coffee consumption and risk of type 2
diabetes</p>
<p><strong>Strengths</strong>: Large prospective cohort, objective
outcome assessment <strong>Limitations</strong>: Self-reported coffee
consumption, residual confounding</p>
<h3 data-number="2.56.2" id="case-control-studies-2"><span class="header-section-number">2.56.2</span> Case-Control Studies</h3>
<h4 data-number="2.56.2.1" id="key-questions"><span class="header-section-number">2.56.2.1</span> Key Questions:</h4>
<ol type="1">
<li><strong>Case definition</strong>: Clear, consistent criteria?</li>
<li><strong>Control selection</strong>: Appropriate source
population?</li>
<li><strong>Exposure assessment</strong>: Recall bias minimized?</li>
<li><strong>Matching</strong>: Appropriate variables matched?</li>
<li><strong>Response rates</strong>: High participation?</li>
<li><strong>Analysis</strong>: Conditional vs. unconditional logistic
regression?</li>
</ol>
<h4 data-number="2.56.2.2" id="common-issues"><span class="header-section-number">2.56.2.2</span> Common Issues:</h4>
<ul>
<li><strong>Recall bias</strong>: Cases remember exposures better</li>
<li><strong>Selection bias</strong>: Controls not representative</li>
<li><strong>Confounding by indication</strong>: Disease severity affects
exposure</li>
</ul>
<h4 data-number="2.56.2.3" id="example-appraisal-1"><span class="header-section-number">2.56.2.3</span> Example Appraisal:</h4>
<p><strong>Study</strong>: Oral contraceptives and venous
thromboembolism</p>
<p><strong>Strengths</strong>: Population-based, validated outcomes
<strong>Limitations</strong>: Potential recall bias, confounding by
smoking</p>
<h3 data-number="2.56.3" id="cross-sectional-studies-2"><span class="header-section-number">2.56.3</span> Cross-Sectional Studies</h3>
<h4 data-number="2.56.3.1" id="key-questions-1"><span class="header-section-number">2.56.3.1</span> Key Questions:</h4>
<ol type="1">
<li><strong>Sampling</strong>: Random? Representative?</li>
<li><strong>Measurement timing</strong>: Exposure and outcome measured
simultaneously?</li>
<li><strong>Response rates</strong>: High participation?</li>
<li><strong>Analysis</strong>: Appropriate for cross-sectional
design?</li>
</ol>
<h4 data-number="2.56.3.2" id="limitations"><span class="header-section-number">2.56.3.2</span> Limitations:</h4>
<ul>
<li><strong>Temporality</strong>: Cannot determine cause-effect</li>
<li><strong>Prevalence-incidence bias</strong>: Mix of prevalent and
incident cases</li>
<li><strong>Survival bias</strong>: Only survivors included</li>
</ul>
<h2 data-number="2.57" id="critical-appraisal-of-experimental-studies"><span class="header-section-number">2.57</span> Critical Appraisal of
Experimental Studies</h2>
<h3 data-number="2.57.1" id="randomized-controlled-trials-rcts-1"><span class="header-section-number">2.57.1</span> Randomized Controlled Trials
(RCTs)</h3>
<h4 data-number="2.57.1.1" id="key-questions-2"><span class="header-section-number">2.57.1.1</span> Key Questions:</h4>
<ol type="1">
<li><strong>Randomization</strong>: Adequate method? Concealed
allocation?</li>
<li><strong>Blinding</strong>: Participants, investigators, assessors
blinded?</li>
<li><strong>Groups comparable</strong>: Baseline characteristics
similar?</li>
<li><strong>Intervention</strong>: Clearly described? Compliance
monitored?</li>
<li><strong>Outcome assessment</strong>: Objective? Blinded?</li>
<li><strong>Analysis</strong>: Intention-to-treat? Handling of missing
data?</li>
<li><strong>Follow-up</strong>: Complete? Differential loss?</li>
</ol>
<h4 data-number="2.57.1.2" id="quality-assessment-jadad-scale"><span class="header-section-number">2.57.1.2</span> Quality Assessment (Jadad
Scale):</h4>
<ul>
<li><strong>Randomization</strong>: Adequate method (+1), inadequate
(-1)</li>
<li><strong>Blinding</strong>: Adequate method (+1), inadequate
(-1)</li>
<li><strong>Withdrawals</strong>: Described (+1)</li>
<li><strong>Maximum score</strong>: 5 points</li>
</ul>
<h4 data-number="2.57.1.3" id="common-biases"><span class="header-section-number">2.57.1.3</span> Common Biases:</h4>
<ul>
<li><strong>Performance bias</strong>: Different care between
groups</li>
<li><strong>Attrition bias</strong>: Differential dropouts</li>
<li><strong>Reporting bias</strong>: Selective outcome reporting</li>
</ul>
<h3 data-number="2.57.2" id="non-randomized-trials"><span class="header-section-number">2.57.2</span> Non-Randomized Trials</h3>
<h4 data-number="2.57.2.1" id="additional-questions"><span class="header-section-number">2.57.2.1</span> Additional Questions:</h4>
<ol type="1">
<li><strong>Assignment method</strong>: How were groups formed?</li>
<li><strong>Baseline differences</strong>: Statistical adjustment
performed?</li>
<li><strong>Confounding</strong>: Important confounders controlled?</li>
</ol>
<h4 data-number="2.57.2.2" id="limitations-1"><span class="header-section-number">2.57.2.2</span> Limitations:</h4>
<ul>
<li><strong>Selection bias</strong>: Groups not comparable</li>
<li><strong>Confounding</strong>: Unmeasured confounders</li>
<li><strong>Lower evidence quality</strong>: GRADE approach</li>
</ul>
<h2 data-number="2.58" id="assessing-risk-of-bias"><span class="header-section-number">2.58</span> Assessing Risk of Bias</h2>
<h3 data-number="2.58.1" id="cochrane-risk-of-bias-tool-for-rcts"><span class="header-section-number">2.58.1</span> Cochrane Risk of Bias Tool
(for RCTs)</h3>
<ol type="1">
<li><strong>Selection bias</strong>: Random sequence generation,
allocation concealment</li>
<li><strong>Performance bias</strong>: Blinding of participants and
personnel</li>
<li><strong>Detection bias</strong>: Blinding of outcome assessment</li>
<li><strong>Attrition bias</strong>: Incomplete outcome data</li>
<li><strong>Reporting bias</strong>: Selective reporting</li>
<li><strong>Other bias</strong>: Other sources of bias</li>
</ol>
<h3 data-number="2.58.2" id="robins-i-tool-for-non-randomized-studies"><span class="header-section-number">2.58.2</span> ROBINS-I Tool (for
Non-Randomized Studies)</h3>
<ul>
<li><strong>Domains</strong>: Confounding, selection, classification,
deviation, missing data, measurement, reporting</li>
<li><strong>Overall risk</strong>: Low, moderate, serious, critical, no
information</li>
</ul>
<h2 data-number="2.59" id="evaluating-precision-and-validity"><span class="header-section-number">2.59</span> Evaluating Precision and
Validity</h2>
<h3 data-number="2.59.1" id="precision"><span class="header-section-number">2.59.1</span> Precision</h3>
<ul>
<li><strong>Confidence intervals</strong>: Narrow vs. wide</li>
<li><strong>P-values</strong>: Statistical significance vs. clinical
importance</li>
<li><strong>Sample size</strong>: Adequate power?</li>
<li><strong>Standard errors</strong>: Measurement precision</li>
</ul>
<h3 data-number="2.59.2" id="internal-validity-1"><span class="header-section-number">2.59.2</span> Internal Validity</h3>
<ul>
<li><strong>Bias control</strong>: How well were biases minimized?</li>
<li><strong>Confounding</strong>: Appropriately controlled?</li>
<li><strong>Measurement error</strong>: Reliable and valid
measures?</li>
</ul>
<h3 data-number="2.59.3" id="external-validity-generalizability-1"><span class="header-section-number">2.59.3</span> External Validity
(Generalizability)</h3>
<ul>
<li><strong>Study population</strong>: Similar to target
population?</li>
<li><strong>Setting</strong>: Clinic vs. community vs. hospital?</li>
<li><strong>Time period</strong>: Current applicability?</li>
<li><strong>Intervention delivery</strong>: Feasible in practice?</li>
</ul>
<h2 data-number="2.60" id="quantitative-synthesis"><span class="header-section-number">2.60</span> Quantitative Synthesis</h2>
<h3 data-number="2.60.1" id="meta-analysis"><span class="header-section-number">2.60.1</span> Meta-Analysis</h3>
<ul>
<li><strong>Heterogeneity</strong>: I² statistic, Cochran’s Q test</li>
<li><strong>Publication bias</strong>: Funnel plots, Egger’s test</li>
<li><strong>Subgroup analysis</strong>: Sources of heterogeneity</li>
<li><strong>Sensitivity analysis</strong>: Robustness of findings</li>
</ul>
<h3 data-number="2.60.2" id="grade-approach"><span class="header-section-number">2.60.2</span> GRADE Approach</h3>
<ul>
<li><strong>Starting quality</strong>: Based on study design</li>
<li><strong>Quality modifiers</strong>: Risk of bias, inconsistency,
indirectness, imprecision, publication bias</li>
<li><strong>Final quality</strong>: High, moderate, low, very low</li>
</ul>
<h2 data-number="2.61" id="practical-application-critical-appraisal-worksheet"><span class="header-section-number">2.61</span> Practical Application:
Critical Appraisal Worksheet</h2>
<h3 data-number="2.61.1" id="study-identification"><span class="header-section-number">2.61.1</span> Study Identification</h3>
<ul>
<li><strong>Citation</strong>: Full reference</li>
<li><strong>Study type</strong>: RCT, cohort, case-control, etc.</li>
<li><strong>Research question</strong>: Clear and focused?</li>
</ul>
<h3 data-number="2.61.2" id="methodology-assessment"><span class="header-section-number">2.61.2</span> Methodology Assessment</h3>
<ul>
<li><strong>Design appropriate</strong>: For research question?</li>
<li><strong>Sample size</strong>: Adequate power?</li>
<li><strong>Data collection</strong>: Valid and reliable?</li>
<li><strong>Analysis</strong>: Appropriate statistical methods?</li>
</ul>
<h3 data-number="2.61.3" id="results-evaluation"><span class="header-section-number">2.61.3</span> Results Evaluation</h3>
<ul>
<li><strong>Findings clear</strong>: Well-presented results?</li>
<li><strong>Precision</strong>: Confidence intervals reported?</li>
<li><strong>Clinical importance</strong>: Statistically significant and
clinically meaningful?</li>
</ul>
<h3 data-number="2.61.4" id="applicability"><span class="header-section-number">2.61.4</span> Applicability</h3>
<ul>
<li><strong>Target population</strong>: Relevant to your context?</li>
<li><strong>Feasibility</strong>: Can intervention be implemented?</li>
<li><strong>Cost-effectiveness</strong>: Value for money?</li>
</ul>
<h3 data-number="2.61.5" id="overall-assessment"><span class="header-section-number">2.61.5</span> Overall Assessment</h3>
<ul>
<li><strong>Strengths</strong>: What are the study’s strong points?</li>
<li><strong>Limitations</strong>: What are the main weaknesses?</li>
<li><strong>Overall quality</strong>: High, moderate, low?</li>
<li><strong>Use in practice</strong>: How will you use these
findings?</li>
</ul>
<h2 data-number="2.62" id="case-studies-in-critical-appraisal"><span class="header-section-number">2.62</span> Case Studies in Critical
Appraisal</h2>
<h3 data-number="2.62.1" id="case-study-1-vitamin-d-and-cancer-prevention"><span class="header-section-number">2.62.1</span> Case Study 1: Vitamin D and
Cancer Prevention</h3>
<p><strong>Study</strong>: RCT of vitamin D supplementation
<strong>Appraisal points</strong>: - Randomization adequate? - Blinding
maintained? - Compliance monitored? - Outcomes clinically relevant?</p>
<h3 data-number="2.62.2" id="case-study-2-mobile-phones-and-brain-cancer"><span class="header-section-number">2.62.2</span> Case Study 2: Mobile Phones
and Brain Cancer</h3>
<p><strong>Study</strong>: Case-control study of mobile phone use
<strong>Appraisal points</strong>: - Case definition clear? - Controls
appropriate? - Recall bias addressed? - Confounding controlled?</p>
<h3 data-number="2.62.3" id="case-study-3-mediterranean-diet-and-cardiovascular-disease"><span class="header-section-number">2.62.3</span> Case Study 3: Mediterranean
Diet and Cardiovascular Disease</h3>
<p><strong>Study</strong>: Prospective cohort study <strong>Appraisal
points</strong>: - Exposure assessment valid? - Outcome ascertainment
complete? - Follow-up adequate? - Residual confounding?</p>
<h2 data-number="2.63" id="common-mistakes-in-critical-appraisal"><span class="header-section-number">2.63</span> Common Mistakes in Critical
Appraisal</h2>
<ol type="1">
<li><strong>Design bias</strong>: Assuming RCT is always best</li>
<li><strong>Statistical fixation</strong>: Focusing only on
p-values</li>
<li><strong>Confirmation bias</strong>: Looking for evidence to support
preconceptions</li>
<li><strong>Over-reliance on single studies</strong>: Ignoring the body
of evidence</li>
<li><strong>Ignoring context</strong>: Not considering local
applicability</li>
</ol>
<h2 data-number="2.64" id="resources-for-critical-appraisal"><span class="header-section-number">2.64</span> Resources for Critical
Appraisal</h2>
<h3 data-number="2.64.1" id="online-tools"><span class="header-section-number">2.64.1</span> Online Tools</h3>
<ul>
<li><strong>CASP checklists</strong>: casp-uk.net</li>
<li><strong>GRADE handbook</strong>: gradepro.org</li>
<li><strong>STROBE statement</strong>: strobe-statement.org</li>
</ul>
<h3 data-number="2.64.2" id="training-programs"><span class="header-section-number">2.64.2</span> Training Programs</h3>
<ul>
<li><strong>Critical appraisal courses</strong>: University
programs</li>
<li><strong>Journal clubs</strong>: Regular practice sessions</li>
<li><strong>Peer review</strong>: Collaborative appraisal</li>
</ul>
<h3 data-number="2.64.3" id="software-tools"><span class="header-section-number">2.64.3</span> Software Tools</h3>
<ul>
<li><strong>RevMan</strong>: For Cochrane reviews</li>
<li><strong>GRADEpro</strong>: For evidence profiles</li>
<li><strong>R packages</strong>: Meta-analysis tools</li>
</ul>
<h2 data-number="2.65" id="summary-6"><span class="header-section-number">2.65</span> Summary</h2>
<p>Critical appraisal is essential for evidence-based practice. By
systematically evaluating study validity, precision, and applicability,
researchers and practitioners can make informed decisions about the
quality and usefulness of epidemiological evidence. Regular practice and
use of structured frameworks improve appraisal skills and contribute to
better public health decisions.</p>
<h2 data-number="2.66" id="part-ii-statistical-methods"><span class="header-section-number">2.66</span> Part II: Statistical
Methods</h2>
<h1 data-number="3" id="module-1-introduction-to-statistical-methods"><span class="header-section-number">3</span> Module 1: Introduction to
Statistical Methods</h1>
<h2 data-number="3.1" id="learning-objectives-7"><span class="header-section-number">3.1</span> Learning Objectives</h2>
<ul>
<li>Define statistics and its role in research</li>
<li>Understand the difference between descriptive and inferential
statistics</li>
<li>Identify types of data and measurement scales</li>
<li>Understand the research process and study designs</li>
<li>Recognize ethical considerations in statistical analysis</li>
</ul>
<h2 data-number="3.2" id="what-is-statistics"><span class="header-section-number">3.2</span> What is Statistics?</h2>
<p>Statistics is the science of collecting, organizing, analyzing,
interpreting, and presenting data. It provides methods for making
inferences about populations from samples and for quantifying
uncertainty.</p>
<p><strong>Key terms:</strong> - <strong>Population</strong>: Complete
set of individuals or objects of interest - <strong>Sample</strong>:
Subset of the population used for study - <strong>Parameter</strong>:
Numerical characteristic of a population - <strong>Statistic</strong>:
Numerical characteristic of a sample - <strong>Variable</strong>:
Characteristic that varies among individuals</p>
<h2 data-number="3.3" id="branches-of-statistics"><span class="header-section-number">3.3</span> Branches of Statistics</h2>
<h3 data-number="3.3.1" id="descriptive-statistics"><span class="header-section-number">3.3.1</span> 1. Descriptive
Statistics</h3>
<ul>
<li>Organize and summarize data</li>
<li>Describe main features of a dataset</li>
<li>Include measures of central tendency, dispersion, and
distribution</li>
</ul>
<h3 data-number="3.3.2" id="inferential-statistics"><span class="header-section-number">3.3.2</span> 2. Inferential
Statistics</h3>
<ul>
<li>Make inferences about populations from samples</li>
<li>Test hypotheses and draw conclusions</li>
<li>Include estimation, hypothesis testing, and prediction</li>
</ul>
<h2 data-number="3.4" id="types-of-data"><span class="header-section-number">3.4</span> Types of Data</h2>
<h3 data-number="3.4.1" id="by-nature"><span class="header-section-number">3.4.1</span> By Nature</h3>
<ul>
<li><strong>Quantitative</strong>: Numerical measurements
<ul>
<li><strong>Discrete</strong>: Countable values (e.g., number of
children)</li>
<li><strong>Continuous</strong>: Measurable values (e.g., height,
weight)</li>
</ul></li>
<li><strong>Qualitative</strong>: Categorical measurements
<ul>
<li><strong>Nominal</strong>: Categories without order (e.g., gender,
blood type)</li>
<li><strong>Ordinal</strong>: Categories with order (e.g., education
level, pain scale)</li>
</ul></li>
</ul>
<h3 data-number="3.4.2" id="by-measurement-scale"><span class="header-section-number">3.4.2</span> By Measurement Scale</h3>
<ul>
<li><strong>Nominal</strong>: Categories, no quantitative meaning</li>
<li><strong>Ordinal</strong>: Ordered categories, unequal intervals</li>
<li><strong>Interval</strong>: Equal intervals, no true zero</li>
<li><strong>Ratio</strong>: Equal intervals, true zero point</li>
</ul>
<h2 data-number="3.5" id="the-research-process"><span class="header-section-number">3.5</span> The Research Process</h2>
<h3 data-number="3.5.1" id="problem-identification"><span class="header-section-number">3.5.1</span> 1. Problem
Identification</h3>
<ul>
<li>Define research question</li>
<li>Review existing literature</li>
<li>Formulate hypotheses</li>
</ul>
<h3 data-number="3.5.2" id="study-design"><span class="header-section-number">3.5.2</span> 2. Study Design</h3>
<ul>
<li>Choose appropriate design</li>
<li>Determine sample size</li>
<li>Select measurement methods</li>
</ul>
<h3 data-number="3.5.3" id="data-collection"><span class="header-section-number">3.5.3</span> 3. Data Collection</h3>
<ul>
<li>Implement data collection procedures</li>
<li>Ensure data quality</li>
<li>Maintain ethical standards</li>
</ul>
<h3 data-number="3.5.4" id="data-analysis"><span class="header-section-number">3.5.4</span> 4. Data Analysis</h3>
<ul>
<li>Clean and prepare data</li>
<li>Apply statistical methods</li>
<li>Interpret results</li>
</ul>
<h3 data-number="3.5.5" id="reporting-results"><span class="header-section-number">3.5.5</span> 5. Reporting Results</h3>
<ul>
<li>Present findings clearly</li>
<li>Draw appropriate conclusions</li>
<li>Suggest future research</li>
</ul>
<h2 data-number="3.6" id="study-designs-in-research"><span class="header-section-number">3.6</span> Study Designs in Research</h2>
<h3 data-number="3.6.1" id="experimental-designs"><span class="header-section-number">3.6.1</span> Experimental Designs</h3>
<ul>
<li><strong>Randomized Controlled Trials (RCTs)</strong>: Gold standard
for establishing causality</li>
<li><strong>Quasi-experimental</strong>: Intervention without
randomization</li>
<li><strong>Field Experiments</strong>: Natural setting
interventions</li>
</ul>
<h3 data-number="3.6.2" id="observational-designs"><span class="header-section-number">3.6.2</span> Observational Designs</h3>
<ul>
<li><strong>Cohort Studies</strong>: Follow groups over time</li>
<li><strong>Case-Control Studies</strong>: Compare cases and
controls</li>
<li><strong>Cross-Sectional Studies</strong>: Snapshot at single
point</li>
<li><strong>Ecological Studies</strong>: Population-level data</li>
</ul>
<h2 data-number="3.7" id="ethical-considerations-1"><span class="header-section-number">3.7</span> Ethical Considerations</h2>
<h3 data-number="3.7.1" id="key-principles"><span class="header-section-number">3.7.1</span> Key Principles</h3>
<ul>
<li><strong>Respect for persons</strong>: Informed consent, voluntary
participation</li>
<li><strong>Beneficence</strong>: Maximize benefits, minimize harms</li>
<li><strong>Justice</strong>: Fair distribution of benefits and
burdens</li>
<li><strong>Confidentiality</strong>: Protect participant privacy</li>
</ul>
<h3 data-number="3.7.2" id="statistical-ethics"><span class="header-section-number">3.7.2</span> Statistical Ethics</h3>
<ul>
<li><strong>Data integrity</strong>: Accurate data collection and
analysis</li>
<li><strong>Transparency</strong>: Clear reporting of methods and
results</li>
<li><strong>Objectivity</strong>: Avoid bias in analysis and
interpretation</li>
<li><strong>Reproducibility</strong>: Enable verification of
results</li>
</ul>
<h2 data-number="3.8" id="software-tools-for-statistics"><span class="header-section-number">3.8</span> Software Tools for
Statistics</h2>
<h3 data-number="3.8.1" id="statistical-software"><span class="header-section-number">3.8.1</span> Statistical Software</h3>
<ul>
<li><strong>R</strong>: Free, powerful statistical programming
language</li>
<li><strong>Python</strong>: General programming with statistical
libraries</li>
<li><strong>SPSS</strong>: User-friendly interface for statistical
analysis</li>
<li><strong>SAS</strong>: Enterprise statistical software</li>
<li><strong>Stata</strong>: Comprehensive statistical package</li>
</ul>
<h3 data-number="3.8.2" id="data-visualization"><span class="header-section-number">3.8.2</span> Data Visualization</h3>
<ul>
<li><strong>Tableau</strong>: Interactive data visualization</li>
<li><strong>Power BI</strong>: Business intelligence and analytics</li>
<li><strong>ggplot2 (R)</strong>: Advanced plotting capabilities</li>
<li><strong>matplotlib (Python)</strong>: Flexible plotting library</li>
</ul>
<h2 data-number="3.9" id="summary-7"><span class="header-section-number">3.9</span> Summary</h2>
<p>Statistical methods provide the tools for extracting meaningful
insights from data. Understanding the fundamentals of statistics is
essential for conducting valid research and making evidence-based
decisions in health sciences and beyond.</p>
<h2 data-number="3.10" id="key-takeaways"><span class="header-section-number">3.10</span> Key Takeaways</h2>
<ul>
<li>Statistics involves collecting, analyzing, and interpreting
data</li>
<li>Descriptive statistics summarize data, inferential statistics make
predictions</li>
<li>Data types determine appropriate statistical methods</li>
<li>Research follows systematic process from question to conclusion</li>
<li>Ethical considerations are crucial in statistical practice</li>
</ul>
<h2 data-number="3.11" id="practice-questions"><span class="header-section-number">3.11</span> Practice Questions</h2>
<ol type="1">
<li>What is the difference between a population and a sample?</li>
<li>Give examples of nominal, ordinal, interval, and ratio data.</li>
<li>Why are ethical considerations important in statistical
analysis?</li>
<li>Name three statistical software packages and their main uses.</li>
</ol>
<h2 data-number="3.12" id="further-reading"><span class="header-section-number">3.12</span> Further Reading</h2>
<ul>
<li>Kirkwood BR, Sterne JAC. Essential Medical Statistics. 2nd
ed. Oxford: Blackwell Science; 2003</li>
<li>Bland M. An Introduction to Medical Statistics. 3rd ed. Oxford:
Oxford University Press; 2000</li>
<li>Daniel WW. Biostatistics: A Foundation for Analysis in the Health
Sciences. 7th ed. New York: Wiley; 1999 # Module 2: Descriptive
Statistics</li>
</ul>
<h2 data-number="3.13" id="learning-objectives-8"><span class="header-section-number">3.13</span> Learning Objectives</h2>
<ul>
<li>Understand measures of central tendency</li>
<li>Calculate and interpret measures of dispersion</li>
<li>Describe data distributions</li>
<li>Create and interpret data visualizations</li>
<li>Understand sampling distributions</li>
</ul>
<h2 data-number="3.14" id="measures-of-central-tendency"><span class="header-section-number">3.14</span> Measures of Central
Tendency</h2>
<h3 data-number="3.14.1" id="mean-arithmetic-average"><span class="header-section-number">3.14.1</span> Mean (Arithmetic
Average)</h3>
<p><strong>Formula</strong>: <span class="math inline">$\bar{x} =
\frac{\sum x_i}{n}$</span></p>
<p><strong>Example</strong>: Test scores: 85, 90, 78, 92, 88 Mean = (85
+ 90 + 78 + 92 + 88) / 5 = 86.6</p>
<p><strong>Advantages</strong>: - Uses all data points - Mathematically
useful - Foundation for many statistical tests</p>
<p><strong>Disadvantages</strong>: - Affected by extreme values
(outliers) - Not appropriate for ordinal data</p>
<h3 data-number="3.14.2" id="median-middle-value"><span class="header-section-number">3.14.2</span> Median (Middle Value)</h3>
<p><strong>Calculation</strong>: - Sort data in ascending order - For
odd n: Middle value - For even n: Average of two middle values</p>
<p><strong>Example</strong>: Ages: 23, 25, 28, 30, 35 Median = 28</p>
<p><strong>Advantages</strong>: - Not affected by outliers - Appropriate
for ordinal data - Easy to understand</p>
<h3 data-number="3.14.3" id="mode-most-frequent-value"><span class="header-section-number">3.14.3</span> Mode (Most Frequent
Value)</h3>
<p><strong>Definition</strong>: Value that appears most frequently</p>
<p><strong>Example</strong>: Blood types: A, B, AB, A, O, A Mode = A</p>
<p><strong>Uses</strong>: - Categorical data - Identifying most common
category - Bimodal/multimodal distributions</p>
<h2 data-number="3.15" id="measures-of-dispersion"><span class="header-section-number">3.15</span> Measures of Dispersion</h2>
<h3 data-number="3.15.1" id="range"><span class="header-section-number">3.15.1</span> Range</h3>
<p><strong>Formula</strong>: Range = Maximum - Minimum</p>
<p><strong>Example</strong>: Heights: 160, 165, 170, 175, 180 cm Range =
180 - 160 = 20 cm</p>
<p><strong>Limitations</strong>: - Only uses extreme values - Affected
by outliers - No information about data distribution</p>
<h3 data-number="3.15.2" id="variance"><span class="header-section-number">3.15.2</span> Variance</h3>
<p><strong>Population Variance</strong>: <span class="math inline">$\sigma^2 = \frac{\sum (x_i - \mu)^2}{N}$</span></p>
<p><strong>Sample Variance</strong>: <span class="math inline">$s^2 =
\frac{\sum (x_i - \bar{x})^2}{n-1}$</span></p>
<p><strong>Interpretation</strong>: Average squared deviation from
mean</p>
<h3 data-number="3.15.3" id="standard-deviation"><span class="header-section-number">3.15.3</span> Standard Deviation</h3>
<p><strong>Formula</strong>: <span class="math inline">$s =
\sqrt{s^2}$</span></p>
<p><strong>Example</strong>: Data: 10, 12, 14, 16, 18 Mean = 14,
Variance = 8, SD = √8 ≈ 2.83</p>
<p><strong>Coefficient of Variation</strong>: CV = (s/mean) × 100%</p>
<h2 data-number="3.16" id="data-distributions"><span class="header-section-number">3.16</span> Data Distributions</h2>
<h3 data-number="3.16.1" id="normal-distribution"><span class="header-section-number">3.16.1</span> Normal Distribution</h3>
<ul>
<li>Bell-shaped, symmetric</li>
<li>Mean = Median = Mode</li>
<li>68% within 1 SD, 95% within 2 SD, 99.7% within 3 SD</li>
<li>Many statistical tests assume normality</li>
</ul>
<h3 data-number="3.16.2" id="skewness"><span class="header-section-number">3.16.2</span> Skewness</h3>
<ul>
<li><strong>Positive skew</strong>: Tail extends to right</li>
<li><strong>Negative skew</strong>: Tail extends to left</li>
<li><strong>Symmetric</strong>: No skew</li>
</ul>
<h3 data-number="3.16.3" id="kurtosis"><span class="header-section-number">3.16.3</span> Kurtosis</h3>
<ul>
<li><strong>Mesokurtic</strong>: Normal peakedness</li>
<li><strong>Leptokurtic</strong>: More peaked than normal</li>
<li><strong>Platykurtic</strong>: Less peaked than normal</li>
</ul>
<h2 data-number="3.17" id="data-visualization-1"><span class="header-section-number">3.17</span> Data Visualization</h2>
<h3 data-number="3.17.1" id="histograms"><span class="header-section-number">3.17.1</span> Histograms</h3>
<ul>
<li>Show frequency distribution</li>
<li>Bar chart for continuous data</li>
<li>Height represents frequency</li>
</ul>
<h3 data-number="3.17.2" id="box-plots-box-and-whisker-plots"><span class="header-section-number">3.17.2</span> Box Plots (Box-and-Whisker
Plots)</h3>
<ul>
<li>Show median, quartiles, outliers</li>
<li>Box: IQR (Q3-Q1)</li>
<li>Whiskers: 1.5 × IQR</li>
<li>Points: Outliers</li>
</ul>
<h3 data-number="3.17.3" id="scatter-plots"><span class="header-section-number">3.17.3</span> Scatter Plots</h3>
<ul>
<li>Show relationship between two variables</li>
<li>X-axis: Independent variable</li>
<li>Y-axis: Dependent variable</li>
<li>Pattern indicates correlation</li>
</ul>
<h3 data-number="3.17.4" id="bar-charts-and-pie-charts"><span class="header-section-number">3.17.4</span> Bar Charts and Pie
Charts</h3>
<ul>
<li>Categorical data</li>
<li>Bar charts: Compare categories</li>
<li>Pie charts: Show proportions</li>
</ul>
<h2 data-number="3.18" id="sampling-distributions"><span class="header-section-number">3.18</span> Sampling Distributions</h2>
<h3 data-number="3.18.1" id="central-limit-theorem"><span class="header-section-number">3.18.1</span> Central Limit Theorem</h3>
<ul>
<li>Sample means follow normal distribution</li>
<li>Regardless of population distribution</li>
<li>For sufficiently large samples (n ≥ 30)</li>
</ul>
<h3 data-number="3.18.2" id="standard-error"><span class="header-section-number">3.18.2</span> Standard Error</h3>
<p><strong>Formula</strong>: <span class="math inline">$SE =
\frac{s}{\sqrt{n}}$</span></p>
<p><strong>Interpretation</strong>: Standard deviation of sampling
distribution</p>
<p><strong>Uses</strong>: - Confidence interval calculation - Hypothesis
testing - Sample size determination</p>
<h2 data-number="3.19" id="summary-8"><span class="header-section-number">3.19</span> Summary</h2>
<p>Descriptive statistics provide the foundation for understanding data.
Measures of central tendency describe typical values, while measures of
dispersion describe variability. Data visualization helps identify
patterns and outliers, and sampling distributions form the basis for
inferential statistics.</p>
<h2 data-number="3.20" id="key-takeaways-1"><span class="header-section-number">3.20</span> Key Takeaways</h2>
<ul>
<li>Mean, median, and mode describe central tendency</li>
<li>Range, variance, and standard deviation measure dispersion</li>
<li>Normal distribution is fundamental to many statistical methods</li>
<li>Data visualization aids in understanding and communication</li>
<li>Sampling distributions enable inference about populations</li>
</ul>
<h2 data-number="3.21" id="practice-questions-1"><span class="header-section-number">3.21</span> Practice Questions</h2>
<ol type="1">
<li>Calculate mean, median, and mode for: 12, 15, 18, 15, 20, 22,
15</li>
<li>What is the difference between variance and standard deviation?</li>
<li>How does skewness affect data interpretation?</li>
<li>When should you use a histogram vs. a bar chart?</li>
</ol>
<h2 data-number="3.22" id="further-reading-1"><span class="header-section-number">3.22</span> Further Reading</h2>
<ul>
<li>Moore DS, McCabe GP, Craig BA. Introduction to the Practice of
Statistics. 8th ed. New York: W.H. Freeman; 2014</li>
<li>Agresti A, Franklin C. Statistics: The Art and Science of Learning
from Data. 4th ed. Pearson; 2018</li>
<li>Devore JL. Probability and Statistics for Engineering and the
Sciences. 9th ed. Cengage Learning; 2015 # Module 3: Probability
Theory</li>
</ul>
<h2 data-number="3.23" id="learning-objectives-9"><span class="header-section-number">3.23</span> Learning Objectives</h2>
<ul>
<li>Understand basic probability concepts</li>
<li>Calculate probabilities using different rules</li>
<li>Work with common probability distributions</li>
<li>Understand conditional probability and independence</li>
<li>Apply Bayes’ theorem</li>
</ul>
<h2 data-number="3.24" id="basic-probability-concepts"><span class="header-section-number">3.24</span> Basic Probability
Concepts</h2>
<h3 data-number="3.24.1" id="probability"><span class="header-section-number">3.24.1</span> Probability</h3>
<p><strong>Definition</strong>: Measure of likelihood that an event will
occur</p>
<p><strong>Range</strong>: 0 ≤ P(A) ≤ 1 - P(A) = 0: Impossible event -
P(A) = 1: Certain event</p>
<h3 data-number="3.24.2" id="sample-space"><span class="header-section-number">3.24.2</span> Sample Space</h3>
<p><strong>Definition</strong>: All possible outcomes of an
experiment</p>
<p><strong>Examples</strong>: - Coin flip: {Heads, Tails} - Die roll:
{1, 2, 3, 4, 5, 6}</p>
<h3 data-number="3.24.3" id="events"><span class="header-section-number">3.24.3</span> Events</h3>
<ul>
<li><strong>Simple event</strong>: Single outcome</li>
<li><strong>Compound event</strong>: Combination of outcomes</li>
<li><strong>Mutually exclusive</strong>: Cannot occur together</li>
<li><strong>Independent</strong>: Occurrence doesn’t affect other
events</li>
</ul>
<h2 data-number="3.25" id="probability-rules"><span class="header-section-number">3.25</span> Probability Rules</h2>
<h3 data-number="3.25.1" id="addition-rule"><span class="header-section-number">3.25.1</span> Addition Rule</h3>
<p><strong>For mutually exclusive events</strong>: P(A ∪ B) = P(A) +
P(B)</p>
<p><strong>For non-mutually exclusive events</strong>: P(A ∪ B) = P(A) +
P(B) - P(A ∩ B)</p>
<h3 data-number="3.25.2" id="multiplication-rule"><span class="header-section-number">3.25.2</span> Multiplication Rule</h3>
<p><strong>For independent events</strong>: P(A ∩ B) = P(A) × P(B)</p>
<p><strong>For dependent events</strong>: P(A ∩ B) = P(A) × P(B|A)</p>
<h3 data-number="3.25.3" id="complement-rule"><span class="header-section-number">3.25.3</span> Complement Rule</h3>
<p>P(A’) = 1 - P(A)</p>
<h3 data-number="3.25.4" id="conditional-probability"><span class="header-section-number">3.25.4</span> Conditional Probability</h3>
<p><strong>Formula</strong>: P(A|B) = P(A ∩ B) / P(B)</p>
<p><strong>Example</strong>: Probability of having disease given
positive test</p>
<h2 data-number="3.26" id="bayes-theorem"><span class="header-section-number">3.26</span> Bayes’ Theorem</h2>
<h3 data-number="3.26.1" id="formula"><span class="header-section-number">3.26.1</span> Formula</h3>
<p>P(A|B) = [P(B|A) × P(A)] / P(B)</p>
<h3 data-number="3.26.2" id="extended-form"><span class="header-section-number">3.26.2</span> Extended Form</h3>
<p>P(A|B) = [P(B|A) × P(A)] / [P(B|A) × P(A) + P(B|A’) × P(A’)]</p>
<h3 data-number="3.26.3" id="applications"><span class="header-section-number">3.26.3</span> Applications</h3>
<ul>
<li>Medical diagnosis</li>
<li>Spam filtering</li>
<li>Risk assessment</li>
<li>Quality control</li>
</ul>
<h2 data-number="3.27" id="common-probability-distributions"><span class="header-section-number">3.27</span> Common Probability
Distributions</h2>
<h3 data-number="3.27.1" id="discrete-distributions"><span class="header-section-number">3.27.1</span> Discrete Distributions</h3>
<h4 data-number="3.27.1.1" id="binomial-distribution"><span class="header-section-number">3.27.1.1</span> Binomial Distribution</h4>
<ul>
<li>Fixed number of trials (n)</li>
<li>Each trial: success/failure</li>
<li>Constant probability of success (p)</li>
<li>Independent trials</li>
</ul>
<p><strong>Mean</strong>: μ = n × p <strong>Variance</strong>: σ² = n ×
p × (1-p)</p>
<p><strong>Example</strong>: Number of heads in 10 coin flips</p>
<h4 data-number="3.27.1.2" id="poisson-distribution"><span class="header-section-number">3.27.1.2</span> Poisson Distribution</h4>
<ul>
<li>Counts rare events</li>
<li>Events occur randomly over time/space</li>
<li>Constant average rate (λ)</li>
</ul>
<p><strong>Mean = Variance = λ</strong></p>
<p><strong>Example</strong>: Number of accidents per day</p>
<h3 data-number="3.27.2" id="continuous-distributions"><span class="header-section-number">3.27.2</span> Continuous
Distributions</h3>
<h4 data-number="3.27.2.1" id="normal-distribution-1"><span class="header-section-number">3.27.2.1</span> Normal Distribution</h4>
<ul>
<li>Bell-shaped, symmetric</li>
<li>Defined by mean (μ) and standard deviation (σ)</li>
<li>68-95-99.7 rule</li>
</ul>
<p><strong>Standard Normal</strong>: μ = 0, σ = 1
<strong>Z-score</strong>: z = (x - μ) / σ</p>
<h4 data-number="3.27.2.2" id="t-distribution"><span class="header-section-number">3.27.2.2</span> t-Distribution</h4>
<ul>
<li>Similar to normal but with heavier tails</li>
<li>Used for small samples</li>
<li>Degrees of freedom = n - 1</li>
</ul>
<h4 data-number="3.27.2.3" id="chi-square-distribution"><span class="header-section-number">3.27.2.3</span> Chi-Square
Distribution</h4>
<ul>
<li>Sum of squared standard normal variables</li>
<li>Used for goodness of fit and independence tests</li>
<li>Degrees of freedom vary</li>
</ul>
<h2 data-number="3.28" id="expected-value-and-variance"><span class="header-section-number">3.28</span> Expected Value and
Variance</h2>
<h3 data-number="3.28.1" id="expected-value-mean"><span class="header-section-number">3.28.1</span> Expected Value (Mean)</h3>
<p><strong>Discrete</strong>: E[X] = Σ x × P(x)</p>
<p><strong>Continuous</strong>: E[X] = ∫ x × f(x) dx</p>
<h3 data-number="3.28.2" id="variance-1"><span class="header-section-number">3.28.2</span> Variance</h3>
<p>Var(X) = E[X²] - (E[X])²</p>
<h3 data-number="3.28.3" id="properties"><span class="header-section-number">3.28.3</span> Properties</h3>
<ul>
<li>E[aX + b] = aE[X] + b</li>
<li>Var(aX + b) = a²Var(X)</li>
<li>Var(X + Y) = Var(X) + Var(Y) (if independent)</li>
</ul>
<h2 data-number="3.29" id="summary-9"><span class="header-section-number">3.29</span> Summary</h2>
<p>Probability theory provides the foundation for statistical inference.
Understanding probability rules, distributions, and concepts like
conditional probability and Bayes’ theorem is essential for advanced
statistical analysis and decision-making under uncertainty.</p>
<h2 data-number="3.30" id="key-takeaways-2"><span class="header-section-number">3.30</span> Key Takeaways</h2>
<ul>
<li>Probability measures likelihood of events</li>
<li>Addition and multiplication rules combine probabilities</li>
<li>Conditional probability depends on additional information</li>
<li>Bayes’ theorem updates probabilities with new evidence</li>
<li>Different distributions model different types of data</li>
</ul>
<h2 data-number="3.31" id="practice-questions-2"><span class="header-section-number">3.31</span> Practice Questions</h2>
<ol type="1">
<li>If P(A) = 0.3 and P(B) = 0.4, what is P(A ∪ B) if A and B are
mutually exclusive?</li>
<li>A test has 95% sensitivity and 90% specificity. If disease
prevalence is 10%, what is the probability that a positive test
indicates disease?</li>
<li>What is the difference between binomial and Poisson
distributions?</li>
<li>Calculate the expected value of rolling a fair die.</li>
</ol>
<h2 data-number="3.32" id="further-reading-2"><span class="header-section-number">3.32</span> Further Reading</h2>
<ul>
<li>Ross SM. Introduction to Probability Models. 12th ed. Academic
Press; 2019</li>
<li>Blitzstein JK, Hwang J. Introduction to Probability. 2nd ed. Chapman
&amp; Hall/CRC; 2019</li>
<li>Pitman J. Probability. Springer; 1993 # Module 4: Inferential
Statistics</li>
</ul>
<h2 data-number="3.33" id="learning-objectives-10"><span class="header-section-number">3.33</span> Learning Objectives</h2>
<ul>
<li>Understand sampling and sampling distributions</li>
<li>Calculate and interpret confidence intervals</li>
<li>Perform hypothesis testing</li>
<li>Understand Type I and Type II errors</li>
<li>Interpret p-values and statistical significance</li>
</ul>
<h2 data-number="3.34" id="sampling-theory"><span class="header-section-number">3.34</span> Sampling Theory</h2>
<h3 data-number="3.34.1" id="populations-and-samples"><span class="header-section-number">3.34.1</span> Populations and Samples</h3>
<ul>
<li><strong>Population</strong>: Complete set of interest</li>
<li><strong>Sample</strong>: Subset used for inference</li>
<li><strong>Sampling frame</strong>: List of population elements</li>
<li><strong>Sampling methods</strong>: Random, stratified, cluster,
systematic</li>
</ul>
<h3 data-number="3.34.2" id="sampling-distributions-1"><span class="header-section-number">3.34.2</span> Sampling Distributions</h3>
<ul>
<li><strong>Sampling distribution</strong>: Distribution of a statistic
over many samples</li>
<li><strong>Standard error</strong>: Standard deviation of sampling
distribution</li>
<li><strong>Central Limit Theorem</strong>: Sample means approach normal
distribution</li>
</ul>
<h2 data-number="3.35" id="confidence-intervals"><span class="header-section-number">3.35</span> Confidence Intervals</h2>
<h3 data-number="3.35.1" id="concept"><span class="header-section-number">3.35.1</span> Concept</h3>
<ul>
<li>Range of values likely to contain true population parameter</li>
<li>Based on sample data and desired confidence level</li>
</ul>
<h3 data-number="3.35.2" id="formula-for-mean-σ-known"><span class="header-section-number">3.35.2</span> Formula for Mean (σ
known)</h3>
<p>CI = <span class="math inline">$\bar{x} \pm z \times
\frac{\sigma}{\sqrt{n}}$</span></p>
<h3 data-number="3.35.3" id="formula-for-mean-σ-unknown"><span class="header-section-number">3.35.3</span> Formula for Mean (σ
unknown)</h3>
<p>CI = <span class="math inline">$\bar{x} \pm t \times
\frac{s}{\sqrt{n}}$</span></p>
<h3 data-number="3.35.4" id="formula-for-proportion"><span class="header-section-number">3.35.4</span> Formula for Proportion</h3>
<p>CI = <span class="math inline">$p \pm z
\sqrt{\frac{p(1-p)}{n}}$</span></p>
<h3 data-number="3.35.5" id="interpretation"><span class="header-section-number">3.35.5</span> Interpretation</h3>
<ul>
<li>95% CI: 95% confidence that interval contains true parameter</li>
<li>Wider intervals: More uncertainty</li>
<li>Factors affecting width: Sample size, variability, confidence
level</li>
</ul>
<h2 data-number="3.36" id="hypothesis-testing"><span class="header-section-number">3.36</span> Hypothesis Testing</h2>
<h3 data-number="3.36.1" id="steps-in-hypothesis-testing"><span class="header-section-number">3.36.1</span> Steps in Hypothesis
Testing</h3>
<ol type="1">
<li><p><strong>State hypotheses</strong></p>
<ul>
<li>H₀: Null hypothesis (no effect/difference)</li>
<li>H₁: Alternative hypothesis (effect/difference exists)</li>
</ul></li>
<li><p><strong>Choose significance level (α)</strong></p>
<ul>
<li>Common values: 0.05, 0.01, 0.10</li>
</ul></li>
<li><p><strong>Select test statistic</strong></p></li>
<li><p><strong>Determine critical value or p-value</strong></p></li>
<li><p><strong>Make decision</strong></p>
<ul>
<li>Reject H₀ if p &lt; α</li>
<li>Fail to reject H₀ if p ≥ α</li>
</ul></li>
</ol>
<h3 data-number="3.36.2" id="types-of-errors"><span class="header-section-number">3.36.2</span> Types of Errors</h3>
<ul>
<li><strong>Type I Error (α)</strong>: Reject true H₀ (false
positive)</li>
<li><strong>Type II Error (β)</strong>: Fail to reject false H₀ (false
negative)</li>
<li><strong>Power (1-β)</strong>: Probability of correctly rejecting
false H₀</li>
</ul>
<h3 data-number="3.36.3" id="power-analysis"><span class="header-section-number">3.36.3</span> Power Analysis</h3>
<p><strong>Factors affecting power</strong>: - Sample size (primary
factor) - Effect size - Significance level (α) - Variability</p>
<p><strong>Sample size formula</strong>: n = [(zα + zβ)/δ]² × σ²</p>
<h2 data-number="3.37" id="common-statistical-tests"><span class="header-section-number">3.37</span> Common Statistical Tests</h2>
<h3 data-number="3.37.1" id="parametric-tests-normal-data-equal-variances"><span class="header-section-number">3.37.1</span> Parametric Tests (Normal
data, equal variances)</h3>
<h4 data-number="3.37.1.1" id="one-sample-t-test"><span class="header-section-number">3.37.1.1</span> One-sample t-test</h4>
<ul>
<li>Compare sample mean to known value</li>
<li>H₀: μ = μ₀</li>
</ul>
<h4 data-number="3.37.1.2" id="two-sample-t-test"><span class="header-section-number">3.37.1.2</span> Two-sample t-test</h4>
<ul>
<li>Compare means of two groups</li>
<li>Independent samples or paired</li>
</ul>
<h4 data-number="3.37.1.3" id="one-way-anova"><span class="header-section-number">3.37.1.3</span> One-way ANOVA</h4>
<ul>
<li>Compare means of three or more groups</li>
<li>Tests if at least one group differs</li>
</ul>
<h4 data-number="3.37.1.4" id="pearson-correlation"><span class="header-section-number">3.37.1.4</span> Pearson Correlation</h4>
<ul>
<li>Measure linear relationship between variables</li>
<li>Range: -1 to +1</li>
</ul>
<h3 data-number="3.37.2" id="non-parametric-tests-no-normality-assumption"><span class="header-section-number">3.37.2</span> Non-parametric Tests (No
normality assumption)</h3>
<h4 data-number="3.37.2.1" id="chi-square-test"><span class="header-section-number">3.37.2.1</span> Chi-square test</h4>
<ul>
<li>Test independence of categorical variables</li>
<li>Goodness of fit</li>
</ul>
<h4 data-number="3.37.2.2" id="mann-whitney-u-test"><span class="header-section-number">3.37.2.2</span> Mann-Whitney U test</h4>
<ul>
<li>Compare two independent groups</li>
<li>Alternative to t-test</li>
</ul>
<h4 data-number="3.37.2.3" id="kruskal-wallis-test"><span class="header-section-number">3.37.2.3</span> Kruskal-Wallis test</h4>
<ul>
<li>Compare three or more independent groups</li>
<li>Alternative to ANOVA</li>
</ul>
<h4 data-number="3.37.2.4" id="spearman-correlation"><span class="header-section-number">3.37.2.4</span> Spearman correlation</h4>
<ul>
<li>Measure monotonic relationship</li>
<li>Alternative to Pearson correlation</li>
</ul>
<h2 data-number="3.38" id="p-values-and-significance"><span class="header-section-number">3.38</span> p-Values and Significance</h2>
<h3 data-number="3.38.1" id="p-value-definition"><span class="header-section-number">3.38.1</span> p-Value Definition</h3>
<ul>
<li>Probability of observing data as extreme as sample data, assuming H₀
true</li>
<li>Smaller p-values: Stronger evidence against H₀</li>
</ul>
<h3 data-number="3.38.2" id="significance-levels"><span class="header-section-number">3.38.2</span> Significance Levels</h3>
<ul>
<li><strong>p &lt; 0.05</strong>: Statistically significant</li>
<li><strong>p &lt; 0.01</strong>: Highly significant</li>
<li><strong>p &lt; 0.001</strong>: Very highly significant</li>
</ul>
<h3 data-number="3.38.3" id="misconceptions"><span class="header-section-number">3.38.3</span> Misconceptions</h3>
<ul>
<li>p-value ≠ probability that H₀ is true</li>
<li>p-value ≠ importance of result</li>
<li>Statistical significance ≠ clinical significance</li>
</ul>
<h2 data-number="3.39" id="effect-size"><span class="header-section-number">3.39</span> Effect Size</h2>
<h3 data-number="3.39.1" id="importance"><span class="header-section-number">3.39.1</span> Importance</h3>
<ul>
<li>Magnitude of relationship or difference</li>
<li>Independent of sample size</li>
<li>More meaningful than p-values</li>
</ul>
<h3 data-number="3.39.2" id="common-measures"><span class="header-section-number">3.39.2</span> Common Measures</h3>
<ul>
<li><strong>Cohen’s d</strong>: Standardized mean difference</li>
<li><strong>Odds ratio</strong>: For categorical outcomes</li>
<li><strong>Relative risk</strong>: For incidence data</li>
<li><strong>R²</strong>: Proportion of variance explained</li>
</ul>
<h2 data-number="3.40" id="summary-10"><span class="header-section-number">3.40</span> Summary</h2>
<p>Inferential statistics allow us to make conclusions about populations
from sample data. Confidence intervals provide estimates with
uncertainty, while hypothesis testing helps determine if observed
effects are real. Understanding Type I/II errors, power, and effect
sizes is crucial for proper interpretation of statistical results.</p>
<h2 data-number="3.41" id="key-takeaways-3"><span class="header-section-number">3.41</span> Key Takeaways</h2>
<ul>
<li>Sampling distributions enable inference about populations</li>
<li>Confidence intervals estimate parameters with uncertainty</li>
<li>Hypothesis testing evaluates evidence against null hypothesis</li>
<li>Type I/II errors represent different kinds of mistakes</li>
<li>Effect size measures practical importance of results</li>
</ul>
<h2 data-number="3.42" id="practice-questions-3"><span class="header-section-number">3.42</span> Practice Questions</h2>
<ol type="1">
<li>What is the difference between a confidence interval and a
hypothesis test?</li>
<li>Explain Type I and Type II errors with examples.</li>
<li>How does sample size affect statistical power?</li>
<li>Why is effect size important in addition to p-values?</li>
</ol>
<h2 data-number="3.43" id="further-reading-3"><span class="header-section-number">3.43</span> Further Reading</h2>
<ul>
<li>Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd
ed. Lawrence Erlbaum Associates; 1988</li>
<li>Cumming G. Understanding the New Statistics: Effect Sizes,
Confidence Intervals, and Meta-Analysis. Routledge; 2012</li>
<li>Kirk RE. Experimental Design: Procedures for the Behavioral
Sciences. 4th ed. Sage Publications; 2012 # Module 5: Parametric
Statistical Tests</li>
</ul>
<h2 data-number="3.44" id="learning-objectives-11"><span class="header-section-number">3.44</span> Learning Objectives</h2>
<ul>
<li>Understand assumptions of parametric tests</li>
<li>Perform and interpret t-tests</li>
<li>Conduct ANOVA and post-hoc tests</li>
<li>Calculate and interpret correlation coefficients</li>
<li>Understand linear regression</li>
</ul>
<h2 data-number="3.45" id="assumptions-of-parametric-tests"><span class="header-section-number">3.45</span> Assumptions of Parametric
Tests</h2>
<h3 data-number="3.45.1" id="normality"><span class="header-section-number">3.45.1</span> Normality</h3>
<ul>
<li>Data follows normal distribution</li>
<li>Check with histograms, Q-Q plots, Shapiro-Wilk test</li>
<li>Central Limit Theorem helps with large samples</li>
</ul>
<h3 data-number="3.45.2" id="homoscedasticity-equal-variances"><span class="header-section-number">3.45.2</span> Homoscedasticity (Equal
Variances)</h3>
<ul>
<li>Variances equal across groups</li>
<li>Test with Levene’s test or Bartlett’s test</li>
<li>Important for t-tests and ANOVA</li>
</ul>
<h3 data-number="3.45.3" id="independence"><span class="header-section-number">3.45.3</span> Independence</h3>
<ul>
<li>Observations independent of each other</li>
<li>Violated in repeated measures designs</li>
<li>Important for all parametric tests</li>
</ul>
<h3 data-number="3.45.4" id="linearity"><span class="header-section-number">3.45.4</span> Linearity</h3>
<ul>
<li>Relationship between variables is linear</li>
<li>Check with scatter plots</li>
<li>Important for correlation and regression</li>
</ul>
<h2 data-number="3.46" id="t-tests"><span class="header-section-number">3.46</span> t-Tests</h2>
<h3 data-number="3.46.1" id="one-sample-t-test-1"><span class="header-section-number">3.46.1</span> One-Sample t-Test</h3>
<p><strong>Purpose</strong>: Test if sample mean differs from known
population mean</p>
<p><strong>Formula</strong>: t = (x̄ - μ₀) / (s / √n)</p>
<p><strong>Example</strong>: Test if average height differs from
national average</p>
<h3 data-number="3.46.2" id="independent-samples-t-test"><span class="header-section-number">3.46.2</span> Independent Samples
t-Test</h3>
<p><strong>Purpose</strong>: Compare means of two independent groups</p>
<p><strong>Formula</strong>: t = (x̄₁ - x̄₂) / √[(s₁²/n₁) + (s₂²/n₂)]</p>
<p><strong>Assumptions</strong>: - Independent observations - Normal
distribution in each group - Equal variances (or use Welch’s
correction)</p>
<h3 data-number="3.46.3" id="paired-t-test"><span class="header-section-number">3.46.3</span> Paired t-Test</h3>
<p><strong>Purpose</strong>: Compare means of two related groups</p>
<p><strong>Formula</strong>: t = (x̄_d) / (s_d / √n)</p>
<p>Where x̄_d is mean of differences</p>
<p><strong>Uses</strong>: - Before-after studies - Matched pairs -
Repeated measures</p>
<h2 data-number="3.47" id="analysis-of-variance-anova"><span class="header-section-number">3.47</span> Analysis of Variance
(ANOVA)</h2>
<h3 data-number="3.47.1" id="one-way-anova-1"><span class="header-section-number">3.47.1</span> One-Way ANOVA</h3>
<p><strong>Purpose</strong>: Compare means of three or more groups</p>
<p><strong>Logic</strong>: Partition total variation into between-group
and within-group</p>
<p><strong>F-statistic</strong>: F = MS_between / MS_within</p>
<p><strong>Post-hoc tests</strong>: - Tukey’s HSD: Compare all pairs -
Bonferroni: Control family-wise error - Dunnett’s: Compare to control
group</p>
<h3 data-number="3.47.2" id="two-way-anova"><span class="header-section-number">3.47.2</span> Two-Way ANOVA</h3>
<p><strong>Purpose</strong>: Examine effects of two factors and their
interaction</p>
<p><strong>Model</strong>: Y = μ + A + B + AB + ε</p>
<p><strong>Main effects</strong>: Effect of each factor alone
<strong>Interaction</strong>: Combined effect of factors</p>
<h3 data-number="3.47.3" id="repeated-measures-anova"><span class="header-section-number">3.47.3</span> Repeated Measures ANOVA</h3>
<p><strong>Purpose</strong>: Compare means across multiple time points
or conditions</p>
<p><strong>Advantages</strong>: - Controls for individual differences -
Requires fewer subjects - More powerful than independent groups</p>
<h2 data-number="3.48" id="correlation-analysis"><span class="header-section-number">3.48</span> Correlation Analysis</h2>
<h3 data-number="3.48.1" id="pearson-correlation-1"><span class="header-section-number">3.48.1</span> Pearson Correlation</h3>
<p><strong>Purpose</strong>: Measure strength and direction of linear
relationship</p>
<p><strong>Formula</strong>: r = Σ[(x_i - x̄)(y_i - ȳ)] / √[Σ(x_i - x̄)²
Σ(y_i - ȳ)²]</p>
<p><strong>Interpretation</strong>: - +1: Perfect positive correlation -
0: No linear relationship - -1: Perfect negative correlation</p>
<p><strong>Hypothesis testing</strong>: t = r √[(n-2)/(1-r²)]</p>
<h3 data-number="3.48.2" id="correlation-vs.-causation"><span class="header-section-number">3.48.2</span> Correlation
vs. Causation</h3>
<ul>
<li>Correlation does not imply causation</li>
<li>Third variable may explain relationship</li>
<li>Experimental design needed for causality</li>
</ul>
<h2 data-number="3.49" id="linear-regression"><span class="header-section-number">3.49</span> Linear Regression</h2>
<h3 data-number="3.49.1" id="simple-linear-regression"><span class="header-section-number">3.49.1</span> Simple Linear
Regression</h3>
<p><strong>Model</strong>: Y = β₀ + β₁X + ε</p>
<p><strong>Parameters</strong>: - β₀: Intercept (Y when X=0) - β₁: Slope
(change in Y per unit X) - ε: Error term</p>
<p><strong>Estimation</strong>: Least squares method</p>
<h3 data-number="3.49.2" id="multiple-linear-regression"><span class="header-section-number">3.49.2</span> Multiple Linear
Regression</h3>
<p><strong>Model</strong>: Y = β₀ + β₁X₁ + β₂X₂ + … + βₖXₖ + ε</p>
<p><strong>Assumptions</strong>: - Linearity - Independence -
Homoscedasticity - Normality of residuals</p>
<h3 data-number="3.49.3" id="model-evaluation"><span class="header-section-number">3.49.3</span> Model Evaluation</h3>
<ul>
<li><strong>R²</strong>: Proportion of variance explained</li>
<li><strong>Adjusted R²</strong>: Penalizes for additional
variables</li>
<li><strong>F-test</strong>: Overall model significance</li>
<li><strong>t-tests</strong>: Individual coefficient significance</li>
</ul>
<h3 data-number="3.49.4" id="regression-diagnostics"><span class="header-section-number">3.49.4</span> Regression Diagnostics</h3>
<ul>
<li><strong>Residual plots</strong>: Check assumptions</li>
<li><strong>Influential points</strong>: Cook’s distance</li>
<li><strong>Multicollinearity</strong>: VIF &gt; 10</li>
<li><strong>Outliers</strong>: Standardized residuals &gt; 3</li>
</ul>
<h2 data-number="3.50" id="summary-11"><span class="header-section-number">3.50</span> Summary</h2>
<p>Parametric tests provide powerful tools for comparing groups and
examining relationships when assumptions are met. Understanding test
assumptions, proper interpretation, and appropriate use of post-hoc
tests is essential for valid statistical analysis.</p>
<h2 data-number="3.51" id="key-takeaways-4"><span class="header-section-number">3.51</span> Key Takeaways</h2>
<ul>
<li>Parametric tests require normality and equal variances</li>
<li>t-tests compare means between groups</li>
<li>ANOVA extends t-tests to multiple groups</li>
<li>Correlation measures linear relationships</li>
<li>Regression predicts outcomes from predictors</li>
</ul>
<h2 data-number="3.52" id="practice-questions-4"><span class="header-section-number">3.52</span> Practice Questions</h2>
<ol type="1">
<li>What are the main assumptions of parametric tests?</li>
<li>When should you use a paired t-test vs. independent samples
t-test?</li>
<li>Explain the difference between one-way and two-way ANOVA.</li>
<li>How do you interpret an R² value in regression?</li>
</ol>
<h2 data-number="3.53" id="further-reading-4"><span class="header-section-number">3.53</span> Further Reading</h2>
<ul>
<li>Kutner MH, Nachtsheim CJ, Neter J, Li W. Applied Linear Statistical
Models. 5th ed. McGraw-Hill/Irwin; 2005</li>
<li>Montgomery DC, Peck EA, Vining GG. Introduction to Linear Regression
Analysis. 5th ed. Wiley; 2012</li>
<li>Draper NR, Smith H. Applied Regression Analysis. 3rd ed. Wiley; 1998
# Module 6: Non-Parametric Statistical Tests</li>
</ul>
<h2 data-number="3.54" id="learning-objectives-12"><span class="header-section-number">3.54</span> Learning Objectives</h2>
<ul>
<li>Understand when to use non-parametric tests</li>
<li>Perform and interpret chi-square tests</li>
<li>Apply Mann-Whitney and Kruskal-Wallis tests</li>
<li>Use Spearman’s correlation</li>
<li>Understand non-parametric alternatives</li>
</ul>
<h2 data-number="3.55" id="when-to-use-non-parametric-tests"><span class="header-section-number">3.55</span> When to Use Non-Parametric
Tests</h2>
<h3 data-number="3.55.1" id="advantages"><span class="header-section-number">3.55.1</span> Advantages</h3>
<ul>
<li><strong>No normality assumption</strong>: Work with any
distribution</li>
<li><strong>Ordinal data</strong>: Appropriate for ranked data</li>
<li><strong>Robust</strong>: Less affected by outliers</li>
<li><strong>Small samples</strong>: Often more powerful with small
n</li>
</ul>
<h3 data-number="3.55.2" id="disadvantages"><span class="header-section-number">3.55.2</span> Disadvantages</h3>
<ul>
<li><strong>Less powerful</strong>: May miss real effects with normal
data</li>
<li><strong>Less precise</strong>: Often only test for differences, not
magnitude</li>
<li><strong>Ordinal results</strong>: May lose information from
continuous data</li>
</ul>
<h3 data-number="3.55.3" id="decision-criteria"><span class="header-section-number">3.55.3</span> Decision Criteria</h3>
<ul>
<li>Data not normally distributed</li>
<li>Ordinal or nominal data</li>
<li>Small sample sizes</li>
<li>Presence of outliers</li>
</ul>
<h2 data-number="3.56" id="chi-square-tests"><span class="header-section-number">3.56</span> Chi-Square Tests</h2>
<h3 data-number="3.56.1" id="chi-square-goodness-of-fit"><span class="header-section-number">3.56.1</span> Chi-Square Goodness of
Fit</h3>
<p><strong>Purpose</strong>: Test if observed frequencies match expected
distribution</p>
<p><strong>Formula</strong>: χ² = Σ [(O_i - E_i)² / E_i]</p>
<p><strong>Example</strong>: Test if die is fair - Expected: Each face
1/6 = 16.67 - Observed: 20, 15, 18, 16, 17, 14</p>
<h3 data-number="3.56.2" id="chi-square-test-of-independence"><span class="header-section-number">3.56.2</span> Chi-Square Test of
Independence</h3>
<p><strong>Purpose</strong>: Test if two categorical variables are
independent</p>
<p><strong>Contingency table</strong>:</p>
<pre><code>         Variable B
Variable A | B1 | B2 | Total
-----------|----|----|------
A1        |    |    |
A2        |    |    |
-----------|----|----|------
Total     |    |    |</code></pre>
<p><strong>Formula</strong>: Same as goodness of fit, but for all
cells</p>
<p><strong>Expected frequency</strong>: E_ij = (Row total × Column
total) / Grand total</p>
<h3 data-number="3.56.3" id="fishers-exact-test"><span class="header-section-number">3.56.3</span> Fisher’s Exact Test</h3>
<p><strong>Purpose</strong>: Alternative to chi-square for small
samples</p>
<p><strong>Uses</strong>: 2×2 tables with small expected frequencies
(&lt;5)</p>
<h2 data-number="3.57" id="mann-whitney-u-test-1"><span class="header-section-number">3.57</span> Mann-Whitney U Test</h2>
<h3 data-number="3.57.1" id="purpose"><span class="header-section-number">3.57.1</span> Purpose</h3>
<ul>
<li>Compare two independent groups</li>
<li>Alternative to independent samples t-test</li>
<li>Works with ordinal or continuous data</li>
</ul>
<h3 data-number="3.57.2" id="logic"><span class="header-section-number">3.57.2</span> Logic</h3>
<ul>
<li>Rank all observations combined</li>
<li>Compare sum of ranks between groups</li>
<li>Test if groups come from same distribution</li>
</ul>
<h3 data-number="3.57.3" id="formula-1"><span class="header-section-number">3.57.3</span> Formula</h3>
<p>U = n₁n₂ + n₁(n₁+1)/2 - R₁</p>
<p>Where R₁ is sum of ranks in group 1</p>
<h3 data-number="3.57.4" id="effect-size-1"><span class="header-section-number">3.57.4</span> Effect Size</h3>
<p>r = |z| / √(n₁ + n₂)</p>
<h2 data-number="3.58" id="kruskal-wallis-test-1"><span class="header-section-number">3.58</span> Kruskal-Wallis Test</h2>
<h3 data-number="3.58.1" id="purpose-1"><span class="header-section-number">3.58.1</span> Purpose</h3>
<ul>
<li>Compare three or more independent groups</li>
<li>Extension of Mann-Whitney test</li>
<li>Alternative to one-way ANOVA</li>
</ul>
<h3 data-number="3.58.2" id="logic-1"><span class="header-section-number">3.58.2</span> Logic</h3>
<ul>
<li>Rank all observations</li>
<li>Compare mean ranks between groups</li>
<li>Chi-square approximation for large samples</li>
</ul>
<h3 data-number="3.58.3" id="post-hoc-tests"><span class="header-section-number">3.58.3</span> Post-hoc Tests</h3>
<ul>
<li>Dunn’s test for pairwise comparisons</li>
<li>Bonferroni correction for multiple tests</li>
</ul>
<h2 data-number="3.59" id="wilcoxon-signed-rank-test"><span class="header-section-number">3.59</span> Wilcoxon Signed-Rank Test</h2>
<h3 data-number="3.59.1" id="purpose-2"><span class="header-section-number">3.59.1</span> Purpose</h3>
<ul>
<li>Compare two related samples</li>
<li>Alternative to paired t-test</li>
<li>Works with ordinal data</li>
</ul>
<h3 data-number="3.59.2" id="procedure"><span class="header-section-number">3.59.2</span> Procedure</h3>
<ol type="1">
<li>Calculate differences between pairs</li>
<li>Rank absolute differences</li>
<li>Assign signs based on direction</li>
<li>Test if positive and negative ranks balanced</li>
</ol>
<h2 data-number="3.60" id="spearmans-rank-correlation"><span class="header-section-number">3.60</span> Spearman’s Rank
Correlation</h2>
<h3 data-number="3.60.1" id="purpose-3"><span class="header-section-number">3.60.1</span> Purpose</h3>
<ul>
<li>Measure monotonic relationship between variables</li>
<li>Alternative to Pearson correlation</li>
<li>Works with ordinal data</li>
</ul>
<h3 data-number="3.60.2" id="calculation"><span class="header-section-number">3.60.2</span> Calculation</h3>
<ol type="1">
<li>Rank both variables</li>
<li>Calculate Pearson correlation on ranks</li>
</ol>
<p><strong>Formula</strong>: r_s = 1 - (6Σd_i²) / (n(n²-1))</p>
<h2 data-number="3.61" id="summary-12"><span class="header-section-number">3.61</span> Summary</h2>
<p>Non-parametric tests provide robust alternatives when parametric
assumptions are not met. They work with ordinal data and non-normal
distributions, making them valuable tools for real-world data
analysis.</p>
<h2 data-number="3.62" id="key-takeaways-5"><span class="header-section-number">3.62</span> Key Takeaways</h2>
<ul>
<li>Non-parametric tests don’t require normality assumptions</li>
<li>Chi-square tests analyze categorical data</li>
<li>Mann-Whitney and Kruskal-Wallis compare groups using ranks</li>
<li>Wilcoxon signed-rank test compares paired data</li>
<li>Spearman’s correlation measures monotonic relationships</li>
</ul>
<h2 data-number="3.63" id="practice-questions-5"><span class="header-section-number">3.63</span> Practice Questions</h2>
<ol type="1">
<li>When should you choose non-parametric over parametric tests?</li>
<li>How does the Mann-Whitney U test work?</li>
<li>What is the difference between chi-square goodness of fit and test
of independence?</li>
<li>How do you interpret Spearman’s correlation coefficient?</li>
</ol>
<h2 data-number="3.64" id="further-reading-5"><span class="header-section-number">3.64</span> Further Reading</h2>
<ul>
<li>Siegel S, Castellan NJ. Nonparametric Statistics for the Behavioral
Sciences. 2nd ed. McGraw-Hill; 1988</li>
<li>Conover WJ. Practical Nonparametric Statistics. 3rd ed. Wiley;
1999</li>
<li>Hollander M, Wolfe DA, Chicken E. Nonparametric Statistical Methods.
3rd ed. Wiley; 2013</li>
</ul>
</body>
</html>
